21st Annual Resident Research Day in Medicine

The 21st Annual Residents’ Research Day in Medicine was held at the Hamilton Golf and Country Club on Wednesday May 26, 2010.

Seventy-one abstracts were accepted, hav-ing been reviewed by Drs. Azim Gangji, Jennie Johnstone and Fred Spencer. Due to the large number of abstracts accepted this year, two teams of two were identified for judging the clinical posters - Drs. Khalid Azzam and Michelle Gagnon and Drs. Nader Khalidi and Omid Salehian. Drs. David Armstrong, Deborah Cook and Madhu Natarajan took on the role of Scientific and Oral Judges, along with Dr. Paul O’Byrne as Chair of the judging. This full-day event included judging of 41 Clinical and 16 Scientific poster presentations, the noon-hour plenary talk and 10 Oral presentations. The event continued with refreshments, socializing and the awards ceremony.

The plenary session, “Following your Passion

- Pursuing a Career in Research” with Dr. Sonia Anand, was enjoyed by a large audience of resi-dents and faculty. Dr. Paul O’Byrne thanked Dr. Anand as well as Drs. Shariq Haider and Parveen Wasi for their continued efforts in instilling inter-est in the practice of research in our residents.

As Director of Resident Research, Dr. Haider thanked the judges and faculty research mentors for their commitment. Recognition was extended to the residents for the quality of their work and the high degree of participation. Dr. Haider promoted awareness of the annual Core IM Resident Research Award which supports train-ees in pursuing original research while gaining early exposure and practical experience around all aspects of research.

2010 Resident Research Grant recipients Dr. Deborah Siegal $5,000

2010 Oral Presenters: first row Shariq Haider Director, Viktoria Pavlova PGY5 Rheumatology, Sherryn Rambihar PGY 5 Cardiology, Aalok Kumar PGY2 Medicine, Aziz Walele PGY 5 Nephrology, Christine Ribic PGY4 Nephrology; back row, Lindsay Crabbe PGY2 Medicine, Mohamed Panju PGY3 Medi-cine, Doug Wright PGY2 Medicine, Rajveer Hundal PGY1 Medicine, Mukesh Khandelwal PGY4 Nephrology

2010 Oral Presenters

108

Ethanol Lock to Prevent Bloodstream Infection in Home Parenteral Nutrition Patients - Pilot Study Supervisors: Dr. D. Armstrong and Dr. S. Haider

Dr. Rajveer Hundal and Dr. Zain Kassam $4500 Randomized Controlled Trial of Fecal Transplant vs Oral Vancoymycin Therapy for Treatment of Refractory C. Difficile Associated Diarrhea Supervisor: Dr. Christine Lee

Oral PresentationsGold Medal: Sherryn Rambihar, PGY5 Cardiology Resting Heart Rate and Mortality in a Large Cohort of Patients with Stable Coronary Disease: An Analysis of the ONTARGET/TRANSCEND Program Supervisor: Dr. Eva Lonn

Silver Medal: Douglas Wright, PGY2 Medicine Defining and Optimizing Collaboration between Emergency Medicine and Internal Medicine Physicians Supervisors: Drs. Jonathan Sherbino and Ameen Patel

Bronze Medal: Viktoria Pavlova, PGY5 Rheumatology Renal Transplantation in Highly Sensitized Patients: Ánalysis of a Novel Mechanism for Antibody Depletion and Transplantation Outcomes Supervisor: Dr. Azim Gangji

Scientific Poster Medal1st prize: Vincent Ki, PGY3 Medicine Hamilton Stethoscope Hygiene Study - Efficacy of Chlorhexidine and Isopropyl Alcohol Wipes in Disinfecting Diaphragms of Stethoscopes Supervisor: Dr. Christine Lee

2nd prize: Mohamed Panju, Dean Raso, PGY3 Medicine Evaluation of the Use of DVT Prophylaxis in Medical Patients in Hamilton: A Retrospective Analysis Supervisors: Drs. Ameen Patel, Akbar Panju, Jeff Ginsberg

Clinical Poster Medal1st prize: Christine Ribic, PGY 4 Nephrology Statin-Associated Rhabdomyolysis: Is there a Dose-Response Relationship? Supervisor: Dr. Anne Holbrook

2nd prize: Thomas Haffner, Lindsay Crabbe, PGY2 Medicine A Breathtaking Presentation of Metastatic Renal Cell Carcinoma Supervisor: Dr. Sebastien Hotte

Residency Program AwardsDr. Haider introduced and welcomed Dr.

William Walsh who personally presented the William J. Walsh Internist Award to the senior general internal medicine resident who demon-strates excellence in clinical care and teaching - Christian Kraeker, PGY4 GIM.

Dr. Ameen Patel presented the annual Jeff Ginsberg Subspecialty Resident Award which demonstrates excellence in professionalism, leadership and education. This award has been made possible by a generous donation from a patient of Dr. Jeff Ginsberg. Nominees are received from Subspecialty Program Directors for a resident who consistently displays out-standing performance in clinical rotations, excellence in teaching, research and exemplary professionalism and commitment to academic achievement. The 2010 recipient was Craig Ainsworth, PGY5 Cardiology.

The resident-nominated and resident-selected 2010 Faculty Internist and Subspecialty Awards for excellence in clinical teaching were present-ed by Internal Medicine Residents Drs. Ronen Behar and Sam Elfassy. Nominees for the 2010 General Internal Medicine Award were Drs. R. Hanmiah, K. Azzam, Z. Khalid, with Ameen Patel and Will Harper jointly receiving the award. The 2010 Subspecialist Award nominees were Drs.

Sherryn Rambihar Oral Gold Medalist, presented by Shariq Haider

Gold Medal (1st Prize Oral)

M. Gagnon, T. Karachi, M. Soth and S. Haider, with Deborah Cook receiving the award.

This year’s Residency Training Program Faculty Appreciation Award was presented to Mr. Dwayne Martins, Manager in the Department of Medicine. Dwayne has supported all the Program’s initiatives and has worked tirelessly to help us achieve these goals. We wish him success in his new role with the Schulich School of Medicine and Dentistry at the University of Western Ontario.

2010 Resident Awards Dr. Parveen Wasi announced the resident nom-

inees and winners of the following awards:

Nominees for the PGY3 CMR Award for Excellence in Clinical Competence and Teaching: Each of the three CTU Directors nominate indi-viduals they feel have had a strong presence on the CTU and demonstrated excellence in educa-tion, administration and professional responsi-bility, serving as a role model for junior trainees. Nominees: MUMC - S. Elfassy, J. Paikin, R. Dahlan; SJH - M. Tsang, R. Behar, P. Sahni; HGH - H. AlShamsi, K. Legault, V. Ki. Based on the above criteria the award went to V. Ki and M. Tsang.

Nominees for the PGY2 Dr. Hui Lee Award for Excellence in Clinical Care and Teaching:Residents nominated for this award have consis-tently shown excellence in clinical performance, strong educational involvement with the under-graduate program and demonstration of exem-plary professionalism. Nominees based on the above criteria are: L. Crabbe, J. Cohen, Z. Kassam, D. Wright, H-O Chung and the win-ners were Z. Kassam and D. Wright.

Resident Program Contribution: Through the involvement and support of many residents, the Medicine Program continues to grow. Thank you to these outstanding residents who have helped make the program stronger, not only for themselves, but for their colleagues.

Education Committee Resident Representatives: Andrew Burke, Chris Hillis, Han-Oh Chung, Zain Kassam, Ronen Behar, Sam Elfassy

E-Curriculum: Mike Tsang, Juan Guzman,

•

•

Vincent Ki, Puja Sahni, Sachin Chopra, Simon Oczkowski

Survival Guide Chairs: Alex Bojcevski, Farzana Bacchus

Academic Half Day: Jeremy Cohen, Lindsay Crabbe

Journal Club Chairs: Mohamed Panju, Abbas Merali, John Neary

Managerial Curriculum: Andrew Burke, Raj Hundal, Chris Hillis

TREAT Curriculum: Zain Kassam, Andrew Burke, Simon Oczkowski, Raj Hundal, Ian Mazzetti

Hospital Recognition AwardsHHS MSA: Senior Resident Award: Kim Legault Junior Resident Award: Douglas Wright

SJH David L. Feldman Internal Medicine Award nominee: Kim Legault

Subspecialty Rotation AwardThe Outstanding Subspecialty Rotation, a new

award, will be presented annually to the rotation that consistently delivers exemplary educational experience to the residents. The first recipient is Nephrology. An engraved plaque was presented to Drs. Darin Treleaven and David Russell on behalf of their program.

Gail Trevisani Program Administrator Internal Medicine Residency Program

•

•

•

•

•

•

•

Subspecialist Award to Deborah Cook presented by residents Ronen Behar and Sam Elfassy

2010 Subspecialist Award

110

Professor and Chair O’Byrne, Paul M. Respirology

Professor Emeritus Banerjee, Sikhar Physical Medicine and Rehabilitation Bayne, Ronald J. Geriatrics Churchill, David N. Nephrology Clark, David A. Clinical Immunology and Allergy Daniel, Edwin E. Neurology Dwyer, Daniel E. General Internal Medicine Fallen, Ernest L. Cardiology Hargreave, Frederick E. Respirology Heigenhauser, George J.F. Respirology Hirsh, Jack Hematology and Thromboembolism Jones, Norman L. Respirology Kwan, David C.Y. Cardiology Laidlaw, John C. General Internal Medicine Ludwin, David Nephrology Mandell, Lionel A. Infectious Diseases McComas, Alan J. Neurology Morse, John L.C. Respirology Muir, David C.F. Respirology Neufeld, Victor R. General Internal Medicine Powles, Peter A.C. Critical Care/ Respirology Rangachari, P.K. Gastroenterology Robinson, John G. Cardiology Rosenthal, Donald Dermatology Smith, E.K.M. (Kinsey) Nephrology Sweeney, George D. Gastroenterology/ Clinical Pharmacology and TherapeuticsTanser, Paul H. Cardiology Tsega, Edemariam General Internal Medicine Turpie, A. Graham General Internal Medicine /Hematology and Thromboembolism Turpie, Irene D. Geriatrics Walsh, William J. General Internal Medicine Werstiuk, Eva Hematology and Thromboembolism

Endowed Chairs and Professorships Adachi, Rick Alliance For Better Bone Health Chair In Rheumatology Anand, Sonia Eli Lilly Canada/May Cohen Chair In Women’s Health Anand, Sonia Heart And Stroke Foundation Of Ontario/Michael G.

DeGroote Chair In Population Health Research Austin, Richard Amgen Canada Chair In Nephrology Baker, Steven Hamilton Hospitals Assessment Centre Endowed Professorship In Neuromuscular Disease Collins, Stephen GlaxoSmithKline Chair In Gastroenterology Connolly, Stuart Salim Yusuf Chair In CardiologyDenburg, Judah William J. Walsh Professorship In Medicine O‘Donnell, Martin William J. Walsh Chair In General Internal MedicineGerstein, Hertzel Population Health Institute Chair In Diabetes Research And Care Ginsberg, Jeffrey David Braley And Nancy Gordon Chair In Thromboembolic DiseaseLarché, Mark McMaster University/GlaxoSmithKline Chair in Lung Immunology at St. Joseph’s Healthcare Moayyedi, Paul Richard Hunt-AstraZeneca Chair In GastroenterologyMolloy, William St. Peter’s/McMaster Chair In Aging O’Byrne, Paul Moran Campbell Chair In Respiratory Medicine Panju, Akbar Medard DeGroote Chair In Medicine Papaioannou, Alexandra Eli Lilly Canada Chair In Osteoporosis Sahlas, Demetrios Michael G. DeGroote Professorship In Stroke Management Sears, Malcolm AstraZeneca Chair In Respiratory Epidemiology Turnbull, John Andrew Bruce Douglas Chair In Neurology Wallace, John Farncombe Family Chair In Digestive Health ResearchWeitz, Jeffrey Heart And Stroke Foundation Of Ontario/J. Fraser Mustard Chair In Cardiovascular Research Yusuf, Salim Heart And Stroke Foundation Of Ontario/Marion W. Burke Chair In Cardiovascular Disease

Geographic Full-Time Professor Adachi, Jonathan Rheumatology Anand, Sonia Cardiology/ Thromboembolism/ General Internal Medicine

Faculty

Austin, Richard Nephrology Buller, Christopher Cardiology Collins, Stephen M. GastroenterologyConnolly, Stuart J. Cardiology Cook, Deborah J. Critical Care/General Internal MedicineCox, Gerry Respirology Crowther, Mark A. Hematology and ThromboembolismDenburg, Judah A. Clinical Immunology and Allergy Douketis, James D. General Internal Medicine/ Hematology and Thromboembolism Fuller, Hugh D. General Internal Medicine Gerstein, Hertzel C. Endocrinology Ginsberg, Jeffrey Hematology and ThromboembolismGrover, Ashok K. GastroenterologyHart, Lawrence E. Rheumatology Holbrook, Anne M. General Internal Medicine/Clinical Pharmacology and Therapeutics Holder, Douglas A. Cardiology Huizinga, Jan GastroenterologyHunt, Richard H. GastroenterologyIngram, Alistair J. Nephrology Jaeschke, Roman Z. Critical Care/NeurologyJanssen, Luke J. Respirology Kearon, Clive M. Respirology/ Hematology and ThromboembolismKelton, John G. Hematology and ThromboembolismKillian, Kieran J. Respirology Larché, Mark Clinical Immunology and Allergy Leber, Brian F. Hematology and ThromboembolismLonn, Eva M. Cardiology Lumb, Barry J. GastroenterologyMazurek, Michael F. Neurology McIvor, R. Andrew Respirology McKelvie, Robert S. Cardiology Moayyedi, Paul GastroenterologyMolloy, William D. Geriatrics Morillo, Carlos Cardiology Morillo, Luis Neurology O’Byrne, Paul M. RespirologyPanju, Akbar A. General Internal Medicine Papaioannou, Alexandra Geriatrics/ Rheumatology Patel, Ameen General Internal Medicine Patterson, Christopher J. Geriatrics Rathbone, Michel P. Neurology Rodger, Ian Respirology Schulman, Sam Hematology and Thromboembolism

Sears, Malcolm R. Respirology Spencer, Frederick Cardiology/Hematology and ThromboembolismTeo, Koon Cardiology Turnbull, John D. Neurology Upton, Adrian R.M. Neurology Walker, Irwin R. Hematology and ThromboembolismWallace, John GastroenterologyWaserman, Susan Clinical Immunology and Allergy Wasi, Parveen Hematology and ThromboembolismWeitz, Jeffrey I. Hematology and Thromboembolism Yusuf, Salim Cardiology

Associate Professor Allen, Christopher J. Respirology Arck, Petra Clinical Immunology and Allergy Arlen, Dianne J. Nephrology Armstrong, David GastroenterologyBates, Shannon Hematology and ThromboembolismBrimble, Scott Nephrology Carlisle, Euan J.F. Nephrology Clase, Catherine Nephrology Cowan, David Geriatrics Cunnington, John P.W. General Internal Medicine Demers, Catherine Cardiology Dokainish, Hisham Cardiology Dorasamy, Punginathn General Internal Medicine/ RespirologyEikelboom, John Hematology and ThromboembolismEl-Helou, Philippe Infectious DiseasesFox-Robichaud, Alison Critical Care Freitag, Andreas P. Respirology/Critical Care Gagnon, Micheline D.M. Geriatrics Ganguli, Subhas GastroenterologyGauvreau, Gail Respirology Gilani, Ammar Neurology Goodacre, Robert L. GastroenterologyGordon, Elaine P. Cardiology Gross, Peter Hematology and ThromboembolismHaider, Shariq General Internal Medicine/Infectious Diseases Hanmiah, Rajendar General Internal Medicine Harper, William General Internal Medicine/ Endocrinology Harvey, David T. Physical Medicine and Rehabilitation Healey, Jeff Cardiology Heddle, Ms. Nancy Hematology and Thromboembolism

112

FACULTY

Hunt, Dereck General Internal Medicine/ Endocrinology Inman, Mark Respirology Jones, Graham L. Critical Care Kamath, Mark Cardiology/NeurologyKarachi, Tim Critical Care/General Internal Medicine/ Respirology Keith, Paul K. Clinical Immunology and Allergy Kerigan, Anthony T. Respirology/GeriatricsKolb, Martin Respirology Kraus, Peter Critical Care Krepinsky, Joan Nephrology Lester, Frances T. General Internal Medicine Liaw, Patricia Hematology and ThromboembolismLima, Hermenio Dermatology Linkins, Lori-Ann Hematology and ThromboembolismMargetts, Peter Nephrology Marr, Sharon Geriatrics/General Internal MedicineMarshall, John GastroenterologyMcMullin, Joseph General Internal Medicine Meade, Maureen Critical Care Mehta, Shamir Cardiology Misiaszek, Brian Geriatrics Montgomery, Alison Cardiology Morgan, David G. GastroenterologyMukherji, Atreyi Infectious Diseases/ General Internal MedicineMuniz, Flor Physical Medicine and Rehabilitation Mustafa, Bisher Hematology Nair, Girish Cardiology Nair, Parameswaran Respirology Natarajan, Madhu K. Cardiology Prebtani, Ally Endocrinology/General Internal MedicineRabbat, Chris Nephrology Rokoss, Mike Cardiology Russell, David J. Nephrology Sahlas, Demetrios Neurology Salena, Bruno J. GastroenterologySehmi, Roma Respirology Spyropoulos, Alex Hematology and ThromboembolismStanton, Eric B. Cardiology Steinberg, Gregory Endocrinology Talman, Marianne General Internal Medicine Tang, Damu Nephrology Tomlinson, Charles W. Cardiology Treleaven, Darin Nephrology Valettas, Nicholas Cardiology Velianou, James L. Cardiology Welsford, Michelle Emergency Medicine

Werstuck, Geoff Hematology and ThromboembolismWoo, Tricia Geriatrics Worster, Andrew Emergency MedicineYegappan, Chidambaram Neurology

Assistant Professor O’Leary, Ms. Deniece General Internal Medicine St. Onge, Joye Geriatrics Azzam, Khalid General Internal Medicine Beattie, Karen Rheumatology Arnold, Donald M. Hematology and ThromboembolismBader, Mazen Infectious DiseasesBaker, Steven Physical Medicine and Rehabilitation Bercik, Premysl GastroenterologyBobba, Raja Rheumatology Carmona, Rajendra Rheumatology Chakroborty, Amitabha General Internal Medicine/Infectious Diseases Chan, Howard Hematology and ThromboembolismCrossley, John Emergency MedicineDivakaramenon, Syamkumar Cardiology Drost, Nicole Respirology Duong, MyLinh General Internal Medicine/RespirologyForsythe, Paul Respirology Ganame, Javier Cardiology Gangji, Azim Nephrology Greenwald, Eric GastroenterologyJolly, Sanjit Cardiology Joseph, Geena General Internal Medicine/NephrologyLabiris, N. Renée Respirology Larché, Margaret Rheumatology/ Clinical Immunology and Allergy Legassie, Jenny General Internal Medicine Leontiadis, Grigorios GastroenterologyLim, Wendy Hematology and ThromboembolismLuthra, Meera Endocrinology/General Internal MedicineMagloire, Patrick M. Cardiology Matsos, Mark Rheumatology Mazzadi, Sergio General Internal Medicine/ GastroenterologyMcCoy, Kathy GastroenterologyMohammed, Naufal Neurology/General Internal MedicineNeighbour, Helen Clinical Immunology and Allergy/RespirologyPerri, Dan Clinical Pharmacology and TherapeuticsPunthakee, Zubin Endocrinology

Rashid, Shirya Hematology and ThromboembolismRibas, C. Sebastian Cardiology Rudkowski, Jill General Internal Medicine Salehian, Omid Cardiology Shapiro, Michelle Neurology Sherbino, Jonathan Emergency MedicineSheth, Tej Cardiology Singhal, Nishma Infectious DiseasesSoth, Mark Respirology/Critical Care Spaziani, Robert GastroenterologyTiboni, Maria General Internal Medicine Todd, David Respirology Tse, Frances GastroenterologyTsoi, Keith GastroenterologyVerdú, Elena GastroenterologyWebert, Kathryn Hematology and ThromboembolismWhittingham, Heather Critical Care Witt-Sullivan, Helga B. GastroenterologyWoodward, Kevin Infectious DiseasesYang, Robert Nephrology You, John General Internal Medicine

Joint/Associate Members Allaby, Cheryl Geriatrics Bienenstock, John Clinical Immunology and Allergy Brozek, Jan General Internal Medicine Devereaux, Philip J. General Internal Medicine/CardiologyDon-Wauchope, Andrew Endocrinology Gulenchyn, Karen General Internal Medicine Guyatt, Gordon H. General Internal Medicine/ RespirologyHaynes, R. Brian General Internal Medicine Hayward, Catherine P.M. Hematology and ThromboembolismJager, Pieter L. General Internal Medicine Levine, Mitch A.H. Clinical Pharmacology and Therapeutics/ General Internal Medicine Loeb, Mark Infectious DiseasesMarriott, Christopher General Internal Medicine Neville, Alan J. General Internal Medicine Powers, Peter J. Hematology and ThromboembolismSagar, Stephen M. General Internal Medicine Schunemann, Holger General Internal Medicine

Singnurkar, Amit Cardiology Stampfli, Martin Respirology Sur, Ranjan General Internal Medicine Tarnopolsky, Mark A. Physical Medicine and Rehabilitation Waye, John Hematology and ThromboembolismWong, Raimond General Internal Medicine Wong-Pack, William Cardiology

Part-TimeClinical Professor Bensen, William G. Rheumatology Bolli, Peter Nephrology/CardiologyBrown, William Neurology Cividino, Alfred A. Rheumatology Croitoru, Kenneth GastroenterologyDucharme, James Emergency MedicineFernandez, Peter Cardiology Higgins, David A. Respirology Kean, Walter F. Rheumatology Khan, Aliya A. Geriatrics/ Endocrinology Langella, Philippe GastroenterologyMacpherson, Andrew GastroenterologyNewhouse, Michael Respirology Rosenbloom, David Neurology Rotstein, Coleman M.F. Infectious DiseasesSharma, Arya Cardiology/ Endocrinology

Associate Clinical Professor Achong, Michael R. General Internal Medicine/ Infectious Diseases Ackerman, Margaret J. Emergency MedicineAnderson, Julia Hematology and ThromboembolismBarnes, Colin C. Nephrology Bianchi, Fernando A. Rheumatology Bradley, Christine A. Respirology/Critical Care Braun, Anne E. Geriatrics Chiba, Naoki GastroenterologyCrosby, David R. Cardiology Curnew, Gregory P. Cardiology/ General Internal MedicineDarracott, John Physical Medicine and Rehabilitation Davis, Clive Respirology Ddungu, Henry Hematology and ThromboembolismDerby, Ian R.G. Neurology Dolovich, Myrna Respirology Giammarco, Rosella Neurology Gibson, James C. General Internal Medicine/Critical CareGillett, Jane Physical Medicine and

114

FACULTY

Rehabilitation Goodwin, Susan E.B. Neurology Greenway, Keith Emergency MedicineHamielec, Cindy M. Respirology/Critical Care Hawley, Kristopher Emergency MedicineJichici, Draga Critical Care Kagoma, Peter K. Hematology and ThromboembolismKhalidi, Nader Rheumatology Kumbhare, Dinesh A. Physical Medicine and Rehabilitation/ Rheumatology Lee, Agnes Hematology and ThromboembolismMcLellan, Allan P. Respirology/Critical Care Mulji, Amin S. Cardiology O’Donnell, Martin General Internal Medicine/ Hematology and Thromboembolism/ Geriatrics Oczkowski, Wieslaw J. Neurology Paulseth, John E. Neurology Pengelly, David Respirology Perez, Gavino R.D. General Internal Medicine Prasad, Sadhana Geriatrics Pryszlak, Michael Cardiology/Nuclear Medicine Pugsley, Stewart O. Respirology Puksa, Serge Respirology/Critical Care Ramsdale, Helen E. Respirology Rossman, Richard L. GastroenterologySalama, Suzette General Internal Medicine Sealey, Brian Cardiology Seaton, Trevor L. GastroenterologySebaldt, Rolf J. Rheumatology/Clinical Pharmacology and Therapeutics Sternbach, Marion Hematology and ThromboembolismTrotter, Judy E. Physical Medicine and Rehabilitation Vender, Ronald D. Dermatology Whitehead, Lori N. Respirology Wismer, Judy Dermatology Woolfrey, Karen Emergency Medicine

Assistant Clinical ProfessorAbid, Simona Geriatrics Alexander, Michael General Internal Medicine/ Clinical Immunology and Allergy Bellissimo, Agostino Emergency MedicineBenaroia, Mark Nephrology Bentley, Todd Physical Medicine and Rehabilitation Bertley, John Respirology

Biman, Birubi Respirology Bon, Trevor General Internal Medicine Booth, John D. Endocrinology/ General Internal MedicineBoulos, Pauline Rheumatology Cavalcanti, Rodrigo General Internal Medicine Chan, Terence General Internal Medicine Chari, Vinjamuri Physical Medicine and Rehabilitation Cherian, Joe Emergency MedicineChernish, Robert General Internal Medicine Chew, Donald Neurology Chmiel, Agnes Physical Medicine and Rehabilitation Chow, Andrew Rheumatology Chow, Clara Cardiology Connolly, Michael Dermatology Crowe, Adrian Emergency MedicineCyr, Michael Clinical Immunology and Allergy De Rubeis, Debra Neurology Delrue, Andrea General Internal Medicine Didyk, Nicole Geriatrics Eby, Robbie-Jane Emergency MedicineEdstrom, Karen Dermatology Ergaiey, Houda GastroenterologyFan, Jerome Emergency MedicineFaraawi, Rafat Rheumatology Farrauto, Leo Physical Medicine and Rehabilitation Fergani, Houssein GastroenterologyFerreira, Ivone Respirology Fidler, Wesley Rheumatology Fowlis, Ronald Cardiology Frank, Peter Emergency MedicineFulford, Martha Infectious DiseasesGamble, D. Gregory Infectious DiseasesGarnis-Jones, Sylvia Dermatology Ghouse, Ali T. Physical Medicine and Rehabilitation Goode, J. Eric General Internal Medicine/ CardiologyGottschalk, Raymond Respirology Grad, Sharon Physical Medicine and Rehabilitation Graham, Ms. Colleen Geriatrics Grant, Moira Hematology and ThromboembolismGreenbaum, Joseph Clinical Immunology and Allergy Greve, Mr. Allan J. Medicine Gupta, Milan Cardiology Gwardjan, Andrew Physical Medicine and Rehabilitation Ha, Michael Emergency Medicine Hafez, Mohammed Nassoh General Internal Medicine/Critical Care

Hall, Susan E.H. Dermatology Hanna, Brian D. Rheumatology Hastings, Deborah M. Cardiology Hatcher, Michael Emergency MedicineHeckman, George Geriatrics Hentschel, Eric Respirology Hersi, Ali Emergency MedicineHess, Allan Cardiology Ho, Victoria Respirology Husein, Nadira Endocrinology Ibrahim, Khaled GastroenterologyJackson, Mary General Internal Medicine/ RespirologyJohnston, Mr. Neil Respirology Jolly, Shivinder Nephrology Jones, Glenn W. Critical Care Joshi, Atul General Internal Medicine Kaminska, Elzbieta A. Rheumatology Karimi, Khalil Clinical Immunology and Allergy Keen, Sabina Geriatrics Khan, Omar Physical Medicine and Rehabilitation Khandelwal, Mukesh Nephrology Kim, Harold Clinical Immunology and Allergy Kim, Simon General Internal Medicine Kitching, Allan D. Cardiology Klimek, Edwin Neurology Koubaesh, Yousery General Internal Medicine Kronby, Michael H. Neurology Lad, Tara L. Neurology Lagrotteria, Danny Nephrology Lai, Christopher Cardiology Lam, Leo Nephrology Lebert, Phyllis A. General Internal Medicine/Clinical Immunology and Allergy Letcher, Kevin Physical Medicine and Rehabilitation Lewis, David Geriatrics Liu, Louis GastroenterologyLiu, Tom Nephrology Lo, Raymond Neurology Lozinski, Ala Z. Dermatology MacFadyen, John General Internal Medicine Malcolm, W. Neil Critical Care Mallin, A. Rebecca Emergency MedicineMandalfino, Patricia Neurology Martin, Doug Emergency MedicineMartins, Mr. Dwayne Medicine Massarella, Carys Emergency MedicineMathoo, Julian Physical Medicine and Rehabilitation/ Rheumatology McCarron, Bonnie Hematology and Thromboembolism

McClennan, Sarah Emergency MedicineMcMillan, Richard Physical Medicine and Rehabilitation McMillan, Ron Emergency MedicineMessieh, Mary Clinical Immunology and Allergy Meyerson, Jeffrey Endocrinology Miller, Paul Emergency MedicineMizera, Ryszard General Internal Medicine Moore, Ms. Jane Hematology and ThromboembolismMorris, Catherine A.W. General Internal Medicine Muhn, Channy Dermatology Nagai, Ryuta Nephrology Nolan, Thomas General Internal Medicine/ RespirologyO’Malley, Maureen Dermatology Pallie, Sven Cardiology Pardhan, Alim Emergency MedicinePasricha, Ajai General Internal Medicine Peat, Mary I. Geriatrics Preyra, Ian Emergency MedicineQuinn, Mr. Michael Respirology Raco, Dominic Cardiology Rempel, Brenda Endocrinology Richards, Douglas Emergency MedicineRosen, Nathan Dermatology Ryan, Thomas J. General Internal Medicine/ Endocrinology Safranyos, Richard Geriatrics Salem, Khal Cardiology Sarkaria, Gagandeep Geriatrics Savelli, Gordina E. Neurology Saveriano, Nellina Dermatology Saxena, Shiv General Internal Medicine Schwarz, Dan Cardiology Scocchia, Tulio Rheumatology Sellens, Catherine Emergency MedicineSethi, Jagmeet General Internal Medicine Shaikh, Saeed Rheumatology Sharad, Sunil General Internal Medicine Sharieff, Saleem General Internal Medicine Shetty, Panduranga General Internal Medicine Silva, Jaime Neurology Sirek, Ann Endocrinology Sivji, Yasmin General Internal Medicine Smith, Kevin (Dr.) President and CEO, SJHSmith, Mr. Jim Hematology and ThromboembolismSmith, Ruth Physical Medicine and Rehabilitation Stallwood, George R. Cardiology/Critical Care

116

FACULTY

Sullivan, Brian J. Cardiology Sullivan, Hugh P. Cardiology Tihal, Hirawan Cardiology Tougas, Manon General Internal Medicine Turineck, David Emergency MedicineUpadhye, Suneel Emergency MedicineVadera, Rajiv Emergency MedicineVarey, Peter Physical Medicine and Rehabilitation Vignjevic, Peter Dermatology Visram, Farzin Critical Care/General Internal Medicine/ Respirology Vitou, Louise Nephrology Walele, Abdul Aziz Nephrology White, Fred Clinical Immunology and Allergy Whittaker, Susan Hematology and ThromboembolismWilliams, D. Josh Emergency MedicineYakemchuk, Valerie N. Hematology and Thromboembolism Yang, John Geriatrics Zawadowski, Andrew Cardiology Zimakas, George General Internal Medicine

Lecturer Lafferty, Mr. John Hematology and ThromboembolismMcFarlane, Mr. Andrew Hematology and ThromboembolismMoffat, Ms. Karen Hematology and Thromboembolism

Scholars and FellowsClinical ScholarsBainey, Kevin Cardiology Haaland, Derek Rheumatology/Clinical Immunology Johnstone, Jennie Infectious DiseasesKhalid, Zahira General Internal Medicine Khan, Khurram GastroenterologyKoo, Karen Critical Care Krakow, Elizabeth Hematology and ThromboembolismMody, Anita Cardiology O’Shea, Tim General Internal Medicine Pai, Menaka Hematology and ThromboembolismPicard, Pierre NeurologySchwalm, Jon-David CardiologySu, Winnie NephrologyTunks, Marcel RespirologyVerhovsek, Madeleine Hematology and Thromboembolism

Wu, Cynthia Hematology and ThromboembolismYakubovich, Natalia Endocrinology

Clinical FellowsAladsani, Ahmed GastroenterologyAl-Aklabi, Ali HematologyAlanazi, Safug Critical Care MedicineAl-Enezi, Farhan Z. M. A. RespirologyAlghamdi, Khalid Gastroenterology Al-Hanoot, Ibraheem GastroenterologyAl Qami, Fatimah NeurologyAl Rahimi, Jamilah Saad CardiologyAl Shahrami, Mohammed Critical Care MedicineAl-Sheef, Mohammed HematologyAlshehri, Abdulrahman HematologyAsher, Ilan Allergy & Clinical ImmunologyBokhamsen, Ali Ibrahim Critical Care Medicine Braga, Manoela EndocrinologyGoronfolah, Loie Tallat Allergy & Clinical ImmunologyPai, Menaka CIP/HematologyRaju, Nina HematologySobieraj-Teague, Magdalena Hematology

Research FellowsDonadini, Marco HematologyImaoka, Haruki Respirology

Faculty PromotionFull-timeProfessorDr. James DouketisDr. Hugh FullerDr. Lawrence HartDr. Susan Waserman

Associate ProfessorDr. David CowanDr. Ammar GilaniDr. Jeff HealeyDr. Joan KrepinskyDr. Lori-Ann LinkinsDr. Brian MisiaszekDr. Girish NairDr. Mike RokossDr. Marianne TalmanDr. Tricia WooDr. Andrew Worster (CAWAR)

Part-time Associate Clinical Professor Dr. Milan GuptaDr. Richard Mizera

Faculty ReappointmentsFull-timeDr. Raja BobbaDr. John CrossleyDr. George HeckmanDr. Margaret LarchéDr. Wendy LimDr. Patrick MagloireDr. Sergio MazzadiDr. Kathleen McCoyDr. Naufal MohammedDr. Tej ShethDr. Nishma SinghalDr. Mark SothDr. Maria TiboniDr. Elena Verdú

Part-timeDr. Michael AchongDr. Cheryl Allaby Dr. Agostino BellissimoDr. Todd Bentley Dr. Pauline BoulosDr. Alfred Cividino Dr. Adrian Crowe Dr. Greg CurnewDr. Clive Davis Dr. Ian Derby Dr. Myrna DolovichDr. Robbie-Jane EbyDr. Leonardo Farrauto Dr. Houssein FerganiDr. Ali Ghouse Dr. James GibsonDr. Jane Gillett Dr. Susan Goodwin Dr. Joseph Greenbaum Dr. Andrew GwardjanDr. Brian HannaDr. Kristopher Hawley Dr. Ali Hersi Dr. David Higgins Dr. Peter Kagoma Dr. Walter Kean Dr. Nader Khalidi Dr. Leo Lam Dr. David Lewis Dr. Rebecca Mallin Dr. Carys MassarellaDr. Julian Mathoo Dr. Allan McLellan Dr. Jeffrey Meyerson Dr. Channy Muhn Dr. Amin MuljiDr. Ryuta Nagai Dr. Serge Puksa Mr. Michael QuinnDr. Douglas Richards Dr. David Rosenbloom Dr. Richard Safranyos

Dr. Dina Savelli Dr. Trevor Seaton Dr. Catherine Sellens Dr. Saeed ShaikhDr. Yasmin SivjiDr. George Stallwood Dr. Hirawan Tihal Dr. Manon Tougas Dr. Suneel UpadhyeDr. Peter Varey Dr. Peter Vignevic Dr. Lori Whitehead Dr. Valerie Yakemchuk

New Faculty AppointmentsFull-TimeDr. Jan Brozek Clinical Immunology and AllergyDr. Christopher Buller CardiologyDr. Rajendra Carmona RheumatologyDr. Amitabha Chakroborty General Internal Medicine/Infectious DiseasesDr. Hisham Dokainish CardiologyDr. Nicole Drost RespirologyDr. Javier Ganame CardiologyDr. Geena Joseph General Internal Medicine/NephrologyDr. Jenny Legassie General Internal MedicineDr. Hermenio Lima Dermatology/Clinical Immunology and AllergyDr. Mark Matsos RheumatologyDr. Michelle Shapiro NeurologyDr. Kevin Woodward Infectious Diseases

Part-Time Dr. Simona Abid GeriatricsDr. Rodrigo Cavalcanti MedicineDr. Terence Chan General Internal MedicineDr. Andrew Chow RheumatologyDr. Andrea Delrue General Internal MedicineDr. Jerome Fan Emergency MedicineDr. Eric Goode MedicineDr. Victoria Ho RespirologyDr. Atul Joshi MedicineDr. Khalil Karimi Clinical Immunology and AllergyDr. Mukesh Khandelwal NephrologyDr. Yousery Koubaesh MedicineDr. Philippe Langella GastroenterologyDr. Neil Malcolm Critical CareDr. Patricia Mandalfino NeurologyDr. Alim Pardhan Emergency MedicineDr. Gagandeep Sarkaria GeriatricsDr. Panduranga Shetty General Internal Medicine

118

FACULTY

Mr. James Smith HematologyDr. George Zimakas Medicine

Associate MembersDr. Cheryl Allaby GeriatricsDr. Joseph Beyene MedicineDr. Amit Singnurkar CardiologyDr. William Wong-Pack Cardiology

Management StaffDwayne Martins/Annette Rosati Director of AdministrationTerry De Cola Office ManagerSharlene Honaizer Recruitment CoordinatorCathy Stampfli Tenure and Promotion CoordinatorSara Sellers Special Projects CoordinatorJan Taylor Academic Contributions CoordinatorLisa Greer Finance ManagerTammy Lintack Financial CoordinatorJakki Taylor Site Finance Coordinator, MUMC/ SJHHelen Murray Site Finance Coordinator, HGHJoanne Gadawski Site Finance Coordinator, MUMC/ SJHMelissa Robinson AFP Administrative AssistantChristopher Jones AFP Finance CoordinatorLynda Peters Payroll CoordinatorLorrie Reurink Human Resources ManagerZrinka DiVincenzo Human Resources Coordinator Erin Burda/Courtney Humes Operations Site Coordinator, MUMCLorraine Curtis/Sarah-Kai Antanaitis Operations Site Coordinator, SJHRoberta Petitti Operations Site Coordinator, HGHGail LaForme Operations Site Coordinator, HDGH, CHGail Trevisani Administrator, Internal Medicine Residency Training Program

Affiliated CentresHamilton Health SciencesMurray Martin President and CEOTeresa Smith VP Patient ServicesRichard McLean VP, Medical Affairs & QualityBrenda Flaherty Executive VP, Clinical OperationsNancy Fram VP, Professional AffairsMurray Glendining Executive VP, Corporate AffairsLouise Taylor Green VP, Human Resources and Organizational DevelopmentKathy Watts VP, Finance and CFOBarry Lumb Chief of MedicineSalim Yusuf VP, Research & Chief Scientific Officer

Thrombosis & Atherosclerosis Research Institute (TaARI)Jeff Weitz Director

Juravinski Cancer CentreWilliam Evans President

McMaster Children’s HospitalPeter Fitzgerald President

St. Peter’s HospitalDonna Cripps President

St. Joseph’s HealthcareKevin Smith President and CEODavid Higgins PresidentWinnie Doyle VP, Clinical ServicesRomeo Cercone VP, Quality, Complex Continuing CareSusan Hollis VP, Business ServicesEmma Pavlov VP, Human Resources Rebecca Repa VP, Planning, Development & DiagnosticsHugh Fuller Chief, Medicine

Father Sean O’Sullivan Research CentreIan Rodger Director

ADACHI, JDPublications

Curtis JR, Adachi JD, Saag KG. Bridging the osteopo-rosis quality chasm. J Bone Miner Res. 2009; 24:3-7.

Papaioannou A, Kennedy CC, Cranney A, Hawker G, Brown JP, Kaiser SM, Leslie WD, O’Brien CJM, Sawka AM, Khan A, Siminoski K, Tarulli G, Webster D, McGowan J, Adachi JD. Risk factors for low BMD in healthy men age 50 years or older: A Systematic review. Osteoporos Int. 2009; 20:507-18.

Wong AKO, Inglis D, Beattie KA, Doan A, Ioannidis G, Adachi JD, Papaioannou A. Reproducibility of computer-assisted joint alignment measurement in OA knee radiographs. Osteoarthritis Cartilage. 2009; 17:579-85.

Papaioannou A, Kennedy CC, Ioannidis G, Sawka A, Hopman WM, Pickard L, Brown JP, Josse RG, Kaiser S, Anastassiades T, Goltzman D, Papadimitropoulos M, Tenenhouse A, Prior JC, Olszynski WP, Adachi JD. The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int. 2009; 20:703-14.

Goldstein SR, Duvernoy CS, Calaf J, Adachi JD, Mershon JL, Dowsett SA, Agnusdei D, Stuenkel CA. Raloxifene Use in Clinical Practice: Efficacy and Safety. Menopause. 2009; 16:413-29.

Giangregorio L, Dolovich L, Cranney A, Adili A, deBeer J, Papaioannou A, Thabane L, Adachi JD. Osteoporosis risk perceptions among patients who have sustained a fragility fracture. Patient Education and Counselling. 2009; 74:213-20.

Berger C, Langsetmo L, Joseph L, Hanley DA, Davison KS, Josse RG, Prior JC, Kreiger N,Tenenhouse A, Goltzman D, and the CaMos Research Group. Association between change in bmd and fragility fracture in women and men. J Bone Miner Res. 2009; 24:361-9.

Chen P, Krege JH, Adachi JD, Prior JC, Tenenhouse A, Brown JP, Papadimitropoulos M, Kreiger N, Olszynski WP, Josse RG, Goltzman D. Vertebral fracture status and the World Health Organization (WHO) Risk factors for predicting osteoporotic fracture risk. J Bone Miner Res. 2009; 24:495-502.

Adachi JD. Glucocorticoid-induced osteoporosis. Osteoporos Int. 2009; 20(suppl 3):239-40.

Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Walsh A, Jiwa F, Adachi JD. Family physicians’ personal and practice character-istics that are associated with improved utilization of bone mineral density testing and osteoporosis medication prescribing. Popul Health Manag. 2009; 12:131-9.

Craven BC, Robertson LA, McGillivray CF, Adachi JD. Detection and treatment of sublesional osteoporosis among patients with chronic spinal cord injury: pro-posed paradigms. Top Spinal Cord Inj Rehabil. 2009; 14:1–22.

Kendler DL, Adachi JD, Josse RG, Slosman DO. Monitoring strontium ranelate therapy in patients with osteoporosis. Osteoporosis Int. 2009; 20:1101-6.

Hooven FH, Adachi JD, Adami S, Boonen S, Compston J, Cooper C, Delmas P, Diez-Perez A, Gehlbach S, Greenspan SL, LaCroix A, Lindsay R, Netelenbos JC, Pfeilschifter J, Roux C, Saag KG, Sambrook P, Silverman S, Siris E, Watts NB, Anderson FA. The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int. 2009; 20:1107-16.

Eriksen EF, Lyles K, Colon-Emeric C, Pieper C, Magaziner J, Adachi J, Hyldstrup L, Recknor C, Nordsletten L, Lavecchia C, Hu H, Boonen S, Mesenbrink P. Antifracture efficacy and reduction of mortality in relation to timing of first dose of zole-dronic acid after hip fracture. J Bone Miner Res. 2009; 24:1308-13.

Brown JP, Albert C, Nassar BA, Adachi JD, Cole D, Davison KS, Dooley KC, Don-Wauchope A, Douville P, Hanley DA, Jamal SA, Josse R, Kaiser S, Krahn J, Krause R, Kremer R, Lepage R, Letendre E, Morin S, Ooi DS, Papaioaonnou A, Ste-Marie LG. Bone turn-over markers in the management of postmenopausal osteoporosis. Clin Biochem. 2009; 42:929-42.

Haaland DA, Cohen DR, Kennedy CC, Khalidi NA, Adachi JD, Papaioannou A. Closing the osteoporosis care gap - increased osteoporosis awareness among geriatrics and rehabilitation teams. BMC Geriatrics. 2009; 9:28.

Carmona R, Adachi JD. Treatment of postmenopausal osteoporosis, patient perspectives - focus on once yearly zoledronic acid. Patient Prefer Adherence. 2009; 3:189-93.

Ioannidis G, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L, Kennedy CC, Prior JC, Olszynski WP, Davison KS, Goltzman D, Thabane L, Gafni A, Papadimitropoulos EA, Brown JP, Josse RG, Hanley DA, Adachi JD. Fractures increase mortality rates: The Canadian multicentre osteoporo-sis study. CMA J. 2009; 181:265-71.

Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Walsh A, Jiwa F, Adachi JD. The utilization of appropriate osteoporosis medications improves following a multifaceted educational inter-vention: The Canadian Quality Circle Project (CQC). BMC Med Ed. 2009; 9:54.

Emond PD, Choi A, O’Neill J, Xie J, Adachi R, Gordon CL. The development of EERA: software for assessing rheumatic joint erosions. CARJ. 2009; 60:63-8.

Lau AN, Adachi JD. Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy. J Rheumatol. 2009; 36:1835-7.

Wong AKO, Beattie KA, Emond PD, Inglis D, Duryea J, Doan A, Ioannidis G, Webber CE, O’Neill J, de Beer JMD, Adachi JD, Papaioannou A. Quantitative analysis of subchondral sclerosis of the tibia by bone texture parameters in knee radiographs: site-specific relation-ships with joint space width. Osteoarthritis Cartilage. 2009; 17,1453-60.

Adachi JD, Kennedy CC, Papaioannou A, Ioannidis G, Leslie WD, Walker V. Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers? Osteoporos Int. 2009; 20:1785-93.

Publications

120

PUBLICATIONS

Mulgund M, Beattie K, Wong AKO, Papaioannou A, Adachi JD. Assessing adherence to teriparatide thera-py, causes of nonadherence and effect of adherence on bone mineral density measurements in osteoporotic patients at high fracture risk. Therapeutic Advances in Musculoskeletal Disease. 2009; 1:5-12.

Fraser L-A, Adachi JD. Glucocorticoid-induced osteo-porosis: treatment update and review. Ther Adv Musculoskel Dis. 2009; 1:71-85.

Giangregorio L, Thabane L, deBeer J, Letcher, K, Farrauto, L, McCartney N, Adachi JD, Papaioannou A. Body weight supported treadmill training for patients with hip fracture: a feasibility study. Arch Phys Med Rehab. 2009; 90:2125-30.

Adachi JD, Faraawi RY, O’Mahony MFJ, Nayar A, Massaad R, Evans JK, Yacik C. Alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a randomized, double-blind, placebo-con-trolled, 12-week, exploratory study of upper gastroin-testinal tolerability. Clin Ther. 2009; 31:1747-53.

Kumbhare D, Parkinson W, Dunlop RB, Richards C, Kerr C, Buckley N, Adachi J. Injury measurement properties of circulating interleukin-6 following lumbar decom-pression surgery. J Surg Res. 2009; 157:161-7.

Langsetmo L, Goltzman D, Kovacs CS, Adachi JD, Hanley DA, Kreiger N, Josse R, Papaioannou A, Olszynski WP, Jamal SA. Repeat low-trauma fractures occur frequently among men and women who have osteopenic bone mineral density. J Bone Miner Res. 2009; 24:1515-22.

Hopman WM, Berger C, Joseph L, Towheed T, Prior JC, Anastassiades T, Poliquin S, Zhou W, Adachi JD, Hanley DA, Papadimitropoulos EA, Tenenhouse A. Health-relat-ed quality of life in Canadian adolescents and young adults: normative data using the SF-36. Can J Public Health. 2009; 100:449-52.

ANAND, S.Publications

Anand S, Xie C, Pare G, Montpetit A, Serre D, Rangarajan S, McQueen M, Cordell H, Keavney B, Yusuf S, Hudson T, Engert J. Genetic Variants Associated with Acute Myocardial Infarction in 8,000 Individuals from Five Ethnic Groups: The INTERHEART Genetics Study. Circulation Genetics. 2009; 2:16-25.

Myocardial Infarction Genetics Consortium. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy num-ber variants. Nat Genet. 2009 Mar; 41(3):334-41.

Burman D, Mente A, Hegele RA, Islam S, Yusuf S, Anand SS for the SHARE Investigators. Relationship of the APOE polymorphism to plasma lipid traits among South Asians, Chinese, and Europeans living in Canada. Atherosclerosis. 2009 Mar; 203(1):192-200 .

Mente A, de Koning L, Shannon H, Anand SS. A sys-tematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009 Apr; 169(7):659-69.

Elliott P, Chambers J, Zhang W, Clarke R, Hopewell J, Peden J, Erdmann J, Braund P, Engert J, Bennett D, Coin L, Ashby D, Tzoulaki I, Brown I, Mt-Isa S, McCarthy M, Peltonen L, Freimer N, Farrall M, Ruokonen A, Hamsten A, Lim N, Froguel P, Waterworth D, Vollenweider P, Waeber G, Jarvelin MF, Mooser V, Scott J, Hall A, Schunkert H, Anand SS, Collins

R, Samani N, Watkins H, Kooner J. Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease. JAMA. 2009 Jul 1; 302(1):37-48.

Heid I, Huth C, Loos R, Kronenberg F, Adamkova V, Anand S, Ardlie K, Biebermann H, Bjerregaard P, Boeing H, Bouchard C, Ciullo M, Cooper J, Corella D, Dina C, Engert J, Fisher E, Frances F, Froguel P, Hebebrand J, Hegele R, Hinney A, Hoehe M, Hu F, Hubacek J, Humphries S, Hunt S, Illig T, Jarvelin M, Kaakinen M, Kollerits B, Krude H, Kumar J, Lange L, Langer B, Li S, Lyon H, Meyre D, Mohlke K, Mooser V, Nebel A, Nguyen T, Paulweber B, Perusse L, Qi L, Rankinen T, Rosskopf D, Schreiber S, Sengupta S, Sorice R, Suk A, Thorleifsson G, Thorsteinsdottir U, Volzke H, Vimaleswaran K, Wareham N, Waterworth D, Yusuf S, Lindgren C, McCarthy M, Lange C, Hirschhorn J, Laird N, Wichmann H. Meta-analysis of the INSIG2 Assocation with Obesity Including 74,290 Individuals: Heterogeneity of Estimates Relates to Study Design. PLoS Genet. 2009 Oct; 5(10):e1000694.

Liu X, Wang X, Shen Y, Wu L, Ruan X, Lindpaintner K, Yusuf S, Engert J, Anand S, Tan X, Liu L. The functional variant rs1048990 in PSMA6 is associated with suscep-tibility to myocardial infarction in a Chinese popula-tion. Atherosclerosis. 2009 Sept; 206(1):199-203.

Lanktree B, Yusuf S, Anand SS. Hegele R. Multi-ethnic genetic association study of carotid intima-media thick-ness using a targeted cardiovascular SNP microarray. Stroke. 2009; 40(10):3173-9.

Lanktree MB, Anand SS, Yusuf S, Hegele RA. Replication of genetic associations with plasma lipo-protein traits in a multiethnic sample. Journal of Lipid Research. 2009; 50(7):1487-96.

Hegele RA, Ban MR, Hsueh N, Kennedy BA, Cao H, Zou GY, Anand S, Yusuf S, Huff MW, Wang J. A poly-genic basis for four classical Fredrickson hyperlipo-proteinemia phenotypes that are characterized by hypertriglyceridemia. Hum Mol Genet. 2009 Nov 1; 18(21):4189-94.

Kreatsoulas C, Anand SS. Vascular Viewpoint: Disparity in outcomes of surgical revascularization for limb salvage. Race and gender are synergistic deter-minants of vein graft failure and limb loss. Nguyen LL, Hevelone N, Rogers SO, Bandyk DF, Clowes AW, Moneta GL, Lipsitz S, Conte MS. Circulation. 2009; 119:123-30. Vascular Medicine. 2009 Nov; 14(4):397-9.

ARCK, P.Publications

Sausenthaler S, Rzehak P, Chen CM, Arck P, Bockelbrink A, Schäfer T, Schaaf B, Borte M, Herbarth O, Krämer U, von Berg A, Wichmann HE, Heinrich J; LISA Study Group. Stress-related maternal factors during preg-nancy in relation to childhood eczema: results from the LISA Study. J Investig Allergol Clin Immunol. 2009; 19(6):481-7.

Barrientos G, Tirado-González I, Klapp BF, Karimi K, Arck PC, Garcia MG, Blois SM. The impact of dendritic cells on angiogenic responses at the fetal-maternal interface. J Reprod Immunol. 2009 Dec; 83(1-2):85-94.

Paus R, Arck P. Neuroendocrine perspectives in alope-cia areata: does stress play a role? J Invest Dermatol. 2009 Jun; 129(6):1324-6.

Tariverdian N, Siedentopf F, Rücke M, Blois SM, Klapp BF, Kentenich H, Arck PC. Intraperitoneal immune cell status in infertile women with and without endome-

triosis. J Reprod Immunol. 2009 Jun; 80(1-2):80-90.

Barrientos G, Fuchs D, Schröcksnadel K, Ruecke M, Garcia MG, Klapp BF, Raghupathy R, Miranda S, Arck PC, Blois SM. Low levels of serum asymmetric anti-bodies as a marker of threatened pregnancy. J Reprod Immunol. 2009 Jan; 79(2):201-10.

Benson S, Arck PC, Tan S, Hahn S, Mann K, Rifaie N, Janssen OE, Schedlowski M, Elsenbruch S. Disturbed stress responses in women with polycystic ovary syndrome. Psychoneuroendocrinology. 2009 Jun; 34(5):727-35.

Benson S, Arck PC, Tan S, Mann K, Hahn S, Janssen OE, Schedlowski M, Elsenbruch S. Effects of obesity on neuroendocrine, cardiovascular, and immune cell responses to acute psychosocial stress in premeno-pausal women. Psychoneuroendocrinology. 2009 Feb; 34(2):181-9.

ARMSTRONG, D.Publications

Brozek JL, Guyatt GH, Heels-Ansdell D, Degl’Innocenti A, Armstrong D, Fallone CA, Wiklund I, van Zanten SV, Chiba N, Barkun AN, AklEA, Schünemann HJ. Specific HRQL instruments and symptom scores were more responsive than preference-based generic instru-ments in patients with GERD. J Clin Epidemiol. 2009; 62(1):102-10.

El-Desouki M, Deen MJ, Fang Q, Liu L, Tse F, Armstrong D. CMOS image sensors for high speed applications. Sensors. 2009; 9:439-44.

Labenz J, Armstrong D, Zetterstrand S, Eklund S, Leodolter A. Clinical trial: factors associated with reso-lution of heartburn in patients with reflux oesophagitis – results from the EXPO study. Aliment Pharmacol Ther. 2009; 29(9):959-66.

Labenz J, Armstrong D, Zetterstrand S, Eklund S, Leodolter A. Clinical trial: factors associated with free-dom from relapse of heartburn in patients with healed reflux esophagitis: results from the maintenance phase of the EXPO study. Aliment Pharmacol Ther. 2009; 29(11):1165-71.

Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: the “No Mans’ Land” of gluten sensitivity. Am J Gastroenterol. 2009; 104(6):1587-94.

ARNOLD, D.Publications

Arnold DM, Anderson J, Kearon C. Preoperative risk assessment for bleeding and thromboembolism. BMJ. 2009 Sep 3; 339:b2299.

Cook DJ, Douketis J, Arnold DM, Crowther MA. Bleeding and venous thromboembolism in the criti-cally ill with emphasis on patients with renal insuf-ficiency. Current Opinion in Pulmonary Medicine. 2009 July 15; 455-62.

Arnold DM, Nazi I, Kelton JG. New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses. Expert Opin Investig Drugs. 2009 June; 18(6):805-19.

Arnold DM, Webert K, Adhikari N, Cook DJ. Pilot Trials in Transfusion Medicine. Transfusion. 2009 Jul; 49(7):1293-5.

Arnold DM, Bernotas A, Nazi I, Stasi R, Kuwana M, Liu Y, Kelton JG and Crowther MA. Platelet Count response to H.pylori treatment in patients with Immune Thrombocytopenic Purpura with and without H. pylori infection: a systematic review. Haematologica. 2009 June; 94(6):850-6.

Foley, SR, Webert K, Arnold DM, Rock GA, Clark WF, Barth D, Sutton DM, Members of the Canadian Apheresis Group (CAG). A Canadian phase II study evaluating the efficacy of rituximab in the manage-ment of patients with relapsed/refractory thrombotic thrombocytopenic purpura. Kidney Int. 2009 Feb; (112): S55-8.

Arnold DM, Burns KE, Adhikari NK, Kho ME, Meade MO, Cook DJ, McMaster Critical Care Interest Group. The design and interpretation of pilot trials in clinical research in critical care. Crit Care Med. 2009 Jan; 37(1 Suppl):S69-74.

Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN. Standardization of terminology, defi-nitions and outcome criteria in immune thrombocy-topenic purpura (ITP) of adults and children: Report from an International Working Group. Blood. 2009 Mar 12;113(11):2386-93.

Book Chapters

Arnold DM, Smith JW, Warkentin TE. Management of Immune Thrombocytopenia. In: Rossi’s Principles of Transfusion Medicine, 4th ed. (eds. Simon TL, Snyder EL, Solheim BG, Stowell CP, Strauss RG, Petrides M), Section II, Part1, Chapter 23, Jan 2009.

Webert KW, Arnold DM, Chan H, Smith JW, Heddle NM, Kelton JG. Red Cell, Platelet, and White Cell Antigens. In: Wintrobe’s Clinical Hematology, Twelfth Edition, Lippincott Williams & Wilkins, 2009.

AUSTIN, R.C.Publications

Sohn K-J, Jang H, Campan M, Weisenberger DJ, Kickhout J, Wang Y-C, Cho RC, Yates Z, Lucock M, Chiang E-P, Austin RC, Choi S-W, Laird PW, and Kim Y-I. The methylenetetrahydrofolate reductase C677T muta-tion induces cell-specific changes in genomic DNA methylation and uracil misincorporation: A possible molecular basis for the site-specific cancer risk modifi-cation. Int J Cancer. 2009 May 1; 124(9):1999-2005.

Gupta S, Kuhnisch J, Mustafa A, Lhotak S, Schlachterman A, Slifker MJ, Klein-Szanto A, High KA, Austin RC, and Kruger WD. Mouse models of cysta-thionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia. FASEB J. 2009 Mar; 23(3):883-93.

Zhou J and Austin RC. Contributions of hyperhomo-cysteinemia to atherosclerosis: causal relationship and potential mechanisms. Biofactors. 2009 Mar-Apr; 35(2):120-9.

Basseri S, Lhoták S, Sharma AM, and Austin RC. The chemical chaperone 4-phenylbutyrate attenu-ates adipogenesis through a mechanism involving the unfolded protein response. J Lipid Res. 2009 Dec; 50(12):2486-501.

Austin RC. The unfolded protein response in health and disease. Antioxid Redox Signal. 11:2279-87.

122

PUBLICATIONS

BADER, M.Publications

Bader M, Loeb M. Bacteremia among elderly patients: relationship between age, comorbidity and mortality. Aging Health. Feb 2009; 5(1):39-42.

Bader M, Loeb M. Bacteremia in the elderly. Aging Health. 2009 Dec; 5(6):743-51.

Cowan CD, Hawboldt JJ, Bader M. Pulmonary infection due to mycobacterium malmoense in a patient with crohn disease. CJHP. 2009 Dec; 62(6):496-9.

BATES, S.Publications

Chunilal SD, Bates SM. Venous thromboembolism in pregnancy: diagnosis, treatment, and prevention. Thromb Haemost. 2009; 101:428-38.

Raju N, Bates SM. Preventing thrombophilia-related pregnancy complications. Expert Rev Hematol. 2009; 2:183-96.

Wu CM, Bates SM. Should D-dimer testing be used to predict the risk of recurrence after discontinuation of anticoagulant therapy for a first unprovoked episode of venous thromboembolism? Polish Arch Intern Med. 2009; 119:225-9.

Jaeschke R, Gajewski P, Bates SM, Douketis J, Solnica B, Crowther M, Lesniak W, Brozek JL, Schunemann HJ, Zawilska K, Tomkowski W, Undas A, Sznajd J, Nizankowski R, Bala M, Guyatt G. Evidence-based clin-ical practice guidelines for diagnosing a first episode of lower extremity deep vein thrombosis in ambulato-ry outpatients. Polish Arch Intern Med. 2009; 119:541-9.

Clark P, Bates SM. North American and British Guidelines – are we reaching consensus? Thromb Res. 2009; 123 Suppl 2:S111-23.

Book Chapter

Bates SM. Anticoagulation in pregnancy. In: New Therapeutic Agents in Thrombosis and Thrombolysis (3rd edition) (eds. Freedman JE, Loscalzo J), Informa Healthcare, New York, NY, 2009.

BEATTIE, K.Publications

Mulgund M, Beattie KA, Wong AKO, Papaioannou A, Adachi JD. Assessing adherence to teriparatide therapy, causes of non-adherence and effect of adher-ence on BMD measurements in osteoporotic patients at high risk for fracture. Therapeutic Advances in Musculoskeletal Disease. 2009; 1(1):5-11.

Wong AKO, Beattie KA, Emond PD, Inglis D, Duryea J, Doan A, Ioannidis G, Webber CE, O’Neill J, de Beer J, Adachi JD, Papaioannou A. Quantitative analysis of subchondral sclerosis of the tibia by bone texture parameters in knee radiographs: site-specific relation-ships with joint space width. Osteoarthritis Cartilage. 2009; 17:1453-60.

Wong AKO, Inglis D, Beattie KA, Doan A, Ioannidis G, Adachi JD, Papaioannou A. Reproducibility of comput-er-assisted joint alignment measurement in OA knee radiographs. Osteoarthritis Cartilage. 2009; 17(5):579-85.

BEYENE, J.Publications

Shahbaba B, Gentles AJ, Beyene J, Plevritis SK, Greenwood CMT. A Bayesian nonparametric method for model evaluation: application to genetic studies. Journal of Nonparametric Statistics. 2009; 21(3):379-96.

Graham SM, Shah PS, Aesch ZC, Beyene J, Bayoumi AM. A systematic review of the quality of trials evalu-ating biomedical HIV prevention interventions shows that many lack power. HIV Clin Trials. 2009; 10:413-31.

Allen U, Barton M, Beyene J, Hu P, Khodai-Booran N, Hébert D, Dipchand A, Ng V, Solomon M, Grant D, Fecteau A, Ngan B, Read S, Zielenska M, Weitzman S. Gene expression using microarrays in transplant recip-ients at risk of EBV lymphoproliferation after organ transplantation: Preliminary proof-of-concept. Pediatr Transplant. 2009 Dec; 13(8):990-8 .

Beyene J, Tritchler D, Asimit JL, Hamid JS. Gene- or region-based analysis of genome-wide association studies. Genet Epidemiol. 2009; 33 Suppl 1:S105-10.

Kwan D, Beyene J, Shah PS. Adverse Consequences of Internet Purchase of Pharmacological Agents or Dietary Supplements. J Pharm Technol. 2009; 25:355-60.

Shah PS, Shah V; Knowledge Synthesis Group On Determinants Of Preterm/LBW Births. Influence of the maternal birth status on offspring: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2009; 88(12):1307-18.

Shah PS, Zao J; Knowledge Synthesis Group of Determinants of Preterm/LBW Births. Induced termina-tion of pregnancy and low birthweight and preterm birth: a systematic review and meta-analyses. BJOG. 2009 Oct; 116(11):1425-42.

Beyene J, Atenafu EG, Hamid JS, To T, Sung L. Determining relative importance of variables in devel-oping and validating predictive models. BMC Med Res Methodol. 2009 Sep 14; 9:64.

Hu P, Greenwood CM, Beyene J. Using the ratio of means as the effect size measure in combining results of microarray experiments. BMC Syst Biol. 2009 Nov 5;3(1):106.

Beyene J, Hu P, Hamid JS, Parkhomenko E, Paterson AD, Tritchler D. Pathway-based analysis of a genome wide case-control association study of rheumatoid arthritis. BMC Proc. 2009 Dec 15; 3 Suppl 7:S128.

Morris SK, Dzolganovski B, Beyene J, Sung L. A Meta-Analysis of the Effect of Immunoglobulin Therapy for the Prevention of Severe Respiratory Syncytial Virus Infection. J of Pediatrics. 2009 Jul 5; 9:106

Hamid JS, Beyene J. A multivariate growth curve model for replicated time course microarray data. Statistical Applications in Genetics and Molecular Biology. 2009; 8(1): Article 33.

Tritchler D, Parkhomenko E, Beyene J. Filtering Genes for Cluster and Network Analysis. BMC Bioinformatics. Jun 23, 2009; 10:193

Hossain A, Beyene J, Willan AR, Hu P. A Flexible Approximate Likelihood Ratio Test for Detecting Differential Expression in Microarray Data. Computational Statistics and Data Analysis. 2009; 53: 3685-95.

Cupples LA, Beyene J, Bickeböller H, Daw EW, Fallin

MD, Gauderman WJ, Ghosh S, Goode EL, Hauser ER, Hinrichs A, Kent JW Jr, Martin LJ, Martinez M, Neuman RJ, Province M, Szymczak S, Wilcox MA, Ziegler A, Maccluer JW, Almasy L. Genetic Analysis Workshop 16: Strategies for genome-wide association study analy-ses. BMC Proc. 2009 Dec 15; 3 Suppl 7:S1.

Moeinedin F, Moineddin R, Jadad A, Hamid JS, To T, Beyene J. Application of biomedical informatics to chronic pediatric diseases: A systematic review. BMC Medical Informatics and Decision Making. 2009 May 5; 9:22.

Roslin NM, Hamid JS, Paterson AD, Beyene J. Genome-wide association analysis of cardiovascular-related quantitative traits in the Framingham Heart Study. BMC Proc. 2009 Dec 15; 3 Suppl 7:S117.

Parkhomenko E, Tritchler D, Lemire M, Hu P, Beyene J. Using higher criticism statistic to detect modest effects in a genome-wide study of rheumatoid arthritis. BMC Proc. 2009 Dec 15; 3 Suppl 7:S40.

Odueyungbo A, Smieja M, Thabane L, Smaill F, Gough K, Gill J, Anderson T, Elston D, Smith S, Beyene J, Lonn E for the Canadian HIV Vascular Study Investigators. Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study. AIDS Research and Therapy. June 11; 6:11.

Sievenpiper JL, Carleton AJ, Chatha S, Jiang HY, de Souza RJ, Beyene J, Kendall CW, Jenkins DJ. Heterogeneous effects of fructose on blood lipids in people with type 2 diabetes: Systematic review and meta-analyses of experimental trials in humans. Diabetes Care. 2009; 32:1930-7.

Burton JM, O’Connor PW, Hohol M, Beyene J. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Diabetes Care. 2009 Jul 10. Cochrane Database Syst Rev. 2009 Jul 8; (3):CD006921.

McDonald SD, Han Z, Mulla S, Murphy KE, Beyene J, Ohlsson A; on behalf of the Knowledge Synthesis Group. Preterm birth and low birth weight among in vitro fertilization singletons: A systematic review and meta-analyses. Eur J Obstet Gynecol Reprod Biol. 2009 Oct; 146(2):138-48.

Shah PS, Ohlsson A; Knowledge Synthesis Group on Determinants of Low Birth Weight and Preterm Births. Effects of prenatal multimicronutrient supplementation on pregnancy outcomes: a meta-analysis. CMAJ. 2009 Jun 9; 180(12):E99-108.

Rujkijyanont P, Adams S-L, Beyene J, Dror Y. Bone Marrow Cells from Patients with Shwachman-Diamond Syndrome Abnormally Express Genes Involved in Ribosome Biogenesis and RNA Processing. British Journal of Haematolog. 2009; 145(6):806-15.

Atenafu EG, Hamid JS, Stephens D, To T, Beyene J. A small p-value from an observed data is not evidence of adequate power for future similar-sized studies: A cau-tionary note. Contemp Clin Trials. 2009; 30(2):155-7.

O’Rielly D, Roslin NM, Beyene J, Pope A, Rahman P. TNF-alpha-308 G/A polymorphism and responsiveness to TNF-alpha blockade therapy in moderate to severe rheumatoid arthritis: a systematic review and meta-analysis. Pharmacogenomics J. 2009; 9(3):161-7.

Hamid JS, Roslin NM, Paterson A, Beyene J. Using a latent growth curve model for an integrative assess-ment of the effects of genetic and environmental fac-tors on multiple phenotypes. BMC Proc. 2009 Dec 15; 3 Suppl 7:S44.

Parkhomenko E, Tritchler D, Beyene J. Sparse Canonical Correlation Analysis with Application to Genomic Data Integration. Statistical Applications in Genetics and Molecular Biology. Stat Appl Genet Mol Biol. 2009 Jan; 8(1):Article 1.

Friedrich JO, Beyene J, Adhikari NKJ. Rosiglitazone: can meta-analysis accurately estimate excess cardio-vascular risk given the available data? Re-analysis of randomized trials using various methodologic approaches. BMC Res Notes. 2009 Jan 10; 2:5.

Hamid JS, Hu P, Roslin NM, Ling V, Greenwood CM, Beyene J. Data integration in genetics and genom-ics. Methods and challenges. Human Genomics and Proteomics, vol. 2009, Article ID 869093, 13 pages, 2009. doi:10.4061/2009/869093.

Pole JD, Mustard CA, To T, Beyene J, Allen AC. Antenatal Steroid Therapy for Fetal Lung Maturation: Is there an association with childhood asthma? J Asthma. 2009; 46(1):47-52.

Shah V, Beyene J, Shah P, Perlman M. Association between hematologic findings and brain injury due to neonatal hypoxic-ischemic encephalopathy. Am J Perinatol. 2009; 26(4):295-302.

Sung L, Alibhai SM, Beyene J, Gamis A, Almeida R, Smith S, Aplenc R. Hematopoietic colony-stimulating factor priming does not influence survival in acute myeloid leukemia: a meta-analysis of randomized tri-als. Leukemia. 2009; 23(4):811-3.

Stevens B, McGrath P, Dupuis A, Gibbins S, Beyene J, Breau L, Camfield C, Finley GA, Franck LS, Howlett A, Johnston C, McKeever P, O’Brien K, Ohlsson A, Yamada J. Indicators of pain in neonates at risk for neurological impairment. J Adv Nurs. 2009; 65(2):285-96.

BIENENSTOCK, J.Publications

Ma XJ, Mao YK, Wang B, Huizinga JD, Bienenstock J, Kunze WA. Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. Am J Physiol Gastrointest Liver Physiol. 2009 Apr; 296(4):G868-75.

Kunze WA, Mao YK, Wang B, Huizinga JD, Ma X, Forsythe P, Bienenstock J. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibit-ing calcium dependent potassium channel opening. J Cell Mol Med. 2009 Aug; 13(8B):2261-70.

O’Mahony, van der Kleij H, Bienenstock J, Shanahan F, O’Mahony L. Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer. Am J Physiol Regul Integr Comp Physiol. 2009 Oct; 297(4):R1118-26.

Book Chapter

Forsythe P, Bienenstock J. Neural regulation of the immune response. In: Allergy Frontiers: Epigenetics to Future Perspectives: Volume 2 (eds. Holgate S, Pawankar R and Rosenwaser L), pp. 493:514, 2009.

BOLLI, P.Publication

Padwal RS, Hemmelgarn BR, Khan NA, Grover S, McKay DW, Wilson T, Penner B, Burgess E, McAlister FA, Bolli P, Hill MD, Mahon J, Myers MG, Abbott C, Schiffrin EL, Honos G, Mann K, Tremblay G, Milot A, Cloutier L, Chockalingam A, Rabkin SL, Dawes M, Touyz

124

PUBLICATIONS

RM, Bell C, Burns KD, Ruzicka M, Campbell MC, Vallee M, Prasad R, Lebel M, Tobe SW, for the Canadian Hypertension Education Program. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1-blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol. 2009; 25: 279-86.

BROZEK, J.Publications

Canonica GW, Bousquet J, Casale T, Lockey RF, Baena-Cagnani CE, Pawankar R, Potter PC, Bousquet PJ, Cox LS, Durham SR, Nelson HS, Passalacqua G, Ryan DP, Brozek JL, Compalati E, Dahl R, Delgado L, van Wijk RG, Gower RG, Ledford DK, Filho NR, Valovirta EJ, Yusuf OM, Zuberbier T, Akhanda W, Almarales RC, Ansotegui I, Bonifazi F, Ceuppens J, Chivato T, Dimova D, Dumitrascu D, Fontana L, Katelaris CH, Kaulsay R, Kuna P, Larenas-Linnemann D, Manoussakis M, Nekam K, Nunes C, O’Hehir R, Olaguibel JM, Onder NB, Park JW, Priftanji A, Puy R, Sarmiento L, Scadding G, Schmid-Grendelmeier P, Seberova E, Sepiashvili R, Solé D, Togias A, Tomino C, Toskala E, Van Beever H, Vieths S. Sub-lingual immunotherapy:World Allergy Organization Position Paper 2009. Allergy. 2009 Dec; 64 Suppl 91:1-59.

Zawilska K, Jaeschke R, Tomkowski W, Mayzner-Zawadzka E, Nizankowski R, Olejek A, Pasierski T, Torbicki A, Undas A, Jawień A, Gajewski P, Sznajd J, Brozek J; [Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update]. Pol Arch Med Wewn. 2009; 119 Suppl 1:1-69.

Bousquet PJ, Brozek J, Bachert C, Bieber T, Bonini S, Burney P, Calderon M, Canonica GW, Compalati E, Daures JP, Delgado L, Demoly P, Dahl R, Durham SR, Kowalski ML, Malling HJ, Merk H, Papadopoulos N, Passalacqua G, Simon HU, Worms M, Wahn U, Zuberbier T, Schünemann HJ, Bousquet J. The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper. Allergy. 2009 Dec; 64(12):1737-45.

Costa DJ, Bousquet PJ, Ryan D, Price D, Demoly P, Brozek J, Schünemann HJ, Bousquet J. Guidelines for allergic rhinitis need to be used in primary care. Prim Care Respir J. 2009 Dec; 18(4):250-7.

Brozek JL, Akl EA, Jaeschke R, Lang DM, Bossuyt P, Glasziou P, Helfand M, Ueffing E, Alonso-Coello P, Meerpohl J, Phillips B, Horvath AR, Bousquet J, Guyatt GH, Schünemann HJ; GRADE Working Group. Grading quality of evidence and strength of recommenda-tions in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. Allergy. 2009 Aug; 64(8):1109-16.

Brozek J, Jankowski M, Płaczkiewicz-Jankowska E, Jaeschke R. International Diabetes Federation docu-ment concerning postmeal glycemic control: assess-ment of quality of clinical practice guidelines using AGREE instrument. Pol Arch Med Wewn. 2009 Jan-Feb; 119(1-2):18-24.

Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, Phillips B, Lelgemann M, Lethaby A, Bousquet J, Guyatt GH, Schünemann HJ; GRADE Working Group. Grading quality of evidence and strength of recommendations in clinical practice guide-lines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009 May; 64(5):669-77.

Jaeschke R, Jankowski M, Brozek J, Antonelli M. How to develop guidelines for clinical practice. Minerva Anestesiol. 2009 Sep; 75(9):504-8.

Brozek JL, Guyatt GH, Heels-Ansdell D, Degl’Innocenti A, Armstrong D, Fallone CA, Wiklund I, van Zanten SV, Chiba N, Barkun AN, Akl EA, Schünemann HJ. Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD. J Clin Epidemiol. 2009 Jan; 62(1):102-10.

BULLER, C.Publications

Džavik V, Buller CE, Devlin G, Carere RG, Mancini GB, Cantor WJ, Buszman PE, Rankin JM, Vozzi C, Ross JR, Forman S, Barton BA, Lamas AG, Hochman JS. Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial. Catheter Cardiovasc Interv. 2009 May 1; 73(6):771-9.

Fung AY, Saw J, Starovoytov A, Densem C, Jokhi P, Walsh SJ, Fox RS, Humphries KH, Aymong E, Ricci DR, Webb JG, Hamburger JN, Carere RG, Buller CE. Abbreviated infusion of eptifibatide after successful coronary intervention The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) randomized trial. J Am Coll Cardiol. 2009; 53:837-45.

Book Chapters

Wood D, Khurana R and Buller CE. Percutaneous Coronary Intervention. Chapter 28. In: Evidence-Based Cardiology, 3rd Edition (eds. Yusuf S, Cairns J, Camm J, Fallen E, Gersh B), Wiley Publishing, 2009.

Motiei A, Holmes DR and Buller CE. Chapter 4: Left ventricular pump failure: general considerations for management. AHA Clinical Series book: Cardiogenic Shock (eds. Hochman J, Ohman EM), Wiley-Blackwell Publishing, Feb 2009.

CARMONA, R.J.Publication

Carmona RJ, Adachi JR. Treatment of Postmenopausal Osteoporosis, patient perspectives - focus on once yearly zoledronic acid. Journal of Patient Preference and Adherence, Jul 2009; 3:189-93.

CHIBA, N.Publications

Brozek JL, Guyatt GH, Heels-Ansdell D, Degl’innocenti A, Armstrong D, Fallone CA, Wiklund I, van Zanten SV, Chiba N, Barkun AN, Akl EA, Schunemann HJ. Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD. J Clin Epidemiol. 2009; 62:102-10.

Rostom A, Moayyedi P, Hunt R, for the Canadian Association of Gastroenterology Consensus Group. Canadian consensus guidelines on long-term nonste-roidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks. Aliment Pharmacol Ther. 2009; 29:481-96.

Sadowski DC, Bernstein CN, Bitton A, Croitoru K, Fedorak RN, Griffiths A, and the CAG Crohn’s Consensus Group. Canadian Association of

Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn’s disease. Can J Gastroenterol. 2009; 23:185-202.

CHOW, A.Publication

Matsos M, Harish S, Zia P, Ho Y, Chow A, Ioannidis G, Khalidi N. Ultrasound of the hands and feet for Rheumatological disorders: influence on clinical diag-nostic confidence and patient management. Skeletal Radiol. 2009 Nov; 38(11):1049-54.

CLARK, D.Publications

Clark DA. An observational study on the role of cell surface CD200 in efficacy of paternal mononuclear leukocyte immunotherapy in recurrent pregnancy loss. Am J Reprod Immunol. 2009; 61:75-84.

Clark DA. Should anti-TNF-alpha therapy be offered to patients with infertility and recurrent spontaneous abortion? Am J Reprod Immunol. 2009; 61:107-12.

Shalev I, Wong KM, Foerster K, Zhu Y, Chan C, Maknojia A, Liu MF, Zhang J, Ma X-Z, Gao JF, Liu H, Selzner N, Clark DA, Adeyi O, Phillips MJ, Gorczynski RM, Grant D, McGilvray I, Levy GA. FGL2 the novel Treg effector molecule plays a critical role in the out-come of murine fulminant viral hepatitis. Hepatology. 2009; 49:387-97.

CLASE, C.Publications

Jahromi AS, Clase CM, Maggisano R, Bailey R, Safar HA, Al Thani H, Cina CS. Progression of internal carotid artery stenosis in patients with peripheral arterial occlusive disease. J Vasc Surg. 2009; 50:292-8.

Holden RM, Clase CM. Use of warfarin in people with low glomerular filtration rate or on dialysis. Semin Dial. 2009 Sep-Oct; 22(5):503-11.

Su W, Yegappan C, Carlisle EJF, Clase CM. Reduced level of consciousness from baclofen in people with low kidney function. BMJ. 2009; 339:b4559. Review.

Book Chapters

Cina CS, Clase CM. When saving blood goes wrong. In: Research off the Rails (eds. Streiner DS). The Guilford Press.

Clase CM. Chronic Renal Failure. In: BMJ Clinical Evidence 2009 (eds. Tovey D. Suffolk UK), William Clowes Ltd.

CONNOLLY, S.J.Publications

Nieuwlaat R, Connolly SJ. Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes. Heart. 2009; 95(2):95-7.

Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ; ATHENA Investigators. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med. 2009 Feb 12; 360(7):668-78.

Robinson M, Healey JS, Eikelboom J, Schulman S, Morillo CA, Nair GM, Baranchuk A, Ribas S, Evans G, Connolly SJ, Turpie AG. Postoperative low-molecu-lar-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol. 2009; 32(3):378-82.

Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A, Calkins H, Connolly SJ, Curtis AB, Darbar E, Ellinor PT, Go AS, Goldschlager NF, Heckbert SR, Jalife J, Kerr CR, Levy D, Lloyd-Jones DM, Massie BM, Nattel S, Olgin JE, Packer DL, Po SS, Tsang TS, Van Wagoner DR, Waldo AL, Wyse DG. Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation. 2009; 119(4):606-18.

ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009; 360(20):2066-78.

Baranchuk A, Healey JS, Simpson CS, Redfearn DP, Morillo CA, Connolly SJ, Fitzpatrick M. Atrial overdrive pacing in sleep apnea: a meta-analysis. Europace. 2009;11(8):1037-40.

Sheldon RS, Amuah JE, Connolly SJ, Rose S, Morillo CA, Talajic M, Kus T, Fouad-Tarazi F, Klingenheben T, Krahn AD, Sheldon A, Koshman ML, Ritchie D. Design and use of an quantitative scale for measuring presyn-cope. J Cardiovasc Electrophysiol. 2009; 20(8):888 93.

van Walraven C, Hart RG, Connolly SJ, Austin PC, Mant J, Hobbs FD, Koudstaal PJ, Petersen P, Perez-Gomez F, Knottnerus JA, Boode B, Ezekowitz MD, Singer DE. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investiga-tors. Stroke 2009; 40(4):1410-6.

Ezekowitz MD, Connolly SJ, Parekh A, Reilly PA, Varrone J, Wang S, Oldgren J, Themeles E, Wallentin L, Yusuf S. Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, war-farin, compared with dabigatran. Am Heart J. 2009; 157(5):805-10.

Sheldon RS, Amuah JE, Connolly SJ, Rose S, Morillo CA, Talajic M, Kus T, Fouad-Tarazi F, Klingenheben T, Krahn T, Krahn AD, Koshman ML, Ritchie D. Effect of metoprolol on quality of life in the prevention of syncope trial. J Cardiovasc Electrophysiol. 2009; 20(10):1083-8.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; the RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibril-lation. N Engl J Med. 2009; 361(12):1139-51.

Connolly SJ, Crijns HJ, Torp-Pedersen C, van Eickels M, Gaudin C, Page RL, Hohnloser SH: ATHENA Investigators. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the pre-vention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. Circulation. 2009; 120(13):1174-80.

Pinter A, Mangat I, Korley V, Connolly SJ, Connors S, Gardner M, Philippon F, Sterns L, Thibault B, Dorian P. Assessment of Resynchronization Therapy on Functional Status and Quality of Life in Patients Requiring an Implantable Defibrillator. Pacing Clin Electrophysiol. 2009 Dec; 32(12):1509-19.

126

PUBLICATIONS

Whitlock RP, Healey JS, Connolly SJ. Left atrial appendage occlusion does not eliminate the need for warfarin. Circulation. 2009; 120(19):1927-32.

COOK, D.J.Publications

Guyatt GH, Cook DJ, Jaeschke R, Pauker S, Schunemann HJ. Grades of recommendation for antithrombotic agents. American College of Chest Physicans Evidence Based Clinical Practice Guidelines, 8th Conference. Chest. 2009; 133(6):112S-31S.

Schunemann HJ, Cook DJ, Guyatt G. Methodology for Antithrombotic and Thrombolytic Therapy Guideline Development. American College of Chest Physicans Evidence Based Clinical Practice Guidelines, 8th Conference. Chest. 2009; 133(6):113S-22S.

Anand K, Zarychanski R, Pinto R, Cook DJ, Marshal J, Lacroix J, Stelfox T, Bagshaw S, Choong K,Lamontagne F, Turgeon A, Lapinsky S, Ahern S, Smith O, Siddiqui F, Jouvet P, Khwaja K, Mclntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Meade M, Hall R, Fowler R for the Canadian Critical Care Trials Group H1N1 Collaborative. Critically lll Patients With 2009 Inffuenza A (H1N1 ) Infection in Canada. JAMA. 2009; 302(17):1872-9.

Russell JA, Walley KR, Gordon AC, Cooper J, Hébert PC, Singer J, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers A for the Vasopressin and Septic Shock Trial (VASST) Investigators. Interaction of vasopressin infusion, corticosteroid treatment and mortality of septic shock. Crit Care Med. 2009; 37:811-8.

Christian MD, Hamielec C, Lazar N, Wax R, Griffith L, Herridge M, Lee D, Cook DJ. A retrospective cohort pilot study to evaluate a triage tool for use in a pan-demic. Crit Care. 2009; 13(5):R170.

Burns KEA, Zubrinich C, Marshall J, Cook DJ. The ‘Consent to Research’ Paradigm in Critical Care: Challenges and Potential Solutions. Intensive Care Med. 2009;35:1655-8.

Briel M, Lane M, Montori VM, Bassler D, Glasziou P, Malaga G, Akl EA, Ferreira-Gonzalez I, Alonso-Coello P, Urrutia G, Kunz R, Ruiz Culebro C, Alves da Silva S, Flynn DN, Elamin MB, Strahm B, Murad MH, Djulbegovic B, Adhikari NKJ, Mills EJ, Gwadry-Sridhar F, Kirpalani H, Soares HP, Abu Elnour NO,You JJ, Karanicolas PJ, Bucher HC, Lampropulos JF, Nordmann AJ, Burns KEA, Mulla SM, Raatz H, Sood A, Kaur J, Bankhead CR, Mullan RJ, Nerenberg KA, Vandvik PO, Coto-Yglesias F, Schünemann H, Tuche F, Chrispim PPM, Cook DJ, Lutz K, Ribic CM, Vale N, Erwin PJ, Perera R, Zhou Q, Heels-Ansdell D, Ramsay T, Walter SD, Guyatt GH. Stopping randomized trials early for benefit: a protocol of the Study of Trial Policy of Interim Truncation-2 (STOPIT-2). Trials. 2009; 10:49.

Zarychanski R, Turgeon AF, Fergusson DA, Cook DJ, Hebert P, Badshaw SM, Monsour D, McIntyre L. Renal outcomes following hydroxyethyl starch resuscitation in critically ill patients: A meta-analysis of randomized trials. Open Medicine. 2009; 3(4):E196-209.

Scales DC, Orla M, Smith OM, Pinto R, Barrett KA, Friedrich JO, Lazar NM, Cook DJ, Ferguson ND for the Canadian Critical Care Trials Group. Patients’ prefer-ences for enrolment into critical care trials. Intensive Care Medicine. 2009 Oct; 35(10):1703-12.

Lim W, Tkaczyk A, Holinski P, Qushmaq I, Jcka M, Khera V, Devereaux PJ, Terrenato I, Schunemann H, Heels-Ansdell D, Crowther MA, Cook DJ. The diagnosis of myocardial infarction in critically ill patients: an agree-ment study. J Crit Care. 2009(3):447-52.

The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009; 360(13):1283-97.

Moher D, Liberati A, Tetzlaff J, Altman DG, and the PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Ann Intern Med. 2009; 151(4):1-8.

Comondore VR, Devereaux PJ, Zhou Q, Stone SB, Busse JW, Ravindran NC, Burns KE, Haines T, Stringer B, Cook DJ, Walter SD, Sullivan T, Berwanger O, Bhandari M, Banglawala S, Lavis JN, Petrisor B, Schunemann H, Bhatnagar N, Guyatt GH. Quality of care in For-Profit and Not For-Profit nursing homes: a systematic review and meta-analysis. BMJ. 2009; 339:1-15.

Cook DJ, Douketis J, Arnold D, Crowther MA. Bleeding and Venous Thromboembolism in the Critically Ill with Emphasis on Patients with Renal Insufficiency. Current Opinion in Pulmonary Medicine. 2009; 15:455-62.

Henderson WR, Dhingra V, Chittock D, Foster D, Hebert P, Cook DJ, Heyland D, Dodek P, Griesdale D, Schulzer M, Ronco JJ in association with the Canadian Critical Care Trials Group. The efficacy and safety of glucose control algorithms in intensive care: A pilot study of the Survival Using Glucose Algorithm Regulation (SUGAR) trial. Polish Archives of Internal Medicine. 2009; 119:440-5.

Arnold DP, Webert KE, Adhikari NKJ, Cook DJ. Pilot Trials in Transfusion Medicine. Transfusion Medicine. 2009; 49:1293-5.

Cook DJ, Tkaczyk A, Lutz K, McMullin J, Haynes RB, Douketis J. Thromboprophylaxis for hospitalized medi-cal patients: A multicenter qualitative study. J Hospital Medicine. 2009; 4(5):269-75.

Cook DJ, Sinuff T, Zytaruk N, Rabbat C, Lee A, O’Donnell M, Thabane L, Linkins L, Treleaven D, Patel R, Meade MO, Crowther MA, Marshall JC, Douketis J for the DIRECT Investigators and Canadian Critical Care Trials Group. Event Adjudication and Data Monitoring in an intensive care unit observational study of throm-boprophylaxis. J Crit Care. 2009; 24:168-75.

Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D. Intensive insulin ther-apy and mortality among critically ill patients: a meta-analylsis including NICE_SUGAR study data. CMAJ. 2009; 180(8):821-7.

Akl EA, Briel M, You JJ, Lamontagne F, Gangji A, Cukierman-Yaffe T, Alshurafa M, Sun X, Nerenberg KA, Johnston BC, Vera C, Mills EJ, Bassler D, Salazar A, Bhatnagar N, Busse JW, Khalid Z, Walter SD, Cook DJ, Schunemann HJ, Altman DG, Guyatt GH. LOST to fol-low-up information in Trials (LOST-IT): a protocol on the potential impact. Trials. 2009; 10(1):1-11.

Scales DC, Riva-Cambrin J, Le TL, Pinto R, Cook DJ, Granton JT; Canadian Critical Care Trials Group. Prophylaxis against venous thromboembolism in neu-rointensive care patients: survey of Canadian practice. J Crit Care. 2009; 24(2):176-84.

Giacomini M, Cook DJ, DeJean D. Life support Decision making in Critical Care: Identifying and

Appraising the Qualitative Research Evidence. Crit Care Med. 2009; 37(4):1475-82.

Donahoe L, McDonald E, Kho ME, Maclennan M, Stratford PW, Cook DJ. Increasing Reliability of APACHE II Scores in a Medical-Surgical Intensive Care Unit: A Quality Improvement Study. Am J Crit Care. 2009; 18(1):58-64.

Sinuff T, Cook DJ, Giacomini M, Swinton M, Shaw R. Living with Death: The evolution of the family mem-ber’s experience of the ventilator. Crit Care Med. 2009; 37:154-8.

Moeller A, Gilpin SE, Ask K, Cox G, Cook DJ, Gauldie J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, O’Byrne PM, Strieter RM, Kolb MRJ. Circulating fibro-cytes are an indicator for poor prognosis in idiopathic pulmonary fibrosis. Am J Resp Crit Care Med. 2009; 179(7):588-94.

Marshall JC, Cook DJ for the Canadian Critical Care Trials Group. Investigator-led clinical research consor-tia: The Canadian Critical Care Trials Group. Crit Care Med. 2009; 36(7):S165-72.

Kho ME, Duffett M, Willison DJ, Cook DJ, Bouwers MC. Written informed consent and selection bias in obser-vational studies using medical records: systematic review. BMJ. 2009; Mar 12:338 .

Ribic C, Lim WP, Cook DJ, Crowther MA. Low molecu-lar weight heparin thromboprophylaxis in medical-sur-gical critically ill patients: A systematic review. J Crit Care. 2009 Jun; (2):197-205.

Berwanger O, Ribeiro RA, Finkelsztejn A, Watanabe M, Suzumura EA, Duncan BB, Devereaux PJ, Cook DJ. The quality of reporting of trial abstracts is suboptimal: sur-vey of major general medical journals. J Clin Epi. 2009; 62(4):387-92.

Kho M, Perri D, McDonald E, Waugh L, Orlicki C, Monahan E, Cook DJ. The Climate of Patient Safety a Canadian Intensive Care Unit. J Crit Care. 2009: (3):469.e7-13.

Book Chapter

Rocker G, Cook DJ. The ICU: A Place for Palliative Care. From advancing disease to bereavement. In: Oxford Specialist Handbook Series: End of Life Care in the Intensive Care Unit (eds. Rocker G, Puntillo K, Azoulay E, Nelson J), Oxford University Press, 2009.

COWAN, D.Publication

Cowan D, Radman H, Lewis D, Turpie I. A Community-Based Pysical Maintenence Program for Frail older Adults: The Stay Well Program. Topics in Geriatric Rehabilitation. 2009; 25(4):355-64.

COX, G.Publications

Behr J, Kolb M, Cox G. Treating IPF- all or nothing A PRO-CON debate. Respirology. 2009; 14:1072-81.

Castro M, Rubin AS, Laviolette M, Fiterman J, De Andrade LM, Shah PL, Fiss E, Olivenstein R, Thomson NC, Niven RM, Pavord ID, Simoff M, Duhamel DR, McEvoy C, Barbers R, Ten Hacken NH, Wechsler ME, Holmes M, Phillips MJ, Erzurum S, Lunn W, Israel E, Jarjour N, Kraft M, Shargill NS, Quiring J, Berry SM,

Cox G; AIR2 Trial Study Group. Circulating Fibrocytes are an indicator of poor prognosis in idiopathic pul-monary fibrosis. Am J Respir Crit Care Med. 2009; 179:588-94.

CROWTHER, M.Publications

Dentali F, Squizzato A, Brivio L, Appio L, Campiotti L, Crowther M, Grandi AM, Ageno W. JAK2V617F muta-tion for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood. 2009 May 28; 113(22):5617-23.

Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving war-farin: a randomized trial.Ann Intern Med. 2009 Mar 3; 150(5):293-300.

Le Gal G, Kovacs MJ, Carrier M, Do K, Kahn SR, Wells PS, Anderson DA, Chagnon I, Solymoss S, Crowther M, Righini M, Perrier A, White RH, Vickars L, Rodger M. Validation of a diagnostic approach to exclude recur-rent venous thromboembolism. J Thromb Haemost. J Thromb Haemost. 2009 May; 7(5):752-9.

Holland L, Warkentin TE, Refaai M, Crowther MA, Johnston MA, Sarode R. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international nor-malized ratio due to warfarin overdose. Transfusion. 2009 Jun; 49(6):1171-7.

Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, Kingdom JC, Barrett J, Gent M. Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the Randomized, Controlled HepASA Trial. J Rheumatol. 2009 Feb; 36(2):279-87.

Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, Dupuis JY, Fremes SE, Kent B, Laflamme C, Lamy A, Legare JF, Mazer CD, McCluskey SA, Rubens FD, Sawchuk C, Beattie WS. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009 Feb 3; 119(4):495-502.

Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: A systematic review of randomized trials. Thromb Res. 2009; 123(5):687-96.

Crowther MA, Warkentin TE. Managing bleeding in anticoagulated patients with a focus on novel thera-peutic agents. J Thromb Haemost. 2009 Jul; 7 Suppl 1:107-10.

Chan WS, Lee A, Spencer FA, Crowther M, Rodger M, Ramsay T, Ginsberg JS. Predicting deep venous throm-bosis in pregnancy: out in “LEFt” field? Ann Intern Med. 2009 Jul 21; 151(2):85-92.

Cook DJ, Douketis J, Arnold D, Crowther MA. Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency. Curr Opin Pulm Med. 2009 Sep; 15(5):455-62.

Garcia D, Ageno W, Bussey H, Eikelboom J, Margaglione M, Marongiu F, Moia M, Palareti G, Pengo V, Poli D, Schulman S, Witt D, Wittkowksy A, Crowther M. Prevention and treatment of bleeding complica-

128

PUBLICATIONS

tions in patients receiving vitamin K antagonists, Part 1: Prevention. Am J Hematol. Am J Hematol. 2009 Sep; 84(9):579-83.

Ageno W, Garcia D, Aguilar MI, Douketis J, Finazzi G, Imberti D, Iorio A, Key NS, Lim W, Marietta M, Prisco D, Sarode R, Testa S, Tosetto A, Crowther M. Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment. Am J Hematol. Am J Hematol. 2009 Sep; 84(9):584-8. Review.

Lepic K, Crowther MA. A logical approach to surgical thromboprophylaxis. Curr Opin Hematol. Curr Opin Hematol. 2009 Sep; 16(5):397-401.

Arnold DM, Bernotas A, Nazi I, Stasi R, Kuwana M, Liu Y, Kelton JG, Crowther MA. Platelet count response to H. pylori treatment in patients with immune throm-bocytopenic purpura with and without H. pylori infec-tion: a systematic review. Haematologica. 2009 Jun; 94(6):850-6.

Witt DM, Delate T, Clark NP, Martell C, Tran T, Crowther MA, Garcia DA, Ageno W, Hylek EM; Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium. Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood. 2009 Jul 30; 114(5):952-6.

Spencer FA, Gore JM, Reed G, Lessard D, Pacifico L, Emery C, Crowther MA, Goldberg RJ. Venous throm-boembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study. Thromb Haemost. 2009 May; 101(5):878-85.

Cook D, Sinuff T, Zytaruk N, Rabbat C, Lee A, O’Donnell M, Thabane L, Linkins L, Treleaven D, Patel R, Meade M, Crowther M, Marshall JC, Douketis J; DIRECT Investigators and Canadian Critical Care Trials Group. Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis. J Crit Care. 2009 Jun; 24(2):168-75.

Ribic C, Lim W, Cook D, Crowther M. Low-molecular-weight heparin thromboprophylaxis in medical-surgi-cal critically ill patients: a systematic review. J Crit Care. 2009 Jun; 24(2):197-205.

Lim W, Tkaczyk A, Holinski P, Qushmaq I, Jacka M, Khera V, Devereaux PJ, Terrenato I, Schunemann H, Heels-Ansdell D, Crowther M, Cook D. The diagnosis of myocardial infarction in critically ill patients: An agree-ment study. J Crit Care. 2009 Sep; 24(3):447-52.

Ainsworth CD, Crowther MA, Treleaven D, Evanovitch D, Webert KE, Blajchman MA. Severe hemolytic ane-mia post-renal transplantation produced by donor anti-D passenger lymphocytes: case report and literature review. Transfus Med Rev. 2009 Apr; 23(2):155-9.

Jaeschke R, Gajewski P, Bates SM, Douketis J, Solnica B, Crowther M, Leńniak W, Brozek JL, Schünemann HJ, Zawilska K, Tomkowski W, Undas A, Sznajd J, Nizankowski R, Bała MM, Guyatt G. 2009 evidence-based clinical practice guidelines for diagnosing a first episode of lower extremities deep vein thrombosis in ambulatory outpatients. Pol Arch Med Wewn. 2009 Sep; 119(9):541-9.

Witt DM, Delate T, McCool KH, Dowd MB, Clark NP, Crowther MA, Garcia DA, Ageno W, Dentali F, Hylek EM, Rector WG; on behalf of the WARPED Consortium. Incidence and predictors of bleeding or thrombosis following polypectomy in patients receiving and not receiving anticoagulation therapy. J Thromb Haemost. 2009 Dec; 7(12):1982-9.

Dentali F, Ageno W, Witt D, Malato A, Clark N, Garcia D, McCool K, Siragusa S, Dyke S, Crowther M; WARPED consortium. Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study. Thromb Haemost. 2009 Sep; 102(3):501-4.

Garcia D, Ageno W, Bussey H, Eikelboom J, Margaglione M, Marongiu F, Moia M, Palareti G, Pengo V, Poli D, Schulman S, Witt D, Wittkowksy A, Crowther M. Prevention and treatment of bleeding complica-tions in patients receiving vitamin K antagonists, Part 1: Prevention. Am J Hematol. 2009 Sep; 84(9):579-83. Review.

Ageno W, Garcia D, Aguilar MI, Douketis J, Finazzi G, Imberti D, Iorio A, Key NS, Lim W, Marietta M, Prisco D, Sarode R, Testa S, Tosetto A, Crowther M. Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment. Am J Hematol. 2009 Sep; 84(9):584-8. Review.

Book Chapters

Lim WP, Crowther MA, Ginsberg JS. Chapter 135: Venous Thromboembolism. In: Hematology Basic Principles and Practice (eds. Hoffman R, Benz EJ, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop H), Elsevier-Churchill Livingstone, Philadelphia, pp. 2043-54, 2009.

Krakow EF, Ginsberg JS, Crowther MA. Chapter 136: Arterial Thromboembolism. In: Hematology Basic Principles and Practice (eds. Hoffman R, Benz EJ, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop H), Elsevier-Churchill Livingstone, Philadelphia, pp. 2055-66, 2009.

DENBURG, J.Publications

Allakhverdi Z, Comeau MR, Smith DE, Toy D, Endam LM, Desrosier M, Liu Y-J, Howie KJ, Denburg JA, Gauvreau GM, Delespesse G. CD34+ hemopoietic pro-genitor cells are potent effectors of allergic inflamma-tion. J Allergy Clin Immunol. 2009; 123:472-8.

Subbarao P, Becker A, Brook JR, Daley D, Mandhane PJ, Miller GE, Turvey SE, Sears MR, et al on behalf of the CHILD study investigators. Epidemiology of asthma: risk factors for development. Expert Rev Clin Immunol. 2009; 5:77-95.

Bousquet J, Bachert C, Canonica GW, Casale TB, Cruz AA, Lockey RJ, Zuberbier T, on behalf of the extended GA2LEN, World Allergy Organization and ARIA Study Groups. Unmet needs in severe chronic upper airway diseases (SCUAD). J Allergy Clin Immunol. 2009; 124:428-33. Denburg JA is a member of the Allergic Rhinitis and its Impact on Asthma (ARIA) Study Group.

Gauvreau GM, Ellis AK, Denburg JA. Hemopoietic pro-cesses in allergic disease: eosinophil/basophil develop-ment. Clin Exp Allergy. 2009; 39:1297-306.

Book Chapter

Befus AD, Denburg JA. Basophilic leucocytes: mast cells and basophils. In: Wintrobe’s Clinical Hematology, 12th Edition (eds.Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber D, Means RT), Lippincott Williams & Wilkins, Baltimore, vol 1, pp. 236-48, 2009.

DEVEREAUX, P.Publications

Nevis IF, Mathew A, Novick RJ, Parikh CR, Devereaux PJ, Natarajan MK, Iansavichus AV, Cuerden MS, Garg AX. Optimal method of coronary revascularization in patients receiving dialysis: systematic review. Clin J Am Soc Nephrol. 2009; 4:369-78.

Myles PS, Leslie K, Peyton P, Paech M, Forbes A, Chan MTV, Sessler D, Devereaux PJ, Silbert BS, Jamrozik K, Beattie S, Badner N, Tomlinson J, Wallace S. Nitrous oxide and perioperative cardiac morbidity (ENIGMA-II) Trial: Rationale and design. Am Heart J. 2009; 157:488-94.

Karanicolas PJ, Montori VM, Devereaux PJ, Schünemann H, Guyatt GH. A new “mechanistic-practi-cal” framework for designing and interpreting random-ized trials. J Clin Epidemiol. 2009; 62:479-84.

Berwanger O, Ribeiro RA, Finkelsztejn A, Watanabe M, Suzumura EA, Duncan BB, Devereaux PJ, Cook D. The quality of reporting trial abstracts is suboptimal: Survey of major general medical journals. J Clin Epidemiol. 2009; 62:387-92.

Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JPA, Thabane L, Gluud LL, Als-Nielsen B, Gluud C. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol. 2009; 38:276-86.

Lim W, Tkacyzk A, Holinski P, Qushmaq I, Jacka M, Khera V, Devereaux PJ, Terrenato I, Schünemann H, Heels-Ansdell D, Crowther M, Cook D. The diagnosis of myocardial infarction in critically ill patients: An agree-ment study. J Crit Care. 2009 Sep; 24(3):447-52.

Karanicolas PJ, Montori VM, Devereaux PJ, Schünemann H, Guyatt GH. The practicalists’ response. J Clin Epidemiol. 2009: 62:489-94.

Cortes OL, Villar JC, Devereaux PJ, Dicenso A. Early mobilization for patients following acute myocardial infarction: A systematic review and meta-analysis of experimental studies. Int J Nurs Stud. 2009 Nov; 46(11):1496-504.

Comondore VR, Devereaux PJ, Zhou Q, Stone SB, Busse JW, Ravindran NC, Burns KE, Haines T, Stringer B, Cook DJ, Walter SD, Sullivan T, Berwanger O, Bhandari M, Banglawala S, Lavis JN, Petrisor B, Schünemann H, Walsh K, Bhatnagar N, Guyatt GH. Quality of care in for-profit and not for-profit nursing homes: A systematic review & meta-analysis. BMJ. 2009 Aug 4; 339:b2732.

Liberati A, Altman D, Tetzlaff JM, Mulrow C, Goetzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA Statement for reporting system-atic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009 Oct; 62(10):e1-34.

Karthikeyan G, Moncur RA, Levine O, Heels-Ansdell D, Chan MTV, Alonso-Coello P, Yusuf S, Sessler D, Villar JC, Berwanger O, McQueen M, Mathew A, Hill S, Gibson S, Berry C, Yeh H-M, Devereaux PJ. Is a pre-operative brain natriuretic peptide or N-terminal pro-B type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol. 2009; 54:1599-606.

Poldermans D, Devereaux PJ. The experts debate: Perioperative beta-blockade for noncardiac surgery

– proven safe or not? Cleveland Clinic Journal of Medicine. 2009; 76 (Suppl 4):S84-92.

Rahim SA, Mody A, Pickering J, Devereaux PJ, Yusuf S. Iatrogenic adverse events in the coronary care unit. Circ Cardiovasc Qual Outcomes. 2009 Sep; 2(5):437-42.

Devereaux PJ. Can attenuation of the perioperative stress response prevent intermediate and long-term cardiovascular outcomes among patients undergoing noncardiac surgery? Anesthesiology. 2009; 111:223-6.

Chow CK, Moayyedi P, Devereaux PJ. Is it safe to use a proton pump inhibitor with clopidogrel? Pol Arch Med Wewn. 2009; 119:564-8.

DOKAINISH, H.Publications

Dokainish H, Sengupta R, Pillai M, Bobek J, Lakkis N. Correlation of Tissue Doppler and Two-Dimensional Speckle Myocardial Velocities and Comparison of Derived Ratios with Invasively Measured Left Ventricular Filling Pressures. J Am Soc Echocardiogr. 2009; 22:284-9.

Alam M, Dokainish H, Lakkis NM. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis. Eur Heart J. 2009; 30:1080-7.

Vazquez J, Coselli J, Dokainish H. Saphenous venous graft pseudoaneurysm masquerading as a liver mass. Can J Cardiol. 2009; 25:e292-3.

Zhang L, Dokainish H. Echocardiography in the Assessment of Heart Failure. Minerva Cardiol. 2009; 57:457-66.

Alam M, Gonzalez R, Delarosa A, Bobek J, Dokainish H, Lakkis N. In vitro inhibition of platelet aggregation in response to increasing concentrations of tirofiban in patients with significant renal insufficiency. Am Heart Hosp J. 2009; 7:17-20.

Book Chapter

Dokainish H. Echocardiography. In: Cardiology Secrets (ed. Levine GN), Elsevier, Inc., Philadelphia, 2009.

DOLOVICH, M.Publication

Dolovich MB. 18F-FDG PET Imaging of Pulmonary Functions, Pathology and Drug Delivery. Proc Amer Thoracic Soc. 2009; 6(5):477-85.

DORASAMY, P.Publications

Goodridge DM, Marciniuk DD, Brooks D, van Dam A, Hutchinson S, Bailey P, Baxter S, Dumont S, Hassan S, Hernandez P, Kerigan A, Rocker G, Wilson D, Young J. End-of-Life care for persons with advanced chronic obstructive pulmonary disease: Report of a national interdisciplinary consensus meeting. Can Respir J. 2009 Sep-Oct; 16(5):e51-3.

Dorasamy P. Cheung J. Pulmonary Arterial Hypertension: Pathophysiologic mechanisms and new therapeutic options. South African Respiratory Journal. 2009 Dec; 15(4):140-6.

130

PUBLICATIONS

DOUKETIS, J.Publications

Cook D, Sinuff T, Zytaruk N, Rabbat C, Lee A, O’Donnell M, Thabane L, Linkins L, Treleaven D, Patel R, Meade M, Crowther M, Marshall JC, Douketis J. Event adju-dication and data monitoring in an intensive care unit observational study of thromboprophylaxis. For the DIRECT Investigators and Canadian Critical Care Trials Group. J Crit Care. 2009 Jun; 24(2):168-75.

Nematullah A, Alabousi A, Blanas N, Douketis J, Sutherland SE. Dental surgery for patients on antico-agulant therapy with warfarin: a systematic review and meta-analysis. Tex Dent J. 2009 Dec; 126(12):1183-93.

Jamula E, Anderson J, Douketis J. Safety of continu-ing warfarin therapy during cataract surgery. A sys-tematic review and meta-analysis. Thromb Res. 2009; 124(3):292-9.

Jamula E, Woods K, Verhovsek M, Douketis J. Comparison of pain and ecchymosis with low-molecular-weight heparin vs. Unfractionated heparin in patients requiring bridging anticoagulation after warfarin interruption: a randomized trial. J Thromb Thrombolysis. 2009 Oct; 28(3):266-8.

Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery. Thromb Res. 2009; 123(5):687-96.

Sud S, Douketis J. ACP Journal Club. The devil is in the details…or not? A primer on individual patient data meta-analysis. Ann Intern Med. 2009; 151(2):JC1-2, JC1-3.

Cook DJ, Douketis J, Arnold D, Crowther MA. Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency. Curr Opin Pulm Med. 2009 Sep; 15(5):455-62.

Couturaud F, Leroyer C, Julian JA, Kahn SR, Ginsberg JS, Wells PS, Douketis JD, Mottier D, Kearon C. Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism. Chest. 2009 Dec; 136(6):1537-45.

Cook D, Tkaczyk A, Lutz K, McMullin J, Haynes RB, Douketis J. Thromboprophylaxis for hospitalized medi-cal patients: a multicenter qualitative study. J Hosp Med. 2009 May; 4(5):269-75.

Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, Benson A, Misselwitz F, Fisher WD;RECORD4 Investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet. 2009 May 16; 373(9676):1673-80.

ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009 May 14; 360(20):2066-78.

Douketis J, Gu C, Piccioli A, Ghirarduzzi A, Pengo V, Prandoni P. The long-term risk of cancer in patients with a first episode of venous thromboembolism. J Thromb Haemost. 2009 Apr; 7(4):546-51.

Jamula E, Woods K, Verhovsek M, Douketis J. Comparison of pain and ecchymosis with low-molecular-weight heparin vs. Unfractionated heparin in patients requiring bridging anticoagulation after warfarin interruption: a randomized trial. J Thromb Thrombolysis. 2009; 28:266-8.

Douketis J. Perioperative management of antithrom-botic therapy: lifting the fog. J Thromb Haemost. 2009 Dec; 7(12):1979-81.

Jaeschke R, Gajewski P, Bates SM, Douketis J, Solnica B, Crowther M, et al. 2009 evidence-based clinical practice guidelines for diagnosing a first episode of lower extremities deep vein thrombosis in ambulatory outpatients. Pol Arch Med Wewn. 2009; 119(9):541-9.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Progue J, Reilly PA, Themeles E, Varrone J. et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 17;361(12):1139-51.

EIKELBOOM, J.Publications

Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, Baanstra D, Schnee J, Goldhaber SZ; RE-COVER Study Group including Eikelboom JW. Dabigatran versus warfarin in the treat-ment of acute venous thromboembolism. N Engl J Med. 2009; 361(24):2342-52.

Fitchett D, Eikelboom JW, Fremes S, Mazer D, Singh S, bittira B, Brister S, Graham JJ, Gupta M, Karkouti K, Lee A, Love M, McArthur R, Peteson M, Verma S, Yau TM. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a posi-tion statement of the Canadian Cardiovascular Society. Can J Cardiol 2009; 5(12):683-9.

Rao S, Eikelboom JW, Steg G, Lincoff M, Weintraub WS, Bassand JP, Rao AK, Gibson M, Petersen JL, Mehran R, Manoukian SV, Mosucci M, Harrington RA; Academic Bleeding Consensus Multidisciplinary Working Group. Standardized reporting of bleeding complications for clinical investigations in acute coro-nary syndromes: a proposal from the academic bleed-ing consensus (ABC) multidisciplinary working group. Am Heart J. 2009; 58(6):881-6.e1.

Sobieraj-Teague M, Eikelboom JW. ACP Journal Club: Percutaneous closure of the left atrial appendage was noninferior to warfarin in atrial fibrillation. Ann Intern Med. 2009; 51(10):JC5-10.

Eikelboom JW, Quinlan DJ, O’Donnell M. Major Bleeding, Mortality and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials. Circulation. 2009; 20(20):2006-11.

Bassand JP, Afzal R, Eikelboom JW, Wallentin L, Peters R, Budaj A, Fox KAA, Joyner CD, Chrolavicius S, Granger CB, Mehta S, Yusuf S on behalf of the OASIS 5 & OASIS 6 investigators. Relationship between base-line hemoglobin and major bleeding complications in acute coronary syndromes. European Heart Journal. 2009; 1(1):50-8.

Sobieraj-Teague M, O’Donnell M, Eikelboom JW. New Anticoagulants for Atrial Fibrillation. Sem Thrombo Haemost. 2009; 5(5):515-24.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom JW, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and investigators. Dabigatran versus warfarin in patients with atrial fibril-lation. N Engl J Med. 2009; 61(12):1139-51.

Garcia D, Ageno W, Bussey H, Eikelboom JW, Margaglione M, Maronguiu F, Moia M, Palareti G, Pengo V, Poli D, Schulman S, Witt D, Wittkoksy,

Crowther M. Prevention of Bleeding Complications in Patients on Oral Anticoagulation Therapy. Am J Hematol. 2009; (84)9:579-83.

Karthikeyan G, Math RS, Matthew N, Shankar B, Kalaivani M, Singh S, Bahl VK, Hirsh J, Eikelboom JW. Accelerated infusion of streptokinase for the treatment of left-sided prosthetic valve thrombosis: a random-ized controlled trial. Circulation. 2009; 120(12):1108-14.

Raju NC, Dimmitt S, Eikelboom JW. Rivaroxaban ver-sus enoxaparin after total knee arthroplasty. Lancet. 2009; 374(9691):681.

Eikelboom JW, Weitz J. Otamixaban in place of heparin for patients with acute coronary syndromes undergo-ing percutaneous coronary interventions. Lancet. 2009; 374 (9692):762-4.

Sun J, Davidson MJ, Lamy A, Eikelboom JW. Antithrombotic management of patients with pros-thetic heart valves: current evidence and future trends. Lancet 2009; 374(9689): 565-76.

Quinlan DJ, Eikelboom JW. Low-molecular-weight heparin as an adjunct to thrombolysis in ST eleva-tion myocardial infarction. Arch Intern Med. 2009; 169(12):1163-4.

Raju N, Hirsh J, Eikelboom JW. Duration of antico-agulation for venous thromboembolism. Med J Aust. 2009; 190 (12):659-60.

Karthikeyan G, Eikelboom JW, Turpie AGG, Hirsh J. Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism? BJH . 2009; 146(2):142-9.

Karthikeyan G, Eikelboom JW, Hirsh J. New oral anti-coagulants: not quite there yet. Pol Arch Med Wewn. 2009; 119(1-2):53-8.

Indian Polycap Study (TIPS) writing group including Yusuf S, Pais P, Afzal R, Xavier D, Teo K, Eikelboom JW, Sigamani A, Mohan V, Gupta R, Thomas N. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet. 2009; 373:1341-51.

ACTIVE Investigators (including Eikelboom JW), Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009; 360(20):2066-78.

Kasiman K, Eikelboom JW, Hankey G, Lee S, Lim J, Lee J, Chang HM, Wong MC, Chen C. Ethnicity Does Not Affect the Homocysteine-Lowering Effect of Vitamin Therapy in Singaporean Stroke Patients: A ran-domised sub-study of the VITATOPS trial. Stroke. 2009; 40(6):2209-11.

Karthikeyan G, Mehta S, Eikelboom JW. Fondaparinux in the treatment of acute coronary syndromes: evi-dence from the Organization for the Assessment of Strategies for Ischemic Syndromes (OASIS) 5 and 6 studies. Expert Rev Cardiovasc Therapy. 2009;7(3):241-9.

Steinhubl S, Bhatt D, Brennan D, Montalescot G, Hankey G, Eikelboom JW, Berger P, Topol E on behalf of CHARISMA Investigators. Aspirin to prevent cardio-vascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding. Ann Intern Med. 2009; 150(6):379-86.

Karthikeyan G, Eikelboom JW. Treatment of Intermittent Claudication. BMJ. 2009; 338:b46.

Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. AAOS and ACCP Guidelines for VTE Prevention in Hip and Knee Arthroplasty Differ: What are the Implications for Clinicians and Patients? Chest. 2009; 135(2):513-20.

Robinson M, Healey JS, Eikelboom JW, Schulman S, Morillo CA, Nair G, Baranchuk A, Ribas S, Evans G, Connolly SJ, Turpie AGG. Post-Operative Low Molecular Weight Heparin Bridging is Associated with an Increase in Wound Hematoma Following Pacemaker and ICD Surgery. PACE. 2009; 32(3):378-82.

Eikelboom JW, Weitz J. Anticoagulation for ST-segment elevation myocardial infarction. Circulation. 2009; 119(9):1186-8.

Weitz JI, Eikelboom JW. Dabigatran Etexilate for Prevention of Venous Thromboembolism. Thromb Haemost. 2009 Jan; 101(1):2-4.

Yong G, Rankin J, Ferguson L, Thom J, French J, Brieger D, Chew DP, Dick R, Eccleston D, Hockings B, Walters D, Wheln A, Eikelboom JW. Randomized trial comparing 600 mg with 300 mg loading dose of clopi-dogrel in patients with non-ST elevation acute coro-nary syndrome undergoing percutaneous coronary intervention: Results of the PRACTICAL Trial. Am Heart J. 2009; 157(1):60.e1-9.

FORSYTHE, P.Publications

Kunze WA, Mao YK, Wang B, Huizinga JD, Ma X, Forsythe P, Bienenstock J. Lactobacillus reuteri enhanc-es excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. J Cell Mol Med. 2009 Aug; 13(8B):2261-70.

Morris KE, St Laurent CD, Hoeve RS, Forsythe P, Suresh MR, Mathison RD, Befus AD. Autonomic ner-vous system regulates secretion of anti-inflammatory prohormone SMR1 from rat salivary glands. Am J Physiol Cell Physiol. 2009 Mar; 296(3):C514-24.

Karimi K, Inman MD, Bienenstock J, Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med. 2009 Feb 1; 179(3):186-93.

Book Chapter

Forsythe P, Bienenstock J. Neural regulation of the immune response. In: Allergy Frontiers: Epigenetics To Future Perspectives: Volume 2 (eds.Holgate S, Pawankar R and Rosenwaser L), pp. 493-514, 2009.

FREITAG, A.Publication

Vandemheen KL, O’Connor A, Bell S, Freitag A, Bye P, Jeanneret A, Berthiaume Y, Brown N, Wilcox P, Ryan G, Brager N, Rabin H, Morrison N, Gibson P, Jackson M, Paterson N, Middleton P, Aaron SD. Randomized trial of a decision aid for cystic fibrosis patients considering lung transplantation. Am J Respir Crit Care Med. 2009; 180:761-8.

Book Chapter

Newhouse MT, Labiris NR, Freitag A. Inhaled anti-biotics: Why Tobi and other aminoglycosides. In: Respiratory Drug Delivery, Europe 2009 (eds. Dalby RN, Byron PR, Peart J), Davis Healthcare Int’l Publishing, LLC., River Grove, Illinois, 2009.

132

PUBLICATIONS

GANGJI, A.Publications

Gangji AS, Brimble KS, Margetts PJ. Association between Markers of Inflammation and Fibrosis and Hypervolemia in Peritoneal Dialysis Patients. Blood Purif. 2009; 28:354-8.

Akl EA, Briel M, You JJ, Lamontagne F, Gangji A, Cukierman-Yaffe T, Alshurafa M, Sun X, Nerenberg KA, Johnston BC, Vera C, Mills E, Bassler D, Salazar A, Bhatnagar N, Busse JW, Khalid Z, Walter SD, Cook DJ, Schunemann HJ, Altman DG and Guyatt GH. LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact. Trials Journal. 2009; 10:40.

GAUVREAU, G.Publications

Boulet L-P, Lemière C, Gauvreau GM, Olivenstein R, Lougheed D, Paradis B, O’Byrne P, Pageau R, Renzi PM. Safety, pharmacodynamics and pharmacokinetics of TPI 1020 in smokers with asthma. Resp Med. 2009; 103:1159-66.

Davis BE, Illamperuma C, Gauvreau GM, Watson RM, O’Byrne PM, Deschesnes F, Boulet LP, Cockcroft DW. Single dose desloratadine and montelukast and aller-gen-induced late airway responses. Eur Respir J. 2009; 33(6):1302-8.

O’Byrne PM, Gauvreau G. Phosphodiesterase-4 inhibi-tion in COPD. Lancet. 2009 Aug 29; 374(9691):665-7.

O’Byrne PM, Gauvreau GM, Murphy DM. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma. J Allergy Clin Immunol. 2009; 124(3):397-403.

Gauvreau GM, Ellis AK, Denburg JA. Haemopoietic processes in allergic disease: eosinophil/basophil development. Clin Exp Allergy. 2009 Sep; 39(9):1297-306.

Book Chapter

Gauvreau GM, Sehmi R. Hematopoetic Mechanisms in Rhinitis and Asthma. In: Allergy Frontiers: From Epigenetics to Future Perspectives (eds. Pawankar R, Holgate S, Rosenwasser LJ), Springer, Japan, 2009.

GERSTEIN, H.Publications

Goyal A, Mehta SR, Díaz R, Gerstein HC, Afzal R, Xavier D, Liu L, Pais P, Yusuf S. Differential Clinical Outcomes Associated With Hypoglycemia and Hyperglycemia in Acute Myocardial Infarction. Circulation. 2009; 120(24):2429-37.

Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR, Moritz TE, Neal BC, Ninomiya T, Patel AA, Paul SK, Travert F, Woodward M. Intensive glucose con-trol and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009; 52:2288-98.

Hanley AJG, Retnakaran R, Qi Y, Gerstein HC, Perkins P, Raboud J, Harris SB, Zinman B. Association of hematological parameters with insulin resistance and beta-cell dysfunction in non-diabetic subjects: The PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort. J Clin Endocrinol Metab. 2009; 94(10):3824-32.

Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJV. Albuminuria in chronic heart failure: Prevalence and prognostic impor-tance. Lancet. 2009; 374:543-50.

Petrik J, Bruin J, Gerstein HC, Holloway AC. Effects of rosiglitazone on ovarian function and fertility in ani-mals with reduced fertility following fetal and neonatal exposure to nicotine. Endocrine. 2009; 36(2):281-90.

Lonn EM, Gerstein HC, Sheridan P, Smith S, Diaz R, Mohan V, Bosch J, Yusuf S, Dagenais GR; DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) and STARR Investigators. Effect of ramipril and of rosiglitazone on carotid inti-ma-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone). J Am Coll Cardiol. 2009; 53:2028-35.

Gerstein HC. Is it possible to reduce cardiovascu-lar risk with glucose-lowering approaches? Nat Rev Endocrinol. 2009; 5(5):270-5.

Holbrook A, Thabane L, Keshavjee K, Dolovich L, Bernstein B, Chan D, Troyan S, Foster G, Gerstein H. Individualized Electronic Decision Support and Reminders Can Improve Diabetes Care in the Community: COMPETE II Randomized Trial for COMPETE II Investigators. Can Med Assoc J. 2009; 181:37-44.

Preiss D, Zetterstrand S, McMurray JJ, Ostergren J, Michelson EL, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Gerstein HC, Sattar N; for the CHARM Investigators. Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Diabetes Care. 2009; 32:915-20.

Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, Miller ME, Coker LH, Murray A, Sullivan MD, Marcovina SM, Launer LJ; Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Investigators. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascu-lar risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care. 2009; 32(2):221-6.

Cukierman-Yaffe T, Gerstein HC, Anderson C, Zhao F, Sleight P, Hilbrich L, Jackson SH, Yusuf S, Teo K, ONTARGET/TRANSCEND Investigators. Glucose intolerance and diabetes as risk factors for cogni-tive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme. Diabetes Res Clin Pract. 2009; 83(3):387-93.

Goyal A, Shamir Mehta S, Gerstein H, Díaz R, Afzal R, Xavier D, Zhu J, Pais P, Lisheng L, Kazmi K, Zubaid M, Piegas L, Widimsky P, Budaj A, Avezum A, Yusuf S. Glucose levels compared with diabetes history in the risk assessment of acute myocardial infarction patients. Am Heart J. 2009; 157:763-70.

GINSBERG, J.Publications

Laskin CA, Crowther MA, Ginsberg JS, Spitzer KA, Clark CA, Hawker GA, Kingdom JS, Barrett J, Gent M. Low molecular weight heparin and aspirin for recur-rent pregnancy loss: Results from the randomized, controlled HepASA trial. J Rheumatol. 2009; 36:279-87.

Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C. Oral vitamin K vs. placebo in the correc-tion of excessively anticoagulated patients on warfarin: results of a randomized, controlled trial. Ann Int Med. 2009; 150:293-300.

RE-MOBILIZE Writing Committee, Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Huo MH, Lieberman JR, Muntz JE, Raskob GE, Clements ML, Hantel S, Schnee JM, Caprini JA. Oral thrombin inhibitor dabigatran etexilate vs North America enoxa-parin regimen for prevention of venous thromboem-bolism after knee arthroplasty surgery. J Arthroplasty. 2009; 24:1-9.

Chan WS, Lee A, Spencer FA, Crowther M, Rodger M, Ramsay T, Ginsberg JS. Predicting deep venous throm-bosis in pregnancy: out in “LEFT” field? Ann Intern Med. 2009; 151:85-92.

Couturaud F, Leroyer C, Julian JA, Kahn SR, Ginsberg JS, Wells PS, Douketis JD, Mottier D, Kearon C. Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism. Chest. 2009; 136:1537-45.

Chan WS, Ginsberg JS. Diagnosis of venous thrombo-embolism in pregnancy: a study in extrapolation or a science in evolution? Expert Rev Cardiovasc Ther. 2009; 7(12):1479-82.

Ginsberg JS, Brill-Edwards P, Demers C, Donovan D, Panju A. D-dimer in patients with clinically suspected pulmonary embolism. Chest 75th Commemorative Edition. 2009; 136(suppl 5)e30.

Book Chapter

O’Donnell M, Ginsberg JS, Kearon C. Thrombosis. In: Hazzard’s Geriatric Medicine and Gerontology 6th Edition (eds. Halter, Ouslander, Tinetti, Studenski, High, Asthana), McGraw Hill Medical, Chicago, pp. 1243-52, 2009.

GRANT, M.Publications

Grant MM. CSMLS prior learning assessment clients – A snapshot. Canadian Journal of Medical Laboratory Science. 2009; 71(5):194-203.

Grant MM. Simulation-based learning in medical labo-ratory education: A critique of the literature. Canadian Journal of Medical Laboratory Science. 2009; 71(3):107-16.

Grant MM, Gropper R. Career awareness and recruit-ment strategies in Canadian health professions programs: A preliminary study. Canadian Journal of Medical Laboratory Science. 2009; 71(1):17-27.

GROSS, P.Publications

Reheman A, Yang H, Zhu G, Jin W, He F, Spring CM, Bai X, Gross PL, Freedman J, Ni H. Plasma fibronectin depletion enhances platelet aggregation and throm-bus formation in mice lacking fibrinogen and von Willebrand factor. Blood. 2009; 113:1809-17.

Zhou J, May L, Liao P, Gross PL, Weitz JI. Inferior vena cava ligation rapidly induces tissue factor and venous thrombosis. Atheroscl Thromb Vasc Biol. 2009; 29:863-9.

Gross PL, Weitz JI. Novel antithrombotics. Clin Pharm Therapeutics. 2009; 86:139-46.

Gui T, Reheman A, Ni H, Gross PL, Monahan PE, Stafford DW. Abnormal hemostasis in a knock-in mouse carrying a variant of Factor IX with impaired binding to collagen type IV. J Thrombosis Hemostas. 2009; 7:1843-51.

Bai X, Weitz, JI, Gross PL. Leukocyte urokinase plas-minogen activator receptor and PSGL 1 play a role in endogenous arterial fibrinolysis. Thromb Hemostas. 2009; 102:1212-18.

Book Chapters

Gross PL, Murray RK, Rand ML. Hemostasis and Thrombosis. Chapter 51. In: Harper’s Biochemistry, 26th edition (ed. Murray RK), Lange-McGraw-Hill, 2009.

Murray RK, Gross PL. Biochemical Case Histories. Chapter 54. In: Harper’s Biochemistry, 26th edition (ed. Murray RK), Lange-McGraw-Hill, 2009.

GROVER, A.Publication

Qayyum F, Al-Bondokji I, Kuszczak I, Samson SE, Grover AK. Sodium-calcium exchange mediated con-traction in left anterior descending and left ventricular branch arteries. J Cell Mol Med. 2009; 13:3742-52.

GULENCHYN, K.Y.Publications

Gulenchyn KY, Webber CE. Is thyroid screening neces-sary for nuclear medicine personnel receiving and administering capsules containing large doses of 131I? JMIRS. 2009(3)40:60-3.

Maziak DE, Darling GE, Inculet RI, Gulenchyn KY, Driedger AA, Ung YC, Miller JD, Gu CS, Cline KJ, Evans WK, Levine MN. Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med. 2009 Aug 18;151(4):221-8, W-48.

D’Egidio G, Nichol G, Williams KA, Guo A, Garrard L, deKemp R, Ruddy TD, DaSilva J, Humen D, Gulenchyn KY, Freeman M, Racine N, Benard F, Hendry P, Beanlands RS; PARR-2 Investigators. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovasc Imaging. 2009 Sep; 2(9):1060-8.

Evans WK, Laupacis A, Gulenchyn KY, Levin L, Levine MN. An evidence-based approach to the introduction of positron emission tomography in Ontario, Canada. J Clin Oncol. 2009 27(33): 5607-13.

Book Chapter

Ashique R, Chirakal R, Schrobilgen GJ, Hughes DW, Farncombe T, Gulenchyn K, Labiris R, Truman T, Saab C. Reactivity and selectivity of F2 toward 3,4,6-Tri-O-acetyl-D-Glucal in anahydrous HF: Synthesis of [18F]2-Fluoro-2-deoxy-ń-D-allose and its use for the detection of a breast tumor. Chapter10 in ACS Symposium Series 1003: Fluorinated Heterocycles. Gakh AA and Kirk KL eds., published by the American Chemical Society, Washington DC, 2009.

134

PUBLICATIONS

GUPTA, M.Publications

Fitchett D, Eikelboom J, Fremes S, Mazer D, Singh S, Bittira B, Brister S, Graham JJ, Gupta M, Karkouti K, Lee A, Love M, McArthur R, Peterson M, Verma S, Yau TM. Dual antiplatelet therapy in patients requir-ing urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society. Can J Cardiol. 2009 Dec; 25(12):683-9.

Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, Couture P, Dufour R, Fodor G, Francis GA, Grover S, Gupta M, Hegele RA, Lau DC, Leiter L, Lewis GF, Lonn E, Mancini GB, Ng D, Pearson GJ, Sniderman A, Stone JA, Ur E. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and preven-tion of cardiovascular disease in the adult - 2009 rec-ommendations. Can J Cardiol. 2009 Oct; 25(10):567-79. Review.

Gupta M, Braga MF, Teoh H, Tsigoulis M, Verma S. Statin effects on LDL and HDL cholesterol in South Asian and white populations. J Clin Pharmacol. 2009 Jul; 49(7):831-7.

Lovren F, Pan Y, Shukla PC, Quan A, Teoh H, Szmitko PE, Peterson MD, Gupta M, Al-Omran M, Verma S. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. Am J Physiol Endocrinol Metab. 2009 Jun; 296(6):E1440-9.

GUYATT, G.Publications

Brozek JL, Guyatt GH, Heels-Ansdell D, Degl’Innocenti A, Armstrong D, Fallone CA, Wiklund I, van Zanten SV, Chiba N, Barkun AN, Akl EA, Schünemann HJ. Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD. J Clin Epidemiol. 2009 Jan; 62(1):102-10.

Attia J, Ioannidis JP, Thakkinstian A, McEvoy M, Scott RJ, Minelli C, Thompson J, Infante-Rivard C, Guyatt G. How to use an article about genetic association: A: Background concepts. JAMA. 2009 Jan 7; 301(1):74-81.

Attia J, Ioannidis JP, Thakkinstian A, McEvoy M, Scott RJ, Minelli C, Thompson J, Infante-Rivard C, Guyatt GH. How to use an article about genetic association: B: Are the results of the study valid? JAMA. 2009 Jan 14; 301(2):191-7.

Attia J, Ioannidis JP, Thakkinstian A, McEvoy M, Scott RJ, Minelli C, Thompson J, Infante-Rivard C, Guyatt GH. How to use an article about genetic association: C: What are the results and will they help me in caring for my patients? JAMA. 2009 Jan 21; 301(3):304-8.

Mullan RJ, Flynn DN, Carlberg B, Tleyjeh IM, Kamath CC, LaBella ML, Erwin PJ, Guyatt GH, Montori VM. Systematic reviewers commonly contact study authors but do so with limited rigor. J Clin Epidemiol. 2009 Feb; 62(2):138-42.

Busse JW, Kaur J, Mollon B, Bhandari M, Tornetta P Third, Schünemann HJ, Guyatt GH. Low intensity pulsed ultrasonography for fractures: systematic review of randomised controlled trials. BMJ. 2009 Feb 27; 338:b351.

Briel M, Ferreira-Gonzalez I, You JJ, Karanicolas PJ, Akl EA, Wu P, Blechacz B, Bassler D, Wei X, Sharman A, Whitt I, Alves da Silva S, Khalid Z, Nordmann AJ, Zhou Q, Walter SD, Vale N, Bhatnagar N, O’Regan C, Mills EJ, Bucher HC, Montori VM, Guyatt GH. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ. 2009 Feb 16; 338:b92.

Karanicolas PJ, Bhandari M, Walter SD, Heels-Ansdell D, Guyatt GH; Collaboration for Outcomes Assessment in Surgical Trials (COAST) Musculoskeletal Group. Radiographs of hip fractures were digitally altered to mask surgeons to the type of implant without compro-mising the reliability of quality ratings or making the rating process more difficult. J Clin Epidemiol. 2009 Feb; 62(2):214-23.

Bae JM, Lee EJ, Guyatt G. Citrus fruit intake and pan-creatic cancer risk: a qualitative systematic review. Pancreas. 2009 Mar; 38(2):168-74.

Nannenga MR, Montori VM, Weymiller AJ, Smith SA, Christianson TJ, Bryant SC, Gafni A, Charles C, Mullan RJ, Jones LA, Bolona ER, Guyatt GH. A treatment deci-sion aid may increase patient trust in the diabetes specialist. The Statin Choice randomized trial. Health Expect. 2009 Mar; 12(1):38-44.

Djulbegovic B, Guyatt GH, Ashcroft RE. Epistemologic inquiries in evidence-based medicine. Cancer Control. 2009 Apr; 16(2):158-68.

Busse JW, Guyatt GH. Optimizing the use of patient data to improve outcomes for patients: narcotics for chronic noncancer pain. Expert Rev Pharmacoecon Outcomes Res. 2009 Apr; 9(2):171-9.

Busse JW, Bhandari M, Guyatt GH, Heels-Ansdell D, Mandel S, Sanders D, Schemitsch E, Swiontkowski M, Tornetta P 3rd, Wai E, Walter SD; The SPRINT Investigators. Use of both short musculoseletal func-tion assessment questionnaire and short form-36 among tibial-fracture patients was redundant. J Clin Epidemiol. 2009 Nov; 62(11):1210-7.

Turner D, Schünemann HJ, Griffith LE, Beaton DE, Griffiths AM, Critch JN, Guyatt GH. Using the entire cohort in the receiver operating characteristic analysis maximizes precision of the minimal important differ-ences. J Clin Epidemiol. 2009 Apr; 62(4):374-9.

Ferreira-Gonzalez I, Permanyer-Miralda G, Busse JW, Devereaux PJ, Guyatt GH, Alonso-Coello P, Montori VM. Composite outcomes can distort the nature and magnitude of treatment benefits in clinical trials. Ann Intern Med. 2009 Apr 21; 150(8):556-7.

Mills EJ, Chan AW, Wu P, Vail A, Guyatt GH, Altman DG. Design, analysis and presentation of crossover. Trials. 2009 Apr 30;10:27.

Barba M, Schünemann HJ, Sperati F, Akl EA, Musicoo F, Guyatt GH, Muti P. The effects of metformin on endog-enous androgens and SHBG in women: a systematic review and meta-analysis. Clin Endocrinol (Oxf). 2009 May; 70(5):661-70.

Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, Phillips B, Lelgemann M, Lethaby A, Bousquet J, Guyatt GH, Schünemann HJ; GRADE Working Group. Grading quality of evidence and strength of recommendations in clinical practice guide-lines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009 May; 64(5):669-77.

Karanicolas PJ, Bhandari M, Kreder Hans, Moroni A, Richardson M, Walter SD, Norman GR, Guyatt GH, and on Behalf of the Collaboration for Outcomes Assessment in Surgical Trials (COAST) Musculoskeletal Group. Evaluating Agreement: Conducting a Reliability Study. J Bone Joint Surg Am. 2009; 91-99-106.

Karanicolas PJ, Montori VM, Devereaux PJ, Schünemann H, Guyatt GH. The practicalists’ response. J Clin Epidemiol. 2009 May; 62(5):489-94.

Elamin MB, Flynn DN, Bassler D, Briel M, Alonso-Coello P, Karanicolas PJ, Guyatt GH, Malaga G, Furukawa TA, Kunz R, Schünemann HJ, Murad M, Barbui C, Cipriani A, Montori VM. Choice of data extraction tools for systematic reviews depends on resources and review complexity. J Clin Epidemiol. 2009 May; 62(5):506-10.

Karanicolas PJ, Montori VM, Devereaux PJ, Schünemann H, Guyatt GH. A new ‘mechanistic-practi-cal’ framework for designing and interpreting random-ized trials. J Clin Epidemiol. 2009 May; 62(5):479-84.

Solanes I, Güell R, Casan P, Sotomayor C, Gonzalez A, Feixas T, Gonzalez M, Guyatt GH. Duration of pul-monary rehabilitation to achieve a plateau in qual-ity of life and walk test in COPD. Respir Med. 2009 May;103(5);722-8.

Oude Elberink JN, van der Heide S, Guyatt GH, Dubois AE. Immunotherapy improves health-related quality of life of adult patients with dermal reactions follow-ing yellow jacket stings. Clin Exp Allergy. 2009 Jun; 39(6):883-9.

Karanicolas PJ, Dubois L, Colquhoun PH, Swallow CJ, Walter SD, Guyatt GH. The more the better?: The impact of surgeon and hospital volume on in-hospital mortality following colorectal resection. Ann Surg. 2009 Jun; 249:96:954-9.

Palmer A, Tomkinson J, Phung C, Ford N, Joffres M, Fernandes KA, Zeng L, Lima V, Montaner JS, Guyatt GH, Mills EJ. Does ratification of human-rights treaties have effects on population health? Lancet. 2009 Jun 6; 373(9679):1987-92.

Akl EA, Briel M, You JJ, Lamontagne F, Gangji A, Cukiermann-Yaffe T, Alshurafa M, Sun X, Nerenberg KA, Johnston BC, Vera C, Mills EJ, Bassler D, Salazar A, Bhatnagar N, Busse JW, Khalid Z, Walter S, Cook DJ, Schünemann HJ, Altman DG, Guyatt GH. LOST to fol-low-up Information in Trials (LOST-IT): a protocol on the potential impact. Trials. 2009 Jun 11;10:40.

Karanicolas PJ, Montori VM, Schünemann HJ, Guyatt GH. ACP Journal Club, ‘Pragmatic’ clinical trails: from whose perspective? Ann Intern Med. 2009 Jun 16; 150(12):JC6-2, JC6-3.

Karanicolas PJ, Bhandari M, Walter DS, Heels-Ansdell D, Anders D, Schemitsch E, Guyatt GH. Interobserver reliability of classification systems to rate the quality of femoral neck fracture reduction. J Orthop Trauma. 2009 Jul; 23(6):408-12.

Briel M, Lane M, Montori VM, Bassler D, Glasziou P, Malaga G, Akl E, Ferreira-Gonzalez I, Alonso-Coello P, Urrutia G, Kunz R, Ruiz Culebro C, Alves da Silva S, Flynn DN, Elamin MB, Strahm B, Murad MH, Djulbegovic B, Adhikari NK, Mills EJ, Gwadry-Sridhar F, Kirpalani H, Soares HP, Abu Elnour NO, You JJ, Karanicolas PJ, Bucher HC, Lampropulos JF, Nordmann AJ, Burns KE, Mulla SM, Raatz H, Sood A, Kaur J, Bankhead CR, Mullan RJ, Nerenberg KA, Vandvik PO, Coto-Yglesias F, Schünemann HJ, Tuche F, Chrispim PP, Cook DJ, Lutz K, Biric CM, Vale N, Erwin PJ, Perera

R, Zhou Q, Heels-Ansdell D, Ramsay T, Walter SD, Guyatt GH. Stopping randomized trails early for ben-efit: a protocol of the Study of Trial Policy of Interm Truncation-2 (STOP-IT2). Trials. 2009 Jul 6; 10(1):49.

Hirsh J, Guyatt GH. Clinical experts or methodolo-gists to write clinical guidelines? Lancet. 2009 Jul 25; 374(9686):273-5.

Jones LA, Weymiller AJ, Shah N, Bryant SC, Christianson TJ, Guyatt GH, Gafni A, Smith SA, Montori VM. Should clinicians deliver decision AIDS? Further exploration of the statin choice randomized trial results. Med Decis Making. 2009 Jul-Aug; 29(4)468-74.

Djulbegovic B, Trikalinos TA, Roback J, Chen R, Guyatt G. Impact of quality of evidence on the strength of rec-ommendations: an empirical study. BMC Health Serv Res. 2009 Jul 21;9:120.

Comondore VR, Devereaux PJ, Zhou Q, Stone SB, Busse JW, Ravindran NC, Burns KE, Haines T, Stringer B, Cook DJ, Walter SD, Sullivan T, Berwanger O, Bhandari M, Banglawala S, Lavis JN, Petrisor B, Schünemann H, Walsh K, Bhatnagar N, Guyatt GH. Quality of Care in for-profit and not-for-profit nursing homes: systematic review and meta-analysis. BMJ. 2009 Aug 4; 339;b2732-47.

Brozek JL, Akl EA, Jaeschke R, Lang DM, Bossuyt P, Glasziou P, Helfand M, Ueffing E, Alonso-Coello P, Meerpohl J, Phillips B, Horvath AR, Bousquet J, Guyatt GH, Schünemann HJ; for the GRADE Working Group. Grading quality of evidence and strength of recom-mendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. Allergy. 2009 Aug; 64(8):1109-16.

Murad MH, Montori VM, Walter SD, Guyatt GH. Estimating risk difference from relative association measures in meta-analysis can infrequently pose inter-pretational challenges. J Clin Epidemiol. 2009 Aug; 62(8):865-7.

Simon LS, Strand CV, Boers M, Brooks PM, Tugwell PS, Bombardier C, Fries JF, Henry D, Goldkind L, Guyatt G, Laupacis A, Lynd L, Macdonald T, Mamdani M, Moore A, Saag KS, Silman AJ, Stevens R, Tyndall A. How to ascertain drug safety in the context of benefit. Controversies and concerns. J Rheumatol. 2009 Sep; 36(9):2114-21.

de Almeida JR, Al Khabori M, Guyatt GH, Witterick IJ, Lin VY, Nedzelski JM, Chen JM. Combined corticoste-roid and antiviral treatment for Bell palsy: a system-atic review and meta-analysis. JAMA. 2009 Sep 2; 302(9):985-93.

O’Regan C, Ghement I, Eyawo O, Guyatt GH, Mills EJ. Incorporating multiple interventions in meta-analysis; an evaluation of the mixed treatment comparison with the adjusted indirect comparison. Trials. 2009 Sep 21; 10:86-98.

Akl EA, Mustafa R, Wilson MC, Symons A, Moheet A, Rosenthal T, Guyatt GH, Schünemann HJ. Curricula for teaching the content of clinical practice guidelines to family medicine and internal medicine residents in the US; a survey study. Implement Sci. 2009 Sep 21; 4:59-67.

Mullan RJ, Montori VM, Shah ND, Christianson TJ, Bryant SC, Guyatt GH, Perestelo-Perez LI, Stroebel RJ, Yawn BP, Yapuncich V, Breslin MA, Pencille L, Smith SA. The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med. 2009 Sep 28; 169(17):1560-8.

136

PUBLICATIONS

Turner D, Schünemann HJ, Griffith LE, Beaton DE, Griffiths AM, Critch JN, Guyatt GH. The minimal detect-able change cannot reliably replace the minimal impor-tant difference. J Clin Epidemiol. Elsevier Inc.

Karanicolas PJ, Montori VM, Schünemann HJ, Guyatt GH. “Pragmatic” clinical trials: from whose perspec-tive? Evid Based Med. 2009 Oct;14(5):130-1. Also pub-lished as Ann Intern Med. 2009 Jun 16; 150(12):JC6-2, JC6-3.

Hill K, Mangovski-Alzamora S, Blouin M, Guyatt G, Heels-Ansdell D, Bragaglia P, Tamari I, Jones K, Goldstein R. Disease-specific education in the primary care setting increases the knowledge of people with chronic obstructive pulmonary disease: A randomized controlled trial. Patient Educ Couns.

Busse JW, Bhandari M, Guyatt GH, Heels-Ansdell D, Mandel S, Sanders D, Schemitsch E, Swiontkowski M, Tornetta P 3rd, Wai E, Walter SD; SPRINT Investigators. Use of both Sort Muscloskeletal Function Assessment questionnaire and Short Form-36 among tibial-fracture patients was redundant. J Clin Epidemiol. 2009 Nov; 62(11);1210-7.

Lamontagne F, Briel M, Guyatt GH, Cook DJ, Bhantnagar N, Meade M. Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: A meta-analysis of randomized controlled trials. J Crit Care.

Sun X, Briel M, Busse JW, Akl EA, You JJ, Bala M, Diaz-Granados N, Bassler D, Mertz D, Srinathan SK, Vandvik PO, Malaga G, Alshurafa M, Dahm P, Alonso-Coello P, Heels-Ansdell DM, Bhatnagar N, Johnston BC, Wang L, Walter SD, Altman DG, Guyatt GH. Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, report-ing and claim of subgroup effects in randomized trials. Trials. 2009 Nov 9; 10(1):101.

HARGREAVE, F.Publications

Nair PK, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichine E, Hargreave FE, O’Byrne PM. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. 2009 Mar 5;360:985-93.

Hargreave FE, Nair P. The definition and diagnosis of Asthma. Clin Exp Allergy. 2009 Nov; 39(11):1652-8.

HAYNES, B.Publications

Kilicoglu H, Demner-Fushman D, Rindflesch TC, Wilczynski NL, Haynes RB. Towards automatic recogni-tion of scientifically rigorous clinical research evidence. J Am Med Inform Assoc. 2009 Jan-Feb; 16(1):25-31.

Cocosila M, Archer N, Haynes RB, Yuan Y. Can wire-less text messaging improve adherence to preventive activities? Results of a randomised controlled trial. Int J Med Informatics. 2009; 78:230-8.

Cook DJ, Tkaczyk A, Lutz K, McMullin J, Haynes RB, Douketis J. Thromboprophylaxis for hospitalized medi-cal patients: A multicenter qualitative study. J Hospital Med. 2009; 4:269-75.

Kastner M, Wilczynski NL, McKibbon KA, Garg AX, Haynes RB. Bibliographic search strategies (“Clinical Queries”) for diagnostic accuracy studies perform well

for conducting systematic reviews of diagnostic tests. J Clin Epidem. 2009; 62:974–81.

Straus SE, Haynes RB. Managing evidence-based knowledge: the need for reliable, relevant and readable resources (Analysis). CMAJ. 2009; 180:943-4.

McKibbon KA, Wilczynski NL, Haynes RB. Retrieving therapy articles from Medline: Comparative data for 38 published search strategies. Health Inform Libr J. 2009; 26:187-202.

Garg AX, Iansavichus AV, Wilczynski NL, Kastner M, Baier LA, Shariff SZ, Rehman F, Weir M, McKibbon KA, Haynes RB. Filtering MEDLINE for a clinical discipline. BMJ. 2009 Sep 18; 339:b3435.

Wilczynski NL, Haynes RB. Consistency and accuracy of indexing systematic review articles and meta-analyses in MEDLINE. Health Info Libr J. 2009 Sep; 26(3):203-10.

Book Chapters

Haynes RB, You JJ. The architecture of diagnostic research. Chapter 2. In: The Evidence Base of Clinical Diagnosis. Theory and methods of diagnostic research. Second edition (eds. Knottnerus JA, Buntinx F), Oxford, Wiley-Blackwell, pp. 20-41, 2009.

Haynes RB. Practicing Evidence-Based Medicine. Chapter VII. In: ACP Medicine (ed. Nabel E, BC Decker, Philadelphia, 2009.

HEALEY, J.Publications

Healey JS, Krahn AD. Bad Lead? Good Lead? What should we believe? Heart Rhythm. 2009; 6(2): 210-1.

Robinson M, Healey JS, Eikelboom J, Schulman S, Morillo CA, Nair GM, Baranchuk A, Ribas S, Evans G, Connolly SJ, Turpie AG. Post-operative low molecular weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemak-ers and implantable defibrillators. Pacing and Clin Electrophysiol. 2009 Mar; 32(3):378-82.

Divakaramenon S, Healey JS. A case of long RP tachycardia. What is the Mechanism. J Cardiovasc Electrophysiol. 2009; 20(6):702-4.

Sumner G, Salehian O, Yi Q, Healey JS, Matthew J, Al-Merri K, Al-Nemer K, Mann JFE, Dagenais G, Lonn E. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients. J Cardiovasc Electrophysiol. 2009; 20(7):781-7.

Krahn AD, Healey JS, Chauhan VS, Birnie DH, Simpson CS, Champagne J, Gardner M, Sanatani S, Exner DV, Klein GJ, Yee R, Skanes AC, Gula LJ, Gollob MH. Systematic Assessment of Patients with Unexplained Cardiac Arrest: Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER). Circulation. 2009; 120(4):278-85.

Krahn AD, Simpson CS, Parkash R, Yee R, Champagne J, Healey JS, Cameron D, Thibault B, Mangat I, Tung S, Sterns LD, Birnie DH, Exner DV, Sivakumaran S, Davies T, Coutu B, Crystal E, Wolfe K, Verma A, Stephenson, Sananatani S, Gow R, Connors S, Ayala Paredes F, Turabian M, Essebag V, Gardiner M. Utilization of a national network for rapid response to device and lead advisories: Impact on the Fidelis lead advisory. The Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm. 2009 Apr; 6(4):474-7.

Whitlock R, Healey JS, Connolly SJ. Left atrial appendage does not eliminate the need for warfarin. Circulation. 2009; 120(19):1927-32.

Baranchuk A, Healey JS, Simpson CS, Redfearn DP, Morillo CA, Connolly SJ, Fitzpatrick M. Atrial overdrive pacing in sleep apnea: A meta-analysis. Europace. 2009; 11(8):1037-40.

Krahn AD, Healey JS, Simpson CS, Essebag V, Sivakumaran S, Birnie DH. Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: Wide variability of peri-operative bridging in Canada. Heart Rhythm. 2009; 6(9):1276-9.

Healey JS. Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation. Thrombosis and Hemostasis. 2009; 102(5):912-3.

Krahn AD, Simpson CS, Parkash R, Yee R, Champagne J, Healey JS, Cameron D, Thibault B, Mangat I, Tung S, Sterns L, Birnie DH, Exner DV, Sivakumaran S, Davies T, Coutu B, Crystal E, Wolfe K, Verma A, Stephenson EA, Kus T, Essebag V, Gardiner M. Formation of a national network for rapid response to device and lead advisories: The Canadian Heart Rhythm Society Device Advisory Committee. Can J. Cardiol. 2009; 25(7):403-5.

Book Chapters

Healey JS. Ventricular Dysrhythmias: Pharmacologic vs. Non-Pharmacologic Treatment. In: Evidence-Based Cardiology. 3rd Edition (eds.Yusuf S, Camm AJ, Fallen E).

Healey JS. Right Ventricular Outflow Tract Tachycardia. In: The Atlas of Advanced ECG Interpretation (eds. Baranchuk A, Simpson CS, Redfearn DP, Abdollah H).

HIRSH, J.Publications

Karthikeyan G, Eikelboom JW, Turpie AG, Hirsh J. Does acetyl salicyclic acid (ASA) have a role in the preven-tion of venous thromboembolism? Br J Haematol. 2009 Jul; 146(2): 142-149.

Karthikeyan G, Math RS, Matthew N, Shankar B, Kalaivani M, Singh S, Bahl VK, Hirsh J, Eikelboom JW. Accelerated infusion of streptokinase for the treatment of left-sided prosthetic valve thrombosis: a randomized controlled trial. Circulation. 2009 Sep 22; 120(12):1108-14.

Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. American Association of Orthopedic Surgeons and American College of Chest Physicians Guidelines for Venous Thromboembolism Prevention in Hip and Knee Arthroplasty Differ: What Are the Implications for Clinicians and Patients? Chest. 2009 Feb; 135(2):513-20.

Hirsh J, Guyatt G. Clinical experts or methodolo-gists to write clinical guidelines? Lancet. 2009 Jul 25; 374(9686):273-5.

HOLBROOK, A.Publications

Bayoumi I, Howard M, Holbrook A, Schabort I. Interventions to Improve Medication Reconciliation in Primary Care. Ann Pharmacother. 2009; 43(10):1667-75.

Hamandi B, Holbrook A, Humar A, Brunton J, Papadimitropoulos EA, Wong GG and Thabane L. Delay of Adequate Empiric Antibiotic Therapy is Associated with Increased Mortality among Solid-Organ Transplant Patients. Am J Transplant. 2009; 9(7):1657-65.

Holbrook A, Thabane L, Keshavjee K, Dolovich L, Bernstein B, Chan D, Troyan S, Foster G, Gerstein H, for COMPETE II Investigators. Individualized Electronic Decision Support and Reminders To Improve Diabetes Care in the Community: COMPETE II Randomized Trial. CMAJ. 2009; 181(1-2):37-44.

Mollon B, Chong JR, Holbrook A, Sung M, Thabane L, Foster G. Features Predicting the Success of Computerized Decision Support for Prescribing: A Systematic Review of Randomized Controlled Trials. BMC Medical Informatics and Decision Making. 2009; 9(11):1-28.

HUIZINGA, J.Publications

Kunze WA, Mao YK, Wang B, et al. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibit-ing calcium-dependent potassium channel opening. J Cell Mol Med. 2009 Aug; 13(8B):2261-70.

Huizinga JD, Lammers WJ. Gut peristalsis is governed by a multitude of cooperating mechanisms. Am J Physiol Gastrointest Liver Physiol. 2009 Jan; 296(1):G1-8.

Wang XY, Huizinga JD, Diamond J, Liu LW. Loss of intramuscular and submuscular interstitial cells of Cajal and associated enteric nerves is related to decreased gastric emptying in streptozotocin-induced diabetes. Neurogastroenterol Motil. 2009 Oct; 21(10):1095-e92.

d’Antonio C, Wang B, McKay C, Huizinga JD. Substance P activates a non-selective cation channel in murine pacemaker ICC. Neurogastroenterol Motil. 2009 Sep; 21(9):985-e79.

Wang J, Huizinga TW, Toes RE. De novo generation and enhanced suppression of human CD4+CD25+ reg-ulatory T cells by retinoic acid. J Immunol. 2009 Sep 15; 183(6):4119-26.

Wang XY, Alberti E, White EJ, et al. Igf1r+/CD34+ imma-ture ICC are putative adult progenitor cells, identified ultrastructurally as fibroblast-like ICC in Ws/Ws rat colon. J Cell Mol Med. 2009 Sep; 13(9B):3528-40.

Kunze WA, Mao YK, Wang B, et al. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibit-ing calcium-dependent potassium channel opening. J Cell Mol Med. 2009 Aug; 13(8B):2261-70.

Ma X, Mao YK, Wang B, Huizinga JD, Bienenstock J, Kunze W. Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. Am J Physiol Gastrointest Liver Physiol. 2009 Apr; 296(4):G868-75.

Huizinga JD, Zarate N, Farrugia G. Physiology, injury, and recovery of interstitial cells of Cajal: basic and clinical science. Gastroenterology. 2009 Nov; 137(5):1548-56.

HUNT, R.Publications

Haag S, Andrews JM, Katelaris PH, Gapasin J, Galmiche JP, Hunt R, Layer P, Malfertheiner P, Holtmann G. Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines. Digestion. 2009; 80(4):226-34.

Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R,

138

PUBLICATIONS

Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, Jung HC, Hoang BH, Kachintorn U, Goh KL, Chiba T, Rani AA; Second Asia-Pacific Conference. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol. 2009 Oct; 24(10):1587-600.

Modlin IM, Hunt RH, Malfertheiner P, Moayyedi P, Quigley EM, Tytgat GN, Tack J, Heading RC, Holtman G, Moss SF; Vevey NERD Consensus Group. Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion. 2009; 80(2):74-88.

Yuan YH, Wang C, Yuan Y, Hunt RH. Meta-analysis: inci-dence of endoscopic gastric and duodenal ulcers in placebo arms of randomized placebo-controlled NSAID trials. Aliment Pharmacol Ther. 2009 Aug; 30(3):197-209.

Hunt RH, Lanas A, Stichtenoth DO, Scarpignato C. Myths and facts in the use of anti-inflammatory drugs. Ann Med. 2009 May 8:1-16.

Yuan Y, Hunt RH. Evolving issues in the management of reflux disease? Curr Opin Gastroenterol. 2009 Jul; 25(4):342-51.

Sharma P, Chey W, Hunt R, Laine L, Malfertheiner P, Wani S. Endoscopy of the esophagus in gastroesopha-geal reflux disease: are we losing sight of symptoms? Another perspective. Dis Esophagus. 2009; 22(5):461-6.

Wang C, Yuan Y, Hunt RH. Helicobacter pylori infec-tion and Barrett’s esophagus: a systematic review and meta-analysis. Am J Gastroenterol. 2009 Feb; 104(2):492-500; quiz 491, 501.

Rostom A, Moayyedi P, Hunt R; Canadian Association of Gastroenterology Consensus Group. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastropro-tection: benefits versus risks. Aliment Pharmacol Ther. 2009 Mar 1; 29(5):481-96.

IACOBELLIS, G.Publications

Iacobellis G. Relation of Epicardial Fat Thickness to Right Ventricular Cavity Size in Obese Subjects. American Journal of Cardiology. 2009; 104:1601-2.

Iacobellis G et al. Epicardial Adipose Tissue and Intracoronary Adrenomedullin levels in Coronary Artery Disease. Hormone and Metabolic Research. 2009; 41:855-60.

Iacobellis et al. Echocardiographic epicardial fat: research and clinical applications. Journal of American Society of Echocardiography. 2009; 22:1311-9.

Iacobellis G. Epicardial and Pericardial Fat: Close but very different. Obesity. 2009:17; 625.

Iacobellis G et al. Intracoronary adiponectin levels rapidly increase after coronary revascularization. International Journal of Cardiology. 2009: Jan 26

Iacobellis G et al. Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin lev-els. Hormone and Metabolic Research. 2009; 41:227-31.

Barbaro G and Iacobellis G. Metabolic syndrome asso-ciated with HIV and highly active antiretroviral therapy. Curr Diab Rep. 2009; 9:37-42.

Book

Iacobellis G. Obesity and Cardiovascular Diseases,

Cardiology. Oxford University Press, UK, September 2009.

Book Chapter

Iacobellis G and Sharma AM. Obesity and Cardiovascular Diseases (Chapter 12). In: Obesity: Science to Practice, Wiley & Sons, 2009.

INMAN, M.Publications

Karimi K, Inman MD, Bienenstock J, Forsythe P. Lactobacillus reuteri Induced Regulatory T Cells Protect Against an Allergic Airway Response in Mice. Am J Respir Crit Care Med. 2009; 179(3):186-93.

Hirota JA, Ask K, Fritz D, Ellis R, Wattie J, Richards CD, Labiris R, Kolb M, Inman MD. Role of STAT6 and SMAD2 in a model of chronic allergen exposure: a mouse strain comparison study. Clin Exp Allergy. 2009; 39:147-58.

Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O’Byrne PM. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. New Engl J Med. 2009; 5;360(10):985-93.

DiGiovanni FA, Ellis R, Wattie J, Hirota JA, Southam DS, Inman MD. Concurrent dual allergen exposure and its effects on airway hyperresponsiveness, inflamma-tion and remodeling in mice. Dis Model Mech. 2009 May-Jun; 2(5-6):275-82.

Mandhane PJ, Hanna SE, Inman MD, Duncan JM, Greene JM, Wang HY, Sears MR. Changes in exhaled nitric oxide related to estrogen and progesterone dur-ing the menstrual cycle. Chest. 2009; 136(5):1301-7.

Farkas L, Farkas D, Ask K, Möller A, Gauldie J, Margetts P, Inman M, Kolb M. VEGF ameliorates pul-monary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. J Clin Invest. 2009 May; 119(5):1298-311.

Lu WY and Inman MD. Gamma-aminobutyric acid nur-tures allergic asthma. Clin Exp. 2009; 39(7):956-61.

Allen JE, Bischof RJ, Sucie Chang HY, Hirota JA, Hirst SJ, Inman MD, Mitzner W, Sutherland TE. Animal mod-els of airway inflammation and airway smooth muscle remodelling in asthma. Pulm Phamacol Ther. 2009 Oct; 22(5):455-65.

JAESCHKE, R.Publications

Zawilska K, Jaeschke R, Tomkowski W, Mayzner-Zawadzka E, Nizankowski R, Olejek A, Pasierski T, Torbicki A, Undas A, Jawień A, Gajewski P, Sznajd J, Brozek J. Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update. Pol Arch Med Wewn. 2009; 119 Suppl 1:1-69.

Mejza F, Nizankowska-Mogilnicka E, Kurzawa R, Górski P, Wirkijowski B, Jaeschke R. Outpatients specialist care of chronic obstructive pulmonary disease patients in Poland - results of the KOMPAS study. Pneumonol Alergol Pol. 2009; 77(6):507-16.

Jaeschke R, Guyatt G. Steroid use in critically ill septic patients: acknowledging the uncertainty. Pol Arch Med Wewn. 2009 Nov; 119(11):694-6.

Jaeschke R, Jankowski M, Brozek J, Antonelli M. How to develop guidelines for clinical practice. Minerva Anestesiol. 2009 Sep; 75(9):504-8.

Bała M, Płaczkiewicz Jankowska E, Topór Madry R, Lesniak W, Wiercinska E, Szczepaniak P, Jaeschke R, Sieradzki J, Grzeszczak W, Banasiak W. Characteristics of patients with type 2 diabetes of short duration in Poland. Rationale, design and preliminary results of the ARETAEUS1 study. Pol Arch Med Wewn. 2009; 119(9):533-40.

Schünemann HJ, Osborne M, Moss J, Manthous C, Wagner G, Sicilian L, Ohar J, McDermott S, Lucas L, Jaeschke R; ATS Ethics and Conflict of Interest Committee and the Documents Development and Implementation Committee. An official American Thoracic Society Policy statement: managing conflict of interest in professional societies. Am J Respir Crit Care Med. 2009 Sep 15; 180(6):564-80.

Jaeschke R, Gajewski P, Bates SM, Douketis J, Solnica B, Crowther M, Leńniak W, Brozek JL, Schünemann HJ, Zawilska K, Tomkowski W, Undas A, Sznajd J, Nizankowski R, Bała MM, Guyatt G. 2009 evidence-based clinical practice guidelines for diagnosing a first episode of lower extremities deep vein thrombosis in ambulatory outpatients. Pol Arch Med Wewn. 2009 Sep; 119(9):541-9.

Jaeschke R, Angus DC. Living with uncertainty in the intensive care unit: should patients with sep-sis be treated with steroids? JAMA. 2009 Jun 10; 301(22):2388-90.

Brozek J, Jankowski M, Płaczkiewicz-Jankowska E, Jaeschke R. International Diabetes Federation docu-ment concerning postmeal glycemic control: assess-ment of quality of clinical practice guidelines using AGREE instrument. Pol Arch Med Wewn. 2009 Jan-Feb; 119(1-2):18-24.

JAGER, P.Publications

Been LB, Hoekstra HJ, Suurmeijer AJ, Jager PL, van der Laan BF, Elsinga PH. [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer. Oral Oncol. 2009 Dec; 45(12):e211-5.

Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, Jager PL, Elsinga PH, Dierckx RA, van der Wal JE, Sluiter WJ, de Vries EG, Links TP. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, com-puter tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess. J Clin Endocrinol Metab. 2009 Oct; 94(10):3922-30.

Bastiaannet E, Hoekstra-Weebers JE, Francken AB, Jager PL, van der Jagt EJ, Hoekstra HJ. Perception of burden experienced during diagnostic tests by melano-ma patients with lymph node metastases. Melanoma Res. 2009 Feb; 19(1):36-41.

Hospers IC, van der Laan JG, Zeebregts CJ, Nieboer P, Wolffenbuttel BH, Dierckx RA, Kreeftenberg HG, Jager PL, Slart RH. Vertebral fracture assessment in supine position: comparison by using conventional semiquantitative radiography and visual radiography. Radiology. 2009 Jun; 251(3):822-8.

Koopmans KP, Neels ON, Kema IP, Elsinga PH, Links TP, de Vries EG, Jager PL. Molecular imaging in neu-roendocrine tumors: molecular uptake mechanisms

and clinical results. Crit Rev Oncol Hematol. 2009 Sep; 71(3):199-213.

Rikhof B, van Doorn J, Suurmeijer AJ, Rautenberg MW, Groenen PJ, Verdijk MA, Jager PL, de Jong S, Gietema JA, van der Graaf WT. Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour. Ann Oncol. 2009 Sep; 20(9):1582-8.

Eshuis SA, Jager PL, Maguire RP, Jonkman S, Dierckx RA, Leenders KL. Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson’s disease and healthy controls. Eur J Nucl Med Mol Imaging. 2009 Mar; 36(3):454-62.

JANSSEN, L.Publications

Janssen LJ. Asthma therapy: from where have we come, why did we fail, and where should we go next? European Respiratory Journal. 2009; 33:11-20.

Mueed I, Zhang Y, Aziz T, Chu V, Janssen LJ. Structural and electrophysiological changes in atherosclerotic radial artery grafts account for impairment of vessel reactivity. Atherosclerosis. 2009; 206(2):405-10.

Tazzeo T, Worek F, Janssen LJ. The NADPH-oxidase inhibitor diphenyleneiodonium is also a potent inhibi-tor of cholinesterases and the internal Ca2+-pump. British Journal of Pharmacology. 2009; 158(3):790-6.

Janssen LJ, Farkas L, Rahman T, Kolb M. Purinergic Ca2+-signaling in cultured human pulmonary fibro-blasts. International Journal of Biochemistry & Cell Biology. 2009; 41(12):2477-84.

van der Kleij H, Charles N, Karimi K, Mao YK, Foster J, Janssen L, Chang Yang P, Kunze W, Rivera J, Bienenstock J. Evidence for neuronal expression of functional Fc (epsilon and gamma) receptors. Journal of Allergy Clinical Immunology. 2009; 125(3):757-60.

Ghayur N, Janssen L. Traditional plant medicines of Canada’s Aboriginal cultures. Alternative and Complementary Therapies. 2009; 15(6):319-21.

Ghayur MN, Janssen LJ. Real-time imaging of Ca2+-handling in intact renal glomeruli using confocal microscopy. Medical Hypotheses and Research. 2009; 5:47-56.

JOHNSTONE, J.Book Chapter

Johnstone J and Joffe AM. Health Care-Acquired Infections. In: Palliative Medicine (ed. Walsh, D), Saunders Elsevier, Philadelphia, PA, pp. 519-27, 2009.

JOLLY, S.Publication

Jolly S, Faxon D, Fox K, Rizwan A, Boden W, Widimsky P, Steg G, Valentin V, Budaj A, Granger C, Joyner C, Chrolavicius S, Yusuf S, Mehta S. Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/llla Inhibitors or Thienopyridines. J Am Coll Cardiol. 2009 Jul; 54(5);468-76.

140

PUBLICATIONS

JONES, G.Publications

Richardson LA, Jones GW. A review of the reliability and validity of the Edmonton Symptom Assessment System (ESAS). Current Oncology. 2009; 16:55.

Yu JB, Khan AM, Jones GW, Reavely MM, Wilson LD. Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma. Am J Clin Oncol. 2009; 32:142-4.

Frobe A, Jones G, Jaksic B, Bokulic T, Budanec M, Iva M, Stancic-Rokotov D, Krabar D, Bolanca A, Rosenblatt E. Kusic A. Intraluminal brachytherapy in the man-agement of squamous carcinoma of the esophagus. Diseases Esophagus. 2009; 22:513-18.

Merrimen JL, Jones G, Walker D, Leung CS, Kapusta LR, Srigley JR. Multifocal high grade prostatic intraepi-thelial neoplasia is a significant risk factor for prostatic Adenocarcinoma. J Urol. 2009; 182:485-90.

Book Chapter

Wilson LD, Jones GW, Kacinski BM. Linfoma cutaneo de celulas T. Capitulo 46. In: Radioterapia Oncologica Enfoque Multidisciplinario, 2nd Edicion. Urdaneta N, Vera A, Peschel RE, and Wilson LD (eds). Radioterapia Oncologica GURVE & Yale University, Editorial Disinlimed, Venezuela, 2009.

KAMATH, M.Publications

Wu J, Poehlman S, Noseworthy M, Kamath MV. Texture Feature based Automated Seeded Region Growing in Abdominal MRI Segmentation. International Journal of Biomedical Science & Engineering. 2009; 2:1-8.

Heyderian R, Noseworthy M, Kamath MV and Poehlman S. Optimizing the Level Set Algorithm for detecting Object Edges in MR and CT images. IEEE Transactions on Nuclear Science. 2009 February; 56:156-66.

Fatemi-Ardekani A, Samavati N, Ting J and Kamath MV. Advances in Multimodality imaging through a Hybrid PET/MRI system. Critical Reviews in Biomedical Engineering. 2009; 36:(6).

KARIMI, K.Publications

Karimi K, Inman MD, Bienenstock J, Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med. 2009 Feb 1; 179(3):186-93.

Sarir H, Mortaz E, Karimi K, Kraneveld AD, Rahman I, Caldenhoven E, Nijkamp FP, Folkerts G. Cigarette smoke regulates the expression of TLR4 and IL-8 pro-duction by human macrophages. J Inflamm (Lond). 2009 May 1; 6:12.

Barrientos G, Tirado-González I, Klapp BF, Karimi K, Arck PC, Garcia MG, Blois SM. The impact of dendritic cells on angiogenic responses at the fetal-maternal interface. J Reprod Immunol. 2009 Dec; 83(1-2):85-94.

KEAN, W.Publication

Kean WF, Bouchard S, Roderich Gossen E. Women with

pain due to osteoarthritis: the efficacy and safety of a once-daily formulation of tramadol. Pain Med. 2009. Sep; 10(6):1001-11.

KEARON, C.Publications

Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfa-rin. Ann Intern Med. 2009; 150:293-300.

Kearon C. Balancing risks and benefits of extended anticoagulant therapy for idiopathic venous thrombo-sis. J Thromb Haemost. 2009; 7 (Suppl. 1):296-300.

Arnold D, Anderson J, Kearon C. Pre-operative Risk Assessment for Bleeding and Thromboembolism (“Rational Testing” Series). BMJ. 2009; 339:692-94.

Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the Internal Society on Thrombosis and Haemostasis. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: A recommendation for standardization. J Thrombo Haemost. 2009 May; 7:879-83.

Kaufman JA, Rundback JH, Kee, ST, Geerts W, Gillespie D, Kahn SR, Kearon C, Rectenward J. Rogers FB, Stavropoulos W, Streiff M, Vedantham S, Venbrux A. Development of a research agenda for inferior vena cava filters: Proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol. 2009; 20:697-707.

Couturaud F, Leroyer C, Julian JA, Kahn SR, Ginsberg JS, Wells PS, Douketis JD, Mottier D, Kearon C. Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism. Chest. 2009; 136:1537-45.

Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H et al. Dabigatran versus war-farin in the treatment of acute venous thromboembo-lism. N Engl J Med. 2009 Dec 10;361:2342-52.

Book Chapter

O’Donnell M, Ginsberg JS, Kearon C. Chapter 105: Thrombosis. In: Halter J, Ouslander J, Tinetti M, Studenski S, High K, Asthana S (eds.), Hazard’s Geriatric Medicine and Gerontology 6th Edition, McGraw-Hill; New York, NY, 1243-52, 2009.

KEITH, P.Publications

Keith PK, Koch C, Djandji M, Bouchard J, Psaradellis E, Sampalis JS, Schellenberg RR, McIvor RA. Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial). Can Respir J. 2009;May-Jun;16 Suppl A:17A-31A.

Keith PK, Scadding GK. Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? Current Medical Research and Opinions. 2009; 25;2021-41.

Bousquet J, Bachert C, Canonica GW, Mullol J, Van Cauwenberge P, Bindslev Jensen C, Fokkens WJ, Ring J, Keith P, Lorber R, Zuberbier T. Efficacy of des-loratadine in intermittent allergic rhinitis: a GALEN study.; The ACCEPT-1 study group. Allergy. 2009 Oct; 64(10):1516-23.

KELTON, J.Publications

Warkentin TE, Sheppard JA, Moore JC, Cook RJ, Kelton JG. Studies of the immune response in heparin-induced thrombocytopenia. Blood. 2009; 113(20);4963-69.

Arnold DM, Nazi I, Kelton JG. New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses. Expert Opin Investig Drugs. 2009;18 (6): 805-19.

Arnold DM, Bernotas A, Nazi I, Stasi R, Kuwana M, Liu Y, Kelton JG, Crowther MA. Platelet count response to H. pylori treatment in patients with immune thrombo-cytopenic purpura with and without H. pylori infection: a systematic review. Haematologica. 2009; 94(6): 850-6.

KHALIDI, N.Publications

Matsos M, Harish S, Zia P, Ho Y, Chow A, Ioannidis G, Khalidi N. Ultrasound of the hands and feet for rheu-matological disorders: influence on clinical diagnostic confidence and patient management. Skeletal Radiol. 2009 Nov; 38(11):1049-54.

Miller S, Miller E, Khalidi N. Catastrophic antiphospho-lipid syndrome and polyarteritis nodosa. J Rheumatol. 2009 Nov; 36(11):2619-21.

Haaland DA, Cohen DR, Kennedy CC, Khalidi NA, Adachi JD, Papaioannou A. Closing the osteoporosis care gap: increased osteoporosis awareness among geriatrics and rehabilitation teams. BMC Geriatr. 2009 Jul 14; 9:28.

Linda D, Rajagopalan A, Salama S, Khalidi N, Harish S. Bilateral tight swollen legs: diagnosis and discussion. Skeletal Radiol. 2009 Jul; 38(7):709-10,729-30.

Humphrey-Murto S, Khalidi N, Smith CD, Kaminska E, Touchie C, Keely E, Wood TJ. Resident evaluations: the use of daily evaluation forms in rheumatology ambula-tory care. J Rheumatol. 2009 Jun; 36(6):1298-303.

Salimi C, O’Neill J, Khalidi N, Harish S. Role of ultra-sound in the assessment of small-joint synovitis. Can Assoc Radiol J. 2009 Apr; 60(2):69-70.

Bernatsky S, Panopolis P, Hudson M, Pope J, Leclercq S, Robinson D, Jones N, Markland J, Abu-Hakima M, Mathieu JP, Docherty P, Khalidi N, Sutton E, Baron M; Canadian Scleroderma Research Group. Demographic and clinical factors associated with physician service use in systemic sclerosis. J Rheumatol. 2009 Jan; 36(1):96-8.

KHAN, A.Publications

John P. Bilezikian, Aliya A. Khan, John T. Potts, Jr on behalf of the Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism SUMMARY STATEMENT: Guidelines for the Management of Asymptomatic Primary

Hyperparathyroidism: Summary Statement from the Third International Workshop. J Clin Endocrinol Metab. 2009 Feb; 94:335-9.

Reid RL, Blake J, Abramson B, Khan AA, Senikas V, Fortier M. Menopause and osteoporosis. JOGC Clinical Practice Guideline SOGC. 2009 Jan; 31; Supplement 1- 48.

Khan AA, Sandor GK, Dore E, Morrison AD, Alsahli M, Amin F, Peters E, Hanley DA, Chaudry SR, Lentle B, Dempster DW, Glorieux FH, Neville AJ, Talwar RM, Clokie CM, Mardini MA, Paul T, Khosla S, Josse RG, Sutherland S, Lam DK, Carmichael RP, Blanas N, Kendler D, Petak S, Ste-Marie LG, Brown J, Evans AW, Rios L, Compston JE, Bisphosphonate associ-ated osteonecrosis of the jaw. J Rheumatol. 2009 Mar; 36(3):478-90.

Aliya A. Khan, John P. Bilezikian, Annie Kung, Zeba A. Syed, Sacha J. Dubois, Timothy Standish. Alendronate Therapy in Men with Primary Hyperparathyroidism, Endocrine Practice Nov/Dec. 2009; 15:1-9.

KOLB, M.Publications

Decologne N, Wettstein G, Kolb MRJ, Margetts P, Garrido C, Campus P, Bonniaud P. Bleomycin induces pleural and subpleural fibrosis in the presence of car-bon black particles. Eur Resp J 2009. Jan; 35(1):176-85.

Janssen LJ, Farkas L, Rahman T, Kolb MRJ. ATP stimu-lates Ca2+ waves and gene expression in cultured human pulmonary fibroblasts. Int. J. Biochem Cell Biol. 2009 Dec; 41(12):2477-84.

Farkas L, Ask K, Möller A, Farkas D, Margetts PJ, Gauldie J, Inman M, Kolb MRJ. VEGF-mediated angio-genesis ameliorates pulmonary hypertension in an animal model of lung fibrosis. J Clin Invest. 2009; 119(5):1298-311.

Möller A, Gilpin SE, Ask K, Cox G, Cook DJ, Gauldie J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, O’Byrne PM, Strieter RM, Kolb MRJ. Circulating Fibrocytes are an indicator for poor prognosis in Idiopathic Pulmonary Fibrosis. Am J Resp Crit Care Med. 2009; 179(7):588-94.

Prasse A, Stahl M, Schulz G, Kayser G, Wang L, Ask K, Yalcintepe J, Kirschbaum A, Bargali E, Zissel G, Kolb MRJ, Muller-Quernheim J, Weiss JM, Renkl AC, Increased Osteopontin production in smoking-related Interstitial Lung Diseases. Am J Path. 2009; 174(5):1683-91.

Hirota JA, Ask K, Fritz D, Ellis R, Wattie J, Richards CD, Labiris R, Kolb MRJ, Inman MD, The role of STAT6 and SMAD2 in a model of chronic allergen exposure: A mouse strain comparison study. Clin Exp Allergy 2009; 39:147-58.

Behr J, Kolb MRJ, Cox G, Treating IPF All or Nothing? A Pro-con debate Respirology. 2009 Nov; 14(8):1072-81.

Jiao Y, Cui Y, Kolb MRJ. How useful is Traditional Herbal Medicine for Pulmonary Fibrosis? Respirology. 2009 Nov; 14(8):1082-91.

Antoniu SA, Kolb MRJ. Update on models of pulmo-nary fibrosis therapy for preclinical drug research. Expert Opin. Drug Discov. 2009; 4(9):939-46.

Kolb MRJ. Yang I. Respirology year in review 2008:

142

PUBLICATIONS

basic science. Respirology. 2009; 14(3): 318-26.

Book Chapter

Kolb M, Xing Z, Gauldie J. Growth Factors. In: Asthma and COPD, 2nd Edition. Basic Mechanisms and Clinical Management. Barnes PJ, Drazen JM, Rennard S, Thomson NC, (Eds.), Academic Press, London, UK, 353-62,2009.

LABIRIS, R.Publications

Hirota JA, Ask K, Fritz D, Ellis R, Wattie J, Richards CD, Labiris R, Kolb M, Inman MD. The role of STAT6 and SMAD2 in a model of chronic allergen expo-sure: A mouse strain comparison study. Clinical and Experimental Allergy. 2009; 39(1):147-58.

Jobse BN, Johnson JR, Farncombe T, Labiris R, Walker TD, Goncharova S, Jordana M. Computed tomography for the evaluation of allergic inflammation in a rat model in vivo. Eur Respir J. 2009 33(6):1437-74.

Book Chapter

Newhouse MT, Labiris NR, Freitag A. Inhaled anti-biotics: Why Tobi and other aminoglycosides. In: Respiratory Drug Delivery. Europe 2009. (Eds.), RN Dalby, PR Byron, J Peart. River Grove Illinois: Davis Healthcare Int’l Publishing, LLC, 2009.

LARCHÉ, MARKPublication

Campbell JD, Buckland KF, McMillan SJ, Kearley J, Oldfield WLG, Stern LJ, Grönlund H, van Hage M, Reynolds C, Boyton R, Cobbold SP, Kay AB, Altmann DM, Lloyd CM, Larché M. Peptide immunotherapy in allergic asthma generates IL-10-dependent immu-nological tolerance associated with linked-epitope suppression. Journal of Experimental Medicine. 2009; 206:1535-47.

LEBER, B.Publications

Gupta V, KrogerN, Aschan J, Xu W, Leber B, Dalley C, Sabloff M, Lipton JH, Messner H, Brune M. A retro-spective comparison of conventional intensity condi-tioning and reduced-intensity conditioning for alloge-neic hematopoietic cell transplantation in myelofibro-sis. Bone Marrow Transplant. 2009 Sep; 44(5):317-20.

Assouline S, Culjkovic B, Cocolakis E, Rousseau C, Beslu N, Amri A, Caplan S, Leber B, Roy DC, Miller WH Jr, Borden KL. Molecular targeting of the oncogene eIf4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. Blood. 2009 Jul 9; 114(2):257-60.

Pellicano F, Copland M, Jorgensen HG, Montford J, Leber B, Holyoake TL. BMS-214662 induces mitochon-drial apoptosis in chronic myeloid leukemia (CML) stem-progenitor cells, including CD34+ 38-cells, through activation of protein kinase Cbeta. Blood. 2009 Nov 5; 114(19):4186-96.

LEONTIADIS, G.Publications

Leontiadis GI, Howden CW. The role of proton pump inhibitors in the management of upper gastrointestinal bleeding. Gastroenterology Clinics of North America. 2009; 38(2): 199-213.

Leontiadis GI, Ford A, Moayyedi P. Helicobacter pylori infection. Clinical Evidence 2009; 10:406.

LEVINE, M.Publications

Farahani P, Levine M. Goal attainment for multiple cardiovascular risk factors in community-based clini-cal practice (a Canadian experience). J Eval Clin Pract. 2009 Feb; 15(1)212-6.

Xie F, Blackhouse G, Assasi N, Campbell K, Levine M, Bowen J, Tarride J, Pi D, Goeree R. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytope-nic purpura. Clinical Therapeutics. 2009; 31(5)1082-91.

Levine MAH, Xu S, Gaebel K, Brazier N, Bedard M, Brazil K, Lohfeld L, MacLeod S. Self-Reported Use of Natural Health Products: A Cross-Sectional Telephone Survey in Older Ontarians. Am J Geriatr Pharmacother. 2009; 7:383-92.

LIAW, P.Publications

Swystun, LL, Shin LYY, Beaudin S, Liaw PC. Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes. J Thromb Haemost. 2009 Apr; 7(4):619-29.

Hirayama S, Cypel M, Sato M, Anraku M, Liaw PC, Liu M, Waddell TK, Kashavjee S. Activated protein C in ischemia-reperfusion injury after experimental lung transplantation. J Heart and Lung Transplantation. 2009 Nov; 28(11):1180-4.

LIM, W.Publications

Lim W. Antiphospholipid antibody syndrome. Hematology Am Soc Hematol Educ Program. 2009; 233-9.

Metjian A, Lim W. ASH evidence-based guidelines: Should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis? Hematology Am Soc Hematol Educ Program. 2009; 247-9.

Lim W. Joe Doupe Lecture: Cardiac troponin in the intensive care unit. Clin Invest Med. 2009 Oct 1; 32(5):E405-10.

Ageno W, Garcia D, Aguilar MI, Douketis J, Finazzi G, Imberti D, Iorio A, Key NS, Lim W, Marietta M, Prisco D, Sarode R, Testa S, Tosetto A, Crowther M. Prevention and treatment of bleeding complications in patients

receiving vitamin K antagonists, part 2: Treatment. Am J Hematol. 2009; 84:584-9.

Ribic C, Lim W, Cook D, Crowther M. Low molecular weight heparin thromboprophylaxis in medical-surgi-cal critically ill patients: A systematic review. J Crit Care. 2009; 24:197-205.

Lim W, Tkaczyk A, Holinski P, Qushmaq I, Jacka M, Khera V, Devereaux PJ, Terrenato I, Schunemann H, Heels-Ansdell D, Crowther M, Cook D. The diagnosis of myocardial infarction in critically ill patients: An agree-ment study. J Crit Care. 2009; 24:447-52.

LINKINS, L.Publication

Sinuff T, Thabane L, Linkins L, Treleaven D, Patel R, Rabbat C, Lee A, O’Donnell M, Meade M, Guyatt G, Geerts W, Crowther M, Anderson D, Zytaruk N, Marshall J, Douketis J, Cook D. Event adjudication and data monitoring in an ICU observational study of thromboprophylaxis. J Crit Care Med. 2009 Jun; 24(2):168-75.

Book Chapters

Linkins LA, Kearon C. Chapter 64: Venous Thromboembolic Disease. In:Yusuf S, Cairns J, Camm J, Fallen E, Gersh B (eds.), Evidence-Based Cardiology 3rd edition. Blackwell Publishing, Oxford, UK., Pgs 1032-49. November 2009.

Linkins LA, Kearon C. Chapter:Venous Thromboembolism. In:O’Shaughnessy D, Makris M, Lillycrap D (eds.), Practical Hemostatis and Thrombosis. Blackwell Publishing, Oxford, UK, July 2009.

LIU, T.Publication

Engel J, Graansma C, Liu T. Resolution of EEG Artifact During Continuous Renal Replacement Therapy: Case Report. Clinical EEG Neurosci. 2009 Jul; 40(3):204-5.

LOEB, M.Publications

Denisov DA, Denisova GF, Lelic A, Loeb M, Bramson JL. Deciphering epitope specificities within polyserum using affinity selection of random peptides and a novel algorithm based on pattern recognition theory. Mol Immunol. 2009; 46:429-36.

Fulop T, Pawelec G, Castle S. Loeb M. Immunosenescence and Vaccination in Nursing Home Residents. Clin. Infect. Dis. 2009 Feb 15; 48(4):443-8.

Gravel D, Gardam M, Taylor G, Miller M, Simor A, McGeer A, Hutchinson J, Moore D, Kelly S, Mulvey M. Canadian Nosocomial Infection Surveillance Program (Loeb M). Infection control practices related to Clostridium difficile infection in acute care hospitals in Canada; Am. J Infect Control. 2009 Feb; 37(1):9-14.

Gravel D, Miller M, Simor A, Taylor G, Gardam M, McGeer A, Hutchison J, Moore D, Kelly S, Boyd D, Mulvey M, and the Canadian Nosocomial Infection Surveillance Program (Loeb M). Health care-associ-ated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: A Canadian nosoco-mial infection surveillance program study. CID. 2009;

48:568-76.

Langley JM, Gravel D, Moore D, Matlow A, Embree J, MacKinnon-Cameron D, and the Canadian Nosocomial Infection Surveillance Program (Loeb M). Study of Cerebrospinal fluid shunt-associated infections in the first year following placement, by the Canadian Nosocomial Infection Surveillance Program. Infect Control Hosp Epidemiol. 2009; 30:285-8.

Loeb M, Neupane B, Walter SD, Hanning R, Carusone SC, Lewis D, Krueger P, Simor AE, Nicolle L, Marrie TJ. Environmental Risk Factors for Community-Acquired Pneumonia Hospitalization in Older Adults. J. Am. Geriatr. Soc. 2009; 57(6):1036-40.

Vayalumkal JV, Gravel D, Moore D, Matlow A, and the Canadian Nosocomial Infection Surveillance Program (Loeb M). Surveillance for healthcare-acquired febrile respiratory infection in pediatric hospitals participat-ing in the Canadian Nosocomial Infection Surveillance Program. Infect Control Hosp Epidemiol. 2009; 30(7):652-8.

Ofner-Agostini M, Simor A, Mulvey M, McGeer A, Hirji Z, McCrasken M, Gravel D, Boyd D, and the Canadian Nosocomial Infection Surveillance Program (Loeb M). Risk factors for and outcomes associated with clini-cal isolates of Escherichia coli and Klebsiella species resistant to extended-spectrum cephalosporins among patients admitted to Canadian hospitals. Can. J. Infect. Dis. Med. Microbiol. 2009; 20:43-8.

Plevneshi A, Svoboda T, Armstrong I, Tyrrell GJ, Miranda A, Green K, Low D, McGeer A; Toronto Invasive Bacterial Diseases Network (Loeb M). Population-based surveillance for invasive pneumococ-cal disease in homeless adults in Toronto. PLoS One. 2009 Sep 29; 4(9):e7255.

Loeb M, Dafoe N, Mahony J, John M, Sarabia A, Glavin V, Webby R, Smieja M, Earn D, Chong S, Webb A, Walter SD. Surgical mask versus N95 respirator for preventing influenza among healthcare workers: a ran-domized trial. JAMA. 2009 Nov 4; 302:1865-71.

Adam HJ, Louie L, Watt C, Gravel D, Bryce E, Loeb M, Matlow A, McGeer A, Mulvey MR, Simor AE; the Canadian Nosocomial Infection Surveillance Program. Detection and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) in Canada: Results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006. Antimicrob Agents Chemother. 2009 Nov; 54:945-9.

Russell ML, Keenliside J, Webby R, Fonseca K, Singh P, Moss L, Loeb M. Protocol: transmission and preven-tion of influenza in Hutterites: zoonotic transmission of influenza A: swine & swine workers. BMC Public Health. 2009 Nov 18;9:420.

Bader, M, Loeb M. Bacteremia among elderly patients: relationship between age, comorbidity and mortality. Aging Health. Feb 2009, Vol. 5(1):39-42.

Book:

Loeb M, Smaill F, Smieja M, (Editors). 2nd Edition of Evidence-Based Infectious Diseases. Blackwell Publishing Ltd. (BMJ Publishing Group). 2009.

Book Chapters:

Simor AE, Loeb M. Epidemiology of healthcare-asso-ciated S. aureus infections. In: The Staphylococci in Human Disease, 2nd Edition. Wiley, 2009.

Loeb M. Influenza and RSV. In: Principles and Practice

144

PUBLICATIONS

of Geriatric Medicine and Gerontology, 6th Edition. (eds.), Hazzard WR, Blass JP, Ettinger WH, Halter JB, Ouslander JG. McGraw-Hill, New York, NY, 2009.

Loeb M. SARS and West Nile Virus. In: Infectious Disease in the Aging: A Clinical Handbook, 2nd Edition. (eds.), T.T. Yoshikawa and D.C. Norman. Humana Press, Springer Dordrecht Heidelberg, London, New York. 2009.

LONN, E.Publications

Verma S, Lonn E, Nanji A, Ward R, Robertson A, Conradson H, Hildebrand K, Brant R, Anderson T. Effect of angiotensin converting enzyme inhibition on C-reactive protein levels. The Ramipril CRP randomized evaluation (4R Trial Results). Can J Cardiol. 2009; 25(7):e236-40.

Sumner G, Salehian O, Yi Q, Healey J, Mathew J, Al-Merri K, Al-Nemer K, Stambler B, Mann J, Dagenais G, Lonn E. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients – A report from the HOPE trial. J Cardiovasc Electrophysiol 2009; 20(7):781-7.

Philpott AC, Lonn EM, Title LM, Verma S, Buithieu J, Charbonneau F, Anderson TJ. Comparison of vascu-lar function to flow mediated dilation as a measure of cardiovascular risk factors. Am J Cardiol. 2009; 103(11):1610-5.

Yusuf S, Lonn E, Bosch J. Lipid lowering for primary prevention. Lancet. 2009; 373:1152-5.

Lonn E, Gerstein H, Sheridan P, Smith S, Diaz R, Mohan V, Bosch J, Yusuf S, Dagenais G for the DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) and STARR Investigators. Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glu-cose tolerance or impaired fasting glucose. J Am Coll Cardiol. 2009; 53:2028-35.

Gianni M, Dentali F, Lonn E. 5 Fluorouracil-induced api-cal ballooning syndrome: a case report. Blood Coagul Fibrinolysis.2009; 20(4):306-8.

Dentali F, Donadini M, Gianni M, Bertolini A, Lonn E, Veno A, Cattozzo G, Ageno W. Brain natriuretic peptide as a preclinical marker of chronic pulmonary hyper-tension in patients with pulmonary embolism. Intern Emerg Med. 2009 Apr; 4(2):123-8.

Yan RT, Yan AT, Anderson TJ, Buithieu J, Charbonneau F, Title L, Verma S, Lonn E. The Differential Association Between Various Anthropometric Indices of Obesity and Subclinical Atherosclerosis. Atherosclerosis. 2009; 207(1):232-8.

Cowan, BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL. The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmis-artan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics. Clin Res Cardiol. 2009 Jul; 98(7):421-33.

Odueyungbo A, Smieja M, Thabane L, Smaill F, Gough K. Gill J, Anderson T. Elston D, Smith S, Beyene J, Lonn E for the Canadian HIV Vascular Study Investigators. Comparison of brachial and carotid artery ultrasounds

for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study. AIDS Res Ther. 2009; 6(1)11.

Lanktree MB, Anand SS, Yusuf S, Hegele RA; SHARE Investigators. Replication of genetic associations with plasma lipoprotein traits in a multiethnic sample. J Lipid Res. 2009 Jul; 50(7):1487-96.

Cowan B, Young A, Anderson C, Doughty R, Krittayaphong R, Lonn E, Marwick T, Sanderson J, Schmieder, Reid C. Wadham A, Worthley S, Yu C, Teo K, Yusuf S, Jennings G, for the ONTARGET Investigators. Left ventricular mass and volume with telmisartan, ramipril or combination in patients with previous atherosclerotic events or diabetes from the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Am J Cardiol. 2009; 104(11):1484-9.

Lonn E, Yusuf S. Polypill – the evidence and the prom-ise. Current Opinion in Lipidology. 2009 Dec; 20(6):453-9.

Genest J, McPherson R, Frohlich J, Anderson T, Campbell N. Carpentier A, Couture P, Dufour R, Fodor G, Francis GA, Grover S. Gupta M, Hegele RA, Lau DC, Leither L, Lewis GF, Lonn E, Mancini GBJ, Ng D, Pearson GJ, Sniderman A, Stone AJ, Ur E. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations. Can J Cardiol. 2009; 25:567-79.

Mount DL, Feeney P, Fabricatore AN, Coday M, Bahnson J, Byington R, Phelan S, Wilmoth S, Knowler WC, Hramiak I, Osei K, Sweeney ME, Espeland MA; Look AHEAD and ACCORD Research Groups. Constructing common cohorts from trials with over-lapping eligibility criteria: implications for compar-ing effect sizes between trials. Clin Trials. 2009 Oct; 6(5):416-29.

Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J; dal-OUTCOMES Committees and Investigators. Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syn-drome. Am Heart J. 2009 Dec; 158(6):896-901.

MARGETTS, P.Publications

Gangji A, Brimble KS, Margetts PJ. Association between Markers of Inflammation and Fibrosis and Hypervolemia in Peritoneal Dialysis Patients. Blood Purif. 2009; 28:354-8.

Farkas L, Ask K, Moller A, Farkas D, Margetts P, Gauldie J, Inman M, Kolb M. VEGF ameliorates pulmonary hypertension through inhibition of endothelial apopto-sis in experimental lung fibrosis in rats. J Clin Invest. 2009; 119:1298-1311.

MacGillivray L, Hernandez J, Maedler C, Chu D, Margetts P. Developing Clinician Scientists: The MD/PhD Program at McMaster University. McMaster University Medical Journal. 2009; 6: 5-10.

Liu L, Shi CX, Ghayur A, Zhang C, Su JY, Hoff CM, Margetts PJ. Prolonged peritoneal gene expression using a helper-dependent adenovirus. Perti Dial Int. 2009; 29:508-16.

Moeller A, Gilpin S, Ask K, Cox G, Cook DJ, Gauldie

J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, O’Byrne PM, Striedter RM, Kolb MRJ. Circulating fibro-cytes are an indicator for poor prognosis in idiopathic pulmonary fibrosis. AJRCCM. 2009; 179: 588-94.

Nathu Z, Dwivedi DJ, Reddan JR, Sheardown H, Margetts PJ, West-Mays JA. Temporal changes in MMP mRNA expression in the lens epithelium during ante-rior subcapsular cataract formation. Exp Eye Res. 2009; 88:323-30.

Margetts PJ. Heparin and the peritoneal membrane. Perit Dial Int. 2009; 29:16-19.

Cina D, Patel P, Bethune C, Thoma J, Rodrigues JC, Hoff CM, Margetts PJ. Peritoneal morphological and functional changes associated with platelet derived growth factor. Nephrol Dial Transplant. 2009; 24:448-57.

MARSHALL, J.Publications

Marshall DA, Johnson FR, Kulin NA, Ozdemir S, Walsh JME, Marshall JK, Van Bebber S, Phillips KA. How do physician expectations of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated choice survey. Health Econ. 2009; 18:1420-39.

Thabane M, Simunovic M, Akhtar-Danesh N, Marshall JK. Development and validation of a risk score for post-infectious irritable bowel syndrome. Am J Gastroenterol. 2009; 104:2267-74.

Assasi N, Blackhouse G, Xie F, Gaebel K, Marshall J, Irvine EJ, Giacomini M, Robertson D, Campbell K, Hopkins R, Goeree R. Anti-TNF-alpha drugs for refractory inflammatory bowel disease: clinical and cost-effectiveness analyses [Technology report num-ber 120]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2009.

Assasi N, Blackhouse G, Xie F, Gaebel K, Marshall J, Irvine EJ, Giacomini M, Robertson D, Campbell K, Hopkins R, Goeree R. Overview of anti-TNF-alpha drugs for refractory inflammatory bowel disease [Technology overview number 52]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2009.

Kottachchi D, Yung D, Marshall JK. Adherence to guide-lines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian tertiary care hospital. Can J Gastroenterol. 2009; 23:613-17.

Sadowski D, Bernstein C, Bitton A, Croitoru K, Fedorak RN, Griffiths A, CAG Crohn’s Consensus Group. Canadian Association of Gastroenterology clinical practice guidelines: the use of tumor necrosis factor alpha-antagonist therapy in Crohn’s disease. Can J Gastroenterol. 2009; 23:185-202.

Dupuis M, Marshall JK, Hayes SM, Murray S. Assessing the educational needs of Canadian gas-troenterologists and gastroenterology nurses: chal-lenges to optimal care in Crohn’s disease. Can J Gastroenterol. 2009; 23:805-10.

Marshall JK. Post-infectious irritable bowel syndrome following water contamination. Kidney Int. 2009; 75:S42-3.

Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol 2009; 15:3591-6.

Marshall JK. Myocardial infarction, peptic ulcer and ASA: of good and evil. Can J Gastroenterol. 2009; 23:618.

MATSOS, M.Publication

Matsos M, Harish S, Zia P, Ho Y, Chow A, Ioannidis G, Khalidi N. Ultrasound of the hands and feet for rheu-matological disorders: influence on clinical diagnostic confidence and patient management. Skeletal Radiol. 2009 Nov; 38(11):1049-54.

MCCOY, K.Publications

Slack E, Hapfelmeier S, Stecher B, Velykoredko Y, Stoel M, Lawson MAE, Geuking MB, Beutler B, Tedder TF, Hardt WD, Bercik P, Verdu EF, McCoy KD, and Macpherson AJ. Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism. Science. 2009 Jul 31; 325(5940):617-20.

Natividad JM, Huang X, Slack E, Jury J, Sanz Y, David C, Denou E, Yang P, Murray J, McCoy KD, Verdú EF. Host Responses to Intestinal Microbial Antigens in Gluten-Sensitive Mice. PLoS One. 2009 Jul 31; 4(7):e6472.

Schildknecht A, Probst HC, McCoy KD, Miescher I, Brenner C, Leone DP, Suter U, Ohashi PS, van den Broek M. Antigens expressed by myelinating glia cells induce peripheral cross-tolerance of endogenous CD8+ T cells. Eur J Immunol. 2009 Jun; 39(6):1505-15.

MCIVOR, A.Publications

McIvor RA. Antibiotics for Acute Exacerbations of Chronic Bronchitis. Can Fam Physician. 2009 Jan; 55(1):15-6,19-21.

Sindi A, McIvor A. The use of inhaled anticholinergics in chronic obstructive pulmonary disease: Is there cause for concern? A review of evidence from clinical trials. Pol Arch Med Wewn. 2009; 119(1-2):74-9.

McIvor RA. Tobacco control and nicotine addiction in Canada: Current trends, management and challenges. Can Respir J. 2009; 16(1):21-6.

Sindi A, McIvor A. Smoking cessation. How can we do better? Can J Diagnosis. 2009; Feb:69-72.

McIvor RA, Assaad JM, Brodsky G, Demarest P, Desmarais P, Hampson C, Kayser J, Khara M, Pathammavong R, Weinbery R. Best practices for smoking cessation in primary care. Can Respir J. 2009 Jul-Aug; 16(4):129-34.

FitzGerald JM, Foucart S, Coyle S, Sampalis JS, Haine D, Paradellis F, McIvor RA. Montelukast as add-on therapy to inhaled corticosteroids in the management of asthma (the SAS trial). Can Respir J. 2009 May-Jun; 16 Suppl A;5A-10A.

McIvor RA, Kaplan A, Koch C, Sampalis JS. Montelukast as an alternative to inhaled corticoste-roids in the management of asthma (the SIMPLE trial): an open-label effectiveness trial. Can Respir J. 2009 May-Jun:16 Suppl A;11A-16A.

Keith PK , Koch C, Djandji M, Bouchard J, Paradellis F,

146

PUBLICATIONS

Sampalis JS, Schellenberg R, McIvor RA. Montelukast as add-on therapy with inhaled corticosteroids or inhaled corticosteroids and long-acting B 2-agonist treatment in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial). Can Respir J. 2009 May-Jun;6 Suppl A;17A-24A.

McIvor RA, Sampalis JS. Real-life asthma care in Canada. Can Respir J. 2009 May-Jun; 16 Suppl A;3A-4A.

McIvor RA. The use of inhaled anticholinergics in chronic obstructive pulmonary disease: Is there cause for concern of cardiovascular safety? Pol Arch Med Wewn. 2009 Nov; 119(11):697-98.

Kaplan A, Bell A., Balter M, Kim H, McIvor RA. Diagnosis of Asthma in Adults. CMAJ. 2009 Nov 10; 181(10):E210-20.

Balter MS, Bell AD, Kaplan AG, Kim H, Balter M, McIvor RA. Management of asthma in adults. CMAJ. 2009 Dec 8; 181(12) 915-22.

MCKELVIE, R.Publications

Howlett JG, McKelvie RS et al. Canadian Cardiovascular Society Consensus Conference guide-lines on heart failure, update 2009: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol. 2009; 25(2):85-105.

Heckman G, McKelvie RS. Diagnosis and management of heart failure with preserved ejection fraction in older adults. Geriatrics & Aging. 2009; 12(2):93-6.

O’Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Houston Miller, N, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Pina IL, for the HF-ACTION Investigators. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION Randomized Controlled Trial. JAMA. 2009; 301(14):1439-50.

McKelvie RS. The CHARM program: the effects of can-desartan for the management of patients with chronic heart failure. Expert Rev. Cardiovasc. Ther. 2009; 7(1):9-16.

White M, Rouleau J-L, Afzal R, Floras J, Yusuf S, McKelvie RS. Effects of enalapril, candesartan or both on neurohumoral activation and left ventricular vol-umes and function in patients with heart failure not treated with a beta-blocker. Ther Adv Cardiovasc Dis. 2009; 3:113-21.

Felker GM, Whellan D, Kraus Wm E, Clare R, Zannad F, Donahue M, Adams K, McKelvie R, Pina HL, O’Connor CM, for the HF-ACTION Investigators. N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the heart failure HF-ACTION study. Am Heart J. 2009; 158(4):S37-S44.

Keteyian SJ, Issac D, Thadani U, Roy BA, Bensimhon DR, McKelvie R, Russell SD, Hellkamp AS, Kraus WE, on behalf of HF-ACTION Investigators. Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J. 2009 Oct; 158(4 Suppl):S72-7.

Book ChaptersMcKelvie RS. The Merck Manual of Diagnosis and

Therapy. Sudden cardiac death in athletes. Sports and the Heart. In: Cardiovascular disorders. Merck Sharp & Dohme (eds.), Whitehouse Station, N.J. USA. August, 2009.

McKelvie RS. The Merck Manual of Diagnosis and Therapy. Athlete’s heart. Sports and the Heart. In: Cardiovascular disorders. Merck Sharp & Dohme (eds.), Whitehouse Station, N.J. USA. August, 2009.

MEADE, M.Publications

Burns KEA, Adhikari NKJ, Keenan SP, Meade MO. Use of noninvasive ventilation to wean critically ill adults off invasive ventilation: meta-analysis and systematic review. BMJ. 2009 May 21; 338:b1574.

Cook DJ, Sinuff T, Zytaruk N, Rabbat C, Lee A, O’Donnell M, Thabane L, Linkins L, Treleaven D, Patel R, Meade MO, Crowther MA, Marshall JC, Douketis J for the DIRECT Investigators and the Canadian Critical Care Trials Group. Event adjudication and data moni-toring in an intensive care unit observational study of thromboprophylaxis. J Crit Care. 2009; 24(2):168-75.

Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Lapinsky S, Ahern S, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Meade MO, Hall R, Rowler R for the Canadian Critical Care Trails Group H1N1 Collaborative. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA. 2009 Nov 4; 302(17):1872-9.

Burns KEA, Meade MO, Lessard MR, Keenan SP, Lellouche F. Wean earlier and automatically with new technology (The WEAN Study): A protocol of a mul-ticentre, pilot randomized controlled trial Trials 2009 Sep 4;10:81.

MEHTA, S.Publications

Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht J-J, Zhu J, Col J, Natarajan MK, Horsman C, Fox KA, Yusuf S; TIMACS Investigators. Early versus Delayed Invasive Management of Acute Coronary Syndromes. N Engl J Med. 2009; 260:2165-75.

Mehta SR. Aspirin for Prevention and Treatment of Cardiovascular Disease. Ann Intern Med. 2009; 150:414-6.

Jolly SS, Pogue J, Haladyn K, Peters RJ, Fox KA, Avezum A, Gersh BJ, Rupprecht HJ, Yusuf S, Mehta SR. Effects of aspirin dose on ischaemic events and bleed-ing after percutaneous coronary intervention: insights from the PCI-CURE study. Eur Heart J. 2009; 900-30.

Jolly SS, Faxon DP, Fox KAA, Afzal R, Boden WE, Widimsky P, Steg PG, Valentin V, Budaj A, Granger CB, Joyner C, Chrolavicius S, Yusuf S, Mehta SR. Efficacy and Safety of Fondaparinux Versus Enoxaparin In Patients with Acute Coronary Syndromes Treated with Glycoprotein IIb IIIa inhibitors or Thienopyridines: Results from the OASIS 5 Trial. J Am Coll Cardiol. 2009; 54:468-76.

Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR.

Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analy-sis of randomized trials. Am Heart J. 2009; 157(1):132-40.

Budaj A, Eikelboom JW, Mehta SR, Afzal R, Chrolavicius S, Bassand JP, Fox KA, Wallentin L, Peters RJ, Granger CB, Joyner CD, Yusuf S; on behalf of OASIS 5 Investigators. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. Eur Heart J. 2009; 30: 655-61

Joyner CD, Peters RJ, AFzal R, Chrolavicius S, Mehta SR, Fox KA, Granger CB, Fanzosi MG, Flather M, Budaj A, Bassand JP, Yusuf S. Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treat-ment effect across different levels of risk. Am Heart J. 2009; 157(3):502-8.

Karthikeyan G, Mehta SR, Eikelboom JW. Fondaparinux in the treatment of acute coronary syn-dromes: evidence from OASIS 5 and 6. Expert Rev Cardiovasc Ther. 2009; 7(3):241-9.

Sculpher MJ, Lozano-Ortega G, Sambrook J, Palmer S, Ormanidhi O, Bakhai A, Flather M, Steg P. Gabriel, Mehta SR, Weintraub W. Fondaparinux versus Enoxaparin in Non-ST-Elevation Acute Coronary Syndromes: Short-Term Cost and Long-Term Cost-Effectiveness Using Data from OASIS-5. OASIS-5 Economic Analysis. Am Heart J. 2009 May; 157(5):845-52.

Swahn E, Alfredsson J, Afzal R, Budaj A, Chrolavicius S, Fox K, Jolly S, Mehta SR, de Winter R, Yusuf S. Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syn-dromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trials. Eur Heart J. 2009 Feb 7.

Goyal A, Mehta SR, Gerstein HC, Diaz R, Afzal R, Xavier D et al. Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction. Am Heart J. 2009; 157:763-70.

Cantor WJ, Fitchett D, Borgundvaag B, Heffernan M, Cohen EA, Morrison LJ, Ducas J, Langer A, Mehta SR, Lazzam C, Schwartz B, Dzavik V, Casanova A, Singh P, Goodman SG for the TRANSFER-AMI Investigators. Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction. N Engl J Med. 2009; 260:2705-18.

Berger JS, Deepak LB, Cannon CP, Chen Z, Jiang L, Jones JB, Mehta SR, Sabatine MS, Steinhubl SR, Topol EJ, Berger PB. The relative efficacy and safety of clopi-dogrel in women and men. A sex specific collabora-tive meta-analysis. J Am Coll Cardiol 2009; 54:1935-45.

Banihashemi B, Goodman SG, Yan RT, Welsh RC, Mehta SR, Montalescot G, Kornder JM, Wong GC, Gyenes G, Steg G, Yan AT, for GRACE/GRACE2 Investigators. Underutilization of clopidogrel and gly-coprotein IIb/IIIa inhibitors in non-ST elevation acute coronary syndrome patients: The Canadian Global Registry of Acute Coronary Events (GRACE) experi-ence. Am Heart J. 2009; 158:917-24.

Goyal A, Mehta SR, Diaz R, Gerstein HC, Afzal R, Xavier D, Liu L, Paris P, Yusuf S. Differential clinical outcomes associated with hypoglycemia and hypergly-cemia in acute myocardial infarction. Circulation. 2009; 120:2429-37.

Book Chapter

Schwalm JD, Mehta SR. Percutaneous Coronary Intervention and Concomitant Antithrombotic Therapy

in UA/NSTEMI. In: Acute Coronary Syndromes, Second Edition: A Companion to Braunwald’s Heart Disease, WB Saunders, Philadelphia, 2009.

MOAYYEDI, P.Publications

Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syn-drome: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009; 7:279-86.

Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Gut. 2009; 58:367-78.

Ford AC. Chey WD. Talley NJ. Malhotra A. Spiegel BM. Moayyedi P. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analy-sis. Archives of Internal Medicine. 2009; 169:651-8.

Modlin IM, Hunt RH, Malfertheiner P, Moayyedi P, Quigley EM, Tytgat GN, Tack J, Heading RC, Holtman G, Moss SF; Vevey NERD Consensus Group. Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion. 2009; 80:74-88.

Ford AC, Ching E, Moayyedi P. Meta-analysis: Yield of Diagnostic Tests for Coeliac Disease in Dyspepsia. Aliment Pharmacol Ther. 2009 Jul; 30(1):28-36.

Rostom A, Moayyedi P, Hunt R; Canadian Association of Gastroenterology Consensus Group. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastropro-tection: benefits versus risks. Aliment Pharmacol Ther. 2009 Mar 1; 29(5):481-96.

Chow CK., Moayyedi P, Devereaux PJ. Is it safe to use a proton pump inhibitor with clopidogrel? Pol Arch Med Wewn. 2009 Sep;119(9):564-8.

Ford AC, Moayyedi P. Managing dyspepsia. Current Gastroenterology Reports. 2009; 11:288-94.

Ford AC, Moayyedi P. Should we step-up or step-down in the treatment of new-onset dyspepsia in primary care? Pol Arch Med Wewn. 2009 Jun; 119(6):391-6. Review.

Moayyedi P, Sadowski DC. Proton pump inhibitors and clopidogrel – hazardous drug interaction or hazard-ous interpretation of data? Can J Gastroenterol. 2009; 23:251-2.

MOFFAT, K.Publications

Moffat KA, Ledford-Kraemer MR, Plumhoff EA, McKay H, Nichols WL, Meijer P, Hayward CPM. Are laborato-ries following published recommendations for lupus anticoagulant testing? An international evaluation of practices. Thromb Haemost. 2009 Jan; 101(1):178-84.

Hayward CPM, Pai M, Liu Y, Moffat KA, Seecharan J, Webert KE, Cook RJ, Heddle NM. Diagnostic utility of light transmission platelet aggregometry: Results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost. 2009 Apr; 7(4):676-84.

Hayward CPM, Moffat KA, Spitzer E, Timleck M,

148

PUBLICATIONS

Plumhoff E, Israels SJ, White J. Results of an external proficiency testing exercise on platelet dense granule deficiency testing by whole mount electron micros-copy. American Journal of Clinical Pathology 2009; 131(5):671-5.

Mullah-Ali AM, Chan AK, Lillicrap D, Decker K, Seroski W, Moffat K, Walker I, Pai MK. Undetected factor VIII level in a patient with type 3 von Willebrands disease mistaken as severe hemophilia A. Haemophilia. 2009 Nov; 15(6):1258-61.

Cattaneo M, Hayward CPM, Moffat KA, Pugliano MT, Liu Y, Michelson AD. Results of a worldwide survey on the assessment of platelet function by light trans-mission aggregometry: a report from the Platelet Physiology Subcommittee of the SSC of the ISTH. J Thromb Haemost. 2009 Jun; 7(6):1029.

MOLLOY, W.Publication

Yavuz BB, Standish T, Almeida E, Cunje A, DiLoreto P, Moore A, Kucher B, Marchese M, Warsi M, Molloy AJ, Molloy DWM. Antibiotics in dementia: What’s next? The DARAD Trial. Akad Geriatri 2009; 1:67-72.

MOORE, J.Publication

Warkentin TE, Sheppard JA, Moore JC, Cook RJ, Kelton JG. Studies of the immune response in hepa-rin-induced thrombocytopenia. Blood. 2009 May 14; 113(20):4963-9.

MORGAN, D.Publications

Tam FY, Mukherjee S, Farrell, Morgan D, Sur R. Endoscopic branchytherapy for obstructive colorectal cancer. Brachytherapy. 2009 Jul-Sep; 8(3):313-7.

Love J, Bernard E-J, Cockeram A, Cohen L, Fishman M, Gray J, Morgan D. A multicentre, observational study of sodium picosulfate and magnesium citrate as a pre-colonoscopy bowel preparation. Can J Gastroenterol. 2009 Oct; 23(10):706-10.

MORILLO, C.Publications

Ramírez JD, Guhl F, Umezawa ES, Morillo CA, Rosas F, Marin-Neto JA, Restrepo S. Evaluation of adult chronic Chagas’ heart disease diagnosis by molecular and serological methods. J Clin Microbiol. 2009 Dec; 47(12):3945-51.

Khaykin Y, Skanes A, Champagne J, Themistoclakis S, Gula L, Rossillo A, Bonso A, Raviele A, Morillo CA, Verma A, Wulffhart Z, Martin DO, Natale A. A random-ized controlled trial of the efficacy and safety of elec-troanatomic circumferential pulmonary vein ablation supplemented by ablation of complex fractionated atrial electrograms versus potential-guided pulmo-nary vein antrum isolation guided by intracardiac ultrasound. Circ Arrhythm Electrophysiol. 2009 Oct; 2(5):481-7.

Marin-Neto JA, Rassi A Jr, Avezum A Jr, Mattos AC, Rassi A, Morillo CA, Sosa-Estani S, Yusuf S; BENEFIT Investigators. The Benefit Trial: Testing the hypothesis

that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem Inst Oswaldo Cruz. 2009 Jul; 104 Suppl 1:319-24.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators. Dabigatran versus Warfarin in patients with atrial fibril-lation. N Engl J Med. 2009 Sep 17; 361(12):1139-51.

Sheldon RS, Amuah JE, Connolly SJ, Rose S, Morillo CA, Talajic M, Kus T, Fouad-Tarazi F, Klingenheben T, Krahn AD, Sheldon A, Koshman ML, Ritchie D; Investigators of the Prevention of Syncope Study. Design and use of a quantitative scale of measuring presyncope. J Cardiovasc Electrophysiol. 2009 Aug; 20(8):888-93.

Michael KA, Redfearn DP, Baranchuk A, Birnie D, Gula LJ, Sterns L, Pantano A, Macle L, Veenhuyzen G, Verma A, Mangat I, Sapp J, Morillo CA. Transesophageal Echocardiography for the Prevention of Embolic Complications after Catheter Ablation for Atrial Fibrillation. J Cardiovasc Electrophysiol. 2009 Nov; 20(11):1217-22.

Sheldon RS, Amuah JE, Connolly SJ, Rose S, Morillo CA, Talajic M, Kus T, Fouad-Tarazi F, Klingenheben T, Krahn AD, Koshman ML, Ritchie D; Prevention of Syncope Trial. Effect of Metoprolol on quality of life in the Prevention of Syncope Trial. J Cardiovasc Electrophysiol. 2009 Oct;0(10):1083-8.

Baranchuk A, Healey JS, Simpson CS, Redfearn DP, Morillo CA, Connolly SJ, Fitzpatrick M. Atrial overdrive pacing in sleep apnoea: a meta-analysis. Europace. 2009 Aug; 11(8):1037-40.

Divakara Menon SM, Healey JS, Nair GM, Ribas CS, Baranchuk A, Nery PB, Sumner GL, Connolly SJ, Morillo CA. A case of long-RP Tachycardia: What is the mechanism? J Cardiovasc Electrophysiol. 2009 Jun; 20(6):702-4.

Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J, Natarajan MK, Horsman C, Fox KA, Yusuf S; TIMACS Investigators. Early versus delayed invasive interven-tion in acute coronary syndromes. N Engl J Med. 2009 May 21; 360(21):2165-75.

ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009 May 14; 360(20):2066-78.

Baranchuk A, Divakaramenon S, Ribas S, Morillo CA. Hypertrophic Cardiomyopathy and Tachyarrhythmias Detected by a Pacemaker. Arq Bras Cardiol. 2009 Mar; 92(3):e13-5.

Torres OA, Calzada JE, Beraún Y, Morillo CA, González CI, González A, Martín J. Association of the macro-phage migration inhibitory factor - 173G/C polymor-phism with Chagas Disease. Hum Immunol. 2009 Jul; 70(7):543-6.

Aydin MA, Maas R, Mortensen K, Steinig T, Klemm H, Risius T, Meinertz T, Willems S, Morillo CA, Ventura R. Predicting recurrence of vasovagal syncope: a simple risk score for the clinical routine. J Cardiovasc Electrophysiol. 2009 Apr; 20(4):416-21.

Robinson M, Healey JS, Eikelboom J, Schulman S, Morillo CA, Nair GM, Baranchuk A, Ribas S, Evans G,

Connolly SJ, Turpie AG. Postoperative low-molecu-lar-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol. 2009 Mar; 32(3):378-82.

Nair GM, Nery PB, Diwakaramenon S, Healey JS, Connolly SJ, Morillo CA. A systematic review of ran-domized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2009 Feb; 20(2):138-44.

Khaykin Y, Wang X, Natale A, Wazni OM, Skanes AC, Humphries KH, Kerr CR, Verma A, Morillo CA. Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study. J Cardiovasc Electrophysiol. 2009 Jan; 20(1):7-12.

Baranchuk A, Nault MA, Morillo CA. The central ner-vous system and sudden cardiac death: what should we know? Cardiol J. 2009; 16(2):105-12. Review.

MULJI, A.Publications

Koo KK, Sun JC, Whitlock RP, Franchetto AA, Mulji A, Lamy A. Para Aortic arch abscess secondary to Staphylococcus aureus pneumonia. Can J Cardiol. 2009 Apr; 25(4):233-6.

Mulji A, Schwalm JD, Mulji A. A case of a leaky Dor. Can J Cardiol. 2009 Aug;25(8):488.

NAIR, G.Publications

Robinson M, Healey JS, Eikelboom J, Schulman S, Morillo CA, Nair GM, Baranchuk A, Ribas S, Evans G, Connolly SJ, Turpie AG. Postoperative low-molecu-lar-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol. 2009 Mar; 32(3):378-82.

Divakara Menon SM, Healey JS, Nair GM, Ribas CS, Baranchuk A, Nery PB, Sumner GL, Connolly SJ, Morillo CA.A Case of Long-RP Tachycardia: What is the Mechanism? J Cardiovasc Electrophysiol. 2009 Jun; 20(6):702-4.

Nair GM, Nery PB, Diwakaramenon S, Healey JS, Connolly SJ, Morilla CA.A Systematic Review of Randomized Trials Comparing Radiofrequency Ablation with Antiarrhythmic Medications in Patients with Atrial Fibrillation. J Cardiovasc Electrophysiol. 2009 Feb; 20(2):138-44.

NAIR, P.Publications

Sanaee MS, O’Byrne PM, Nair P. Diffuse idiopathic pul-monary neuroendocrine hyperplasia, chronic eosino-philic pneumonia, and asthma. Eur Respir J. 2009 Dec; 34(6):1489-92.

Nair P, Hanrahan J, Hargreave FE. Clinical equivalence testing of inhaled bronchodilators. Pol Arch Med Wewn. 2009 Nov; 119(11):731-5.

Hargreave FE, Nair P. The definition and diagnosis of asthma. Clin Exp Allergy. 2009 Nov; 39(11):1652-8.

Fanat AI, Thomson JV, Radford K, Nair P, Sehmi R. Human airway smooth muscle promotes eosinophil differentiation. Clin Exp Allergy. 2009 Jul; 39(7):1009-17.

Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O’Byrne PM. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. 2009 Mar 5; 360(10):985-93.

Sindi A, Todd DC, Nair P. Antiinflammatory effects of long-acting beta2-agonists in patients with asthma: a systematic review and metaanalysis. Chest. 2009 Jul; 136(1):145-54.

NATARAJAN, M.K.Publications

Mercuri M, Xie C, Levy M, Valettas N, Natarajan MK. Predictors of increased radiation dose during percuta-neous coronary intervention. Am J Cardiol. 2009 Nov 1; 104(9):1241-4.

Kotowycz MA, Syal RP, Afzal R, Natarajan MK. Can we improve length of hospitalization in ST elevation myo-cardial infarction patients treated with primary percu-taneous coronary intervention? Can J Cardiol. 2009 Oct; 25(10):585-8.

Madan M, Nikhil J, Hellkamp AS, Pieper KS, Labinaz M, Cohen EA, Buller CE, Cantor WJ, Seidelin P, Ducas J, Carere RG, Natarajan MK, O’Shea JC, Tcheng JE;ESPRIT Investigators. Effect of operator and insti-tutional volume on clinical outcomes after percutane-ous coronary interventions performed in Canada and the United States: a brief report from the Enhanced Suppression of the Plateletglycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) study. Can J Cardiol. 2009 Aug; 25(8):e269-72.

Solomon RJ, Mehran R, Natarajan MK, Doucet S, Katholi RE, Staniloae CS, Sharma SK, Labinaz M, Gelormini JL, Barrett BJ. Contrast-induced nephropa-thy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol. 2009 Jul; 4(7):1162-9.

Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J, Natarajan MK, Horsman C, Fox KA, Yusuf S; TIMACS Investigators. Early versus delayed invasive interven-tion in acute coronary syndromes. N Engl J Med. 2009 May 21; 360(21):2165-75.

Mercuri M, Natarajan MK, Holder DH, Xie C, Gafni A. Insight into capacity planning for cardiac catheteriza-tion services: policy lessons learned from “Looking in the Mirror” over a decade. Health Policy. 2009 Aug; 91(3):314-20.

Nevis IF, Mathew A, Novick RJ, Parikh CR, Devereaux PJ, Natarajan MK, Iansavichus AV, Cuerden MS, Garg AX. Optimal method of coronary revascularization in patients receiving dialysis: systematic review. Clin J Am Soc Nephrol. 2009 Feb; 4(2):369-78.

Bertrand OF, Poirier P, Rodés-Cabau J, Rinfret S, Title L, Dzavik V, Natarajan M, Angel J, Batalla N, Alméras N, Costerousse O, De Larochellière R, Roy L, Després JP; VICTORY trial investigators. A multicentre, random-ized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis pro-gression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial. Can J Cardiol.

150

PUBLICATIONS

2009 Sep; 25(9):509-15

Venkatesh V, Ellins ML, Yang S, Natarajan M, Amlani S, Sheth T. Incremental detection of coronary artery disease by assessment of non-calcified plaque on coronary CT angiography. Clin Radiol. 2009 Mar; 64(3):250-5.

O’BYRNE, P.Publications

O’Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW. Severe exacerbations and the decline in lung function in asthma. Am J Respir Crit Care Med. 2009; 179:19-24.

O’Byrne PM, Gauvreau GM, Brannan J. Provoked mod-els of asthma: what have we learnt? Clin Exp Allergy 2009; 39:181-92.

Nair P, Pizzichini M, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O’Byrne PM. Mepolizumab for prednisone-dependent asthma with persistent sputum eosinophilia. N Engl J Med. 2009; 360:985-93.

Moeller A, Gilpin SE, Ask K, Cox G, Cook DJ, Gauldie J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, O’Byrne PM, Strieter RM, Kolb MRJ. Circulating fibro-cytes are an indicator for poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009; 179:588-94.

Al-Garawi AA, Fattouh R, Walker TD, Jamula EB, Botelho F, Goncharova S, Reed J, Stampfli MR, O’Byrne PM, Coyle AJ, Jordana M. Acute, but not resolved, influenza A infection enhances susceptibility to house dust mite-induced allergic disease. J Immunology. 2009; 182:3095-104.

Davis BE, Illamperuma C, Gauvreau GM, Watson RM, O’Byrne PM, Deschesnes F, Boulet L-P, Cockcroft DW. The effect of single dose desloratadine alone and in combination with montelukast on allergen-induced late airway responses. Eur Respir J. 2009; 33:1302-8.

Boulet L-P, Lemière C, Gauvreau GM, Olivenstein R, Lougheed D, Paradis B, O’Byrne PM, Pageau R, Renzi PM. Safety, pharmacodynamics, pharmacokinetics and efficacy of TPI 1020 in smokers with asthma. Resp Med. 2009; 103:1159-66.

Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O’Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE. An official American Thoracic Society/European Respiratory Society statement: asth-ma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009; 180:59-99.

O’Byrne PM, Gauvreau GM. Phosphodiesterase inhibi-tors for the treatment of COPD. Lancet. 2009; 374:665-7.

O’Byrne PM, Gauvreau GM, Murphy DM. Efficacy of leukotriene receptor antagonists and synthesis inhibi-tors in asthma. J Allergy Clin Immunol. 2009; 124:397-403.

O’Byrne PM. Obstructive lung disease from concep-tion to old age:differences in the treatment of adults and children with asthma. Proc Am Thorac Soc. 2009; 6:720-3.

O’Byrne PM, Lamm CJ, Busse WW, Tan WC, Pedersen

S. The effects of inhaled budesonide on lung function in smokers and non-smokers with mild asthma. Chest. 2009; 136:1514-20.

Sanaee MS, O’Byrne PM, Nair P. Diffuse idiopathic pul-monary neurocrine hyperplasia, chronic eosinophilic pneumonia and asthma. Eur Respir J. 2009; 34:1489-92.

O’Byrne PM, van der Linde J, Cockcroft DW, Gauvreau GM, Brannan JD, FitzGerald JM, Watson RM, Milot J, Davis B, O’Connor M, Hart L, Korducki L, Hamilton AL, Boulet L-P. Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting ß2-agonist, in mild asthmatics. J Allergy Clin Immunol. 2009; 124:1217-24.

O’Byrne PM. Allergen-induced airway inflamma-tion and its therapeutic intervention. Allergy Asthma Immunol Res. 2009; 1:2-8.

Bacharier LB, Guilbert TW, Zeiger RS, Strunk RC, Morgan WJ, Lemanske RF Jr, Moss M, Szefler SJ, Krawiec M, Boehmer S, Mauger D, Taussig LM, Martinez FD; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute (including O’Byrne PM). Patient char-acteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma. J Allergy Clin Immunol. 2009; 123:1077-82.

Rivera-Spoljaric K, Chinchilli VM, Camera LJ, Zeiger RS, Paul IM, Phillips BR, Taussig LM, Strunk RC, Bacharier LB; Childhood Asthma Research and Education (CARE) Network (including O’Byrne PM). Signs and symptoms that precede wheezing in chil-dren with a pattern of moderate-to-severe intermittent wheezing. J Pediatr. 2009; 154:877-81.

O’SHEA, T.Publications

Mahony JB, Blackhouse G, Babwah J, Smieja M, Buracond S, Chong S, Ciccotelli W, O’Shea T, Alnakhli D, Griffiths-Turner M, Goeree R. Cost analysis of multi-plex PCR testing for diagnosing respiratory virus infec-tions. J Clin Microbiol. 2009 Sep; 47(9):2812-7.

Mukaya JE, Ddungu H, Ssali F, O’Shea T, Crowther MA. Prevalence and morphological types of anemia and hookworm infestation in the medical emergency ward, Mulago Hospital, Uganda. S Afr Med J. 2009 Dec; 99(12):881-6.

PAPAIOANNOU, A.Publications

Waugh E, Lam M, Hawker GA, McGowan J, Papaioannou A, Cheung A, Hodsman AB, Leslie WD, Siminoski K, Jamal SA. Risk factors for low bone mass in healthy 40-60 year old women: a systematic review of the literature. Osteoporos Int. 2009; 20:1–21.

Papaioannou A, Kennedy CC, Cranney A, Hawker G, Brown JP, Kaiser SM, Leslie WD, O’Brien CJM, Sawka AM, Khan A, Siminoski K, Tarulli G, Webster D, McGowan J, Adachi JD. Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporosis Int 2009 Apr; 20(4):507-18.

S. A. Jamal, D. Goltzman, D. A. Hanley, A. Papaioannou, J. C. Prior and R. G. Josse. Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study. Osteoporosis Int.

2009 May; 20(5): 737-44.

Langsetmo L, Goltzman D, Kovacs CS, Adachi JD, Hanley DA, Kreiger N, Josse R, Papaioannou A, Olszynski WP, Jamal SA. Repeat Low-trauma Fractures Occur Frequently Among Men and Women who have Osteopenic Bone Mineral Density. J Bone Miner Res. 2009 Sep; 24(9):1515-22.

Giangregorio L, Dolovich L, Cranney A, Adili A, Debeer J, Papaioannou A, Thabane L, Adachi JD. Osteoporosis risk perceptions among patients who have sustained a fragility fracture. Patient Educ Couns. 2009 Feb; 74(2):213-20.

Wong, AKO, Inglis D, Beattie KA, Doan A, Ioannidis G, Adachi JD, Papaioannou A. Reproducibility of com-puter-assisted joint alignment measurement in OA knee radiographs. Osteoarthritis Cartilage. 2009 May; 17(5):579-85.

Brown JP, Albert C, Nassar BA, Adachi JD, Cole D, Davison KS, Dooley KC, Don-Wauchope A, Douville P, Hanley DA, Jamal SA, Josse R, Kaiser S, Krahn J, Krause R, Kremer R, Lepage R, Letendre E, Morin S, Ooi DS, Papaioaonnou A, Ste-Marie LG. Bone turnover markers in the management of postmenopausal osteo-porosis. Clin Biochem. 2009 Jul; 42(10-11):929-42.

Papaioannou A, Kennedy C, Ioannidis G, Sawka A, Hopman W, Pickard L, Brown JP, Josse RG, Kaiser S, Anastassiades T, Goltzman D, Papadimitropoulos M., Tenenhouse A, Prior JC, Olszynski WP, Adachi JD, for the CaMos Study Group. The impact of incident frac-tures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporosis Int. 2009 May; 20(5):703-14.

Wong AKO, Beattie KA, Emond PD, Inglis D, Duryea J, Doan A, Ioannidis G, Webber CE, O’Neill J, de Beer J, Adachi JD, Papaioannou A. Quantitative analysis of subchondral sclerosis of the tibia by bone texture parameters in knee radiographs: site-specific relation-ships with joint space width. Osteoarthritis Cartilage. 2009 Nov; 17(11):1453-60.

Giangregorio LM, Jantzi M, Papaioannou A, Hirdes J, Maxwell CJ, Poss JW. Osteoporosis management among residents living in long-term care. Osteoporosis Int. 2009 Feb 10. Osteoporos Int. 2009 Sep; 20(9):1471-8.

Papaioannou A, Kennedy CC, Cranney A, Hawker G, Brown JP, Kaiser SM, Leslie WD, O’Brien CJM., Sawka AM, Khan A., Siminoski K, Tarulli G., Webster D., McGowan J, Adachi JD. Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporosis Int. 2009 Apr; 20(4):507-18.

Haaland D, Cohen D, Kennedy C, Khalidi N, Adachi J, Papaioannou A. Closing the osteoporosis care gap- increased osteoporosis awareness among geri-atrics and rehabilitation teams. BMC Geriatr. 2009 Jul 14;9:28.

Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Walsh A, Jiwa F, Adachi JD. Family physicians’ personal and practice character-istics that are associated with improved utilization of bone mineral density testing and osteoporosis medica-tion prescribing. Population Health Manag. 2009 Jun; 12(3):131-8.

Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Walsh A, Jiwa F, Adachi JD. The utilization of appropriate osteoporosis medications improves following a multifaceted educational inter-vention: the Canadian quality circle project (CQC). BMC Med Educ. 2009 Aug 6;9:54.

Mulgund M, Beattie KA, Wong AKO, Papaioannou A, Adachi JD. Assessing adherence to teriparatide thera-py, causes of nonadherence and effect of adherence on bone mineral density measurements in osteoporotic patients at high risk for fracture. Ther Adv Musculoskel Dis. 2009; 1(1)5-12.

Ioannidis G, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L, Kennedy CC, Prior JC, Olszynski WP, Davison KS, Goltzman D, Thabane L, Gafni A, Papadimitropoulos EA, Brown JP, Josse RG, Hanley DA, Adachi JD. Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ. 2009 Sep 1; 181(5):265-71.

Abid S, Papaioannou A. Vertebral Compressions Fractures Among Older Adults. Geriatrics and Aging. Jan/Feb 2009; 12(1):10-20.

Adachi JD, Kennedy CC, Papaioannou A, Ioannidis G, Leslie WD, Walker V. Treating Osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers? Osteoporosis International. 2009; 20:1785-93.

Leslie WD, O’Donnell S, Jean S, Lagace C, Walsh P, Bancej C, Morin S, Hanley DA, Papaioannou A. for the Osteoporosis Surveillance Expert Working Group. Trends in Hip Fracture Rates in Canada. JAMA. 2009; 302(8):883-9.

Giangregorio LM, Thabane L, deBeer J, Farrauto L, McCartney N, Adachi JD, Papaioannou A. Body weight- supported treadmill training for patients with hip frac-ture: a feasibility study. Arch Phys Med Rehabil. 2009; 90:2125-30.

RASHID, S.Publications

Rashid S. Key questions resulting from the JUPITER trial assessing cardiovascular disease intervention with rosuvastatin. World J Cardiol. 2009 Dec; 1(1): 41-45.

Cortés VA, Curtis DE, Sukumaran S,. Shao X, Rashid S, Smith AR, Ren J, Hamme RE, Agarwal AK, Horton JD and Garg A. Molecular mechanisms of hepatic ste-atosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy. Cell Metabolism. 2009 Feb; 9(2):165-76.

Book Chapters

Collins T and Rashid S. Hands-on Project 4: Medical Imaging with Image J In: Optical and Digital Image Processing. Cristobal, Schelkens, Thienpont (eds.), WILEY-VCH Verlag GmBH & Co. KGaA Publishers,Weinheim, Germany, 2009.

Rizkalla J, Melone M and Rashid S. Anti-Obesity Drug Discovery and Development: HDL Raising Therapies in Obesity In: Anti-Obesity Drug Discovery and Development. Bentham Science Publishers, the Netherlands, 2009.

RATHBONE, M.Publication

Jiang S, Khan IM, Bain JR, Hansebout CR, Yu ZS, Rathbone MP. Enteric glia transplanted into injured spinal cords of rats enhance functional and histological recovery. Neural Regeneration Research, 2009; 4:1-7.

152

PUBLICATIONS

RODGER, I.Publication

Rodger, I.W. Analgesic targets: today and tomorrow. Inflammopharmacology. 2009 Jun; 17(3):151-61.

ROTSTEIN, C.Publications

Guery B, Arendrup M, Auzinger G, Azoulay E, Borges Sa M, Johnson E, Muller E, Putensen C, Rotstein C, Sganga G, Venditti M, Zaragosa Crespo R, Kullberg BJ. Management of invasive candidiasis and candidaemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med. 2009; 35:55-62.

Guery B, Arendrup M, Auzinger G, Azoulay E, Borges Sa M, Johnson E, Muller E, Putensen C, Rotstein C, Sganga G, Venditti M, Zaragosa Crespo R, Kullberg BJ. Management of invasive candidiasis and candidaemia in adult non-neutropenic intensive care unit patients: Part II. Treatment. Intensive Care Med. 2009; 35:206-14.

De Beer J, Petruccelli D, Rotstein C, Weening B, Royston K, Winemaker M. Antibiotic prophylaxis for total joint replacement surgery: results of a Canadian orthopedic surgeon survey. Can J Surg. 2009; 52:E229-34.

SAGAR, S.Publications

Deng GE, Frenkel M, Choen L, Cassileth BR, Abrams DI, Capodice JL, Courneva KS, Dryden T, Hanser S, Kumar N, Labriola D, Wardell DW, Sagar S. Evidence-based clinical practice guidelines for integrative oncol-ogy: complementary therapies and botanicals. J Soc Integr Oncol. 2009 Summer; 7(3):85-120.

Sagar SM. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol. 2009 Summer; 7(3):83-4.

Sagar SM, Lawenda BD. The role of integrative oncol-ogy in a tertiary prevention survivorship program. Prev Med. 2009 Aug-Sep; 49(2-3): 93-8.

Book Chapters

Sagar S, Wong R, Yance D. Development of anti-angio-genesis therapies for treating cancer from Chinese medicinal herbs. In: Bioactive Natural Products; Gupta V, (eds.), Stadium Press LLC, Houston, 2009.

Sagar S, Sze D, Wong R. Chinese herbal therapies as immune modulators for anti-cancer therapeutic. In: Bioactive Natural Products; Gupta V, (eds.), Stadium Press LLC, Houston, 2009.

Sagar SM. Alternative therapies as primary treatments for cancer. Integr Oncol; Abrams D & Weil A, Oxford University Press, New York, Chapter 26: 502-29,2009.

SAHLAS, D.Publication

Gladstone DJ, Rodan LH, Sahlas DJ, Lee L, Murray BJ, Ween JE, Perry JR, Chenkin J, Morrison LJ, Beck S, Black SE. A citywide prehospital protocol increases access to stroke thrombolysis in Toronto. Stroke. 2009 Dec; 40(12):3841-4.

SALEHIAN, O.Publications

Wright D, Kenny-Scherber C, Montgomery A, Salehian O. Acute Coronary Syndrome in Pregnancy: A Case Report and a Brief Review of Literature. Clinical Med: Cardiol. 2009; 3:e98-e117.

Schwerzmann M, Salehian O, Harris L, Siu SC, Williams WG, Webb GD, Colman JM, Redington A, Silversides C. Ventricular arrhythmias and sudden death after atrial switch operations for transposition of great arteries. Eur Heart J. 2009; 30:1873-9.

Sumner G, Salehian O, Yi Q, Healey JS, Mathew J, Al-Merri K, Al-Nemer K, Dagenais G, Stambler BS, Lonn E. The prognostic significance of bundle branch block in high risk patients. J Cardiovasc Electrophysiol. 2009; 20:781-7.

SCHULMAN, S.Publications

Eischer L, Gartner V, Schulman S, Kyrle PA, Eichinger S; for the AUREC-FVIII investigators. 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Ann Hematol. 2009; 88(5):485-90.

Herrmann F, Wulff K, Auerswald G, Schulman S, Astermark J, Batorova A, Kreuz W, Pollmann H, Ruiz-Saez A, De Bosch N, Salazar-Sanchez L. Factor VII Deficiency: Clinical manifestation of 717 subjects from Europe and Latin America with mutations in the Factor 7 gene. Haemophilia. 2009; 15:267-80.

Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C. Oral vitamin K versus placebo to cor-rect excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med. 2009; 150:293-300.

Schulman S, Eelde A, Blombäck M, Stenflo J. The plasma concentration of activated protein C appears normal in patients with haemophilia. Haemophilia. 2009; 15:566-70.

Robinson M, Healey JS, Eikelboom J, Schulman S, Morillo CA, Nair GM, Baranchuk A, Ribas S, Evans G, Connolly SJ, Turpie AG. Postoperative low-molecu-lar-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol. 2009 Mar; 32(3):378-82.

Berntorp E, Windyga J; European Wilate Study Group (Auerswald G, Diniz MJ, Hanley J, Hay C, Klamroth R, Kyrle P, Lissitchkov T, Male C, Martins N, Matysiak M, Pasi J, Schubert C, Schulman S, Siimes M, Tjønnford G). Treatment and prevention of acute bleedings in von Willebrand disease – efficacy and safety of Wilate, a new generation von Willebrand factor/factor VIII con-centrate. Haemophilia. 2009; 15:122-30.

Meijer K, Schulman S. The absence of ‘minor’ risk factors for recurrent venous thromboembolism: a sys-tematic review of negative predictive values and nega-tive likelihood ratios. J Thromb Haemost. 2009 Oct; 7(10):1619-28.

Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, Baanstra D, Schnee J,

Goldhaber SZ, for the RE-COVER trial investigators. Dabigatran etexilate versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009; 361:2342-52.

Kim Y-K, Schulman S. Cervical artery dissection: Pathology, epidemiology and management. Thromb Res. 2009 Apr; 123(6):810-21.

Schulman S, Reilly PA. Dabigatran etexilate: future directions in anticoagulant treatment.Clin Appl Thromb Hemost. 2009 Sep-Oct; 15 Suppl 1:32S-41S.

Schulman S. Rivaroxaban in Orthopedic Surgery: A Change of Paradigm? Clin Appl Thromb Hemost. 2009; 6:613-20.

Garcia D, Ageno W, Bussey H, Eikelboom J, Margaglione M, Marongiu F, Moia M, Palareti G, Pengo V, Poli D, Schulman S, Witt D, Wittkowksy A, Crowther M. Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention. Am J Hematol. 2009 Sep; 84(9):579-83.

Book Chapter

Schulman S. Bleeding and other adverse events with oral anticoagulation therapy. In: Ansell J, Oertel LB, Wittkowsky AK. (eds). Managing oral anticoagulation therapy. Wolters Kluwer Health, St. Louis, Pgs 193-203, 2009.

SCHWALM, J.D.Publication

Mulji A, Schwalm JD. A Case of a Leaky Dor. Canadian Journal of Cardiology. 2009; 25(8):488.

Book Chapter

Schwalm JD, Chu V. Timing of Cardiac Surgery. In: Evidenced-Based Cardiology, 3rd Edition, Blackwell Publishing, 2009.

SEARS, M.Publications

Sears MR, Ottosson A, Radner F, Suissa S. Long acting ß-agonist safety: A review of formoterol safety data from asthma clinical trials. Eur Respir J. 2009 Jan; 33(1):21-32.

Subbarao P, Becker A, Brook JR, Daley D, Mandhane PJ, Miller GE, Turvey SE, Sears MR, on behalf of the CHILD study investigators. Epidemiology of asthma: risk factors for development. Expert Review Clin Immunol. 2009; 5(1):77-95.

Milne BJ, Caspi A, Crump R, Poulton R, Rutter M, Sears MR, Moffitt TE. The validity of the family history screen for assessing family history of mental disorders. Am J Med Genet B Neuropsychiatr Genet. 2009; 150B(1):41-9.

Hancox RJ, Poulton R, Greene JM, McLachlan CR, Pearce MS, Sears MR. Associations between birth weight, early childhood weight gain, and adult lung function. Thorax. 2009; 64:228-32.

Lougheed MD, Garvey N, Chapman KR, Cicutto L, Dales R, Day AG, Hopman WM, Lam M, Sears MR, Szpiro K, To T, Paterson NAM. Variations and gaps in management of acute asthma in Ontario Emergency Departments. Chest. 2009 Mar; 135(3):724-36.

Gregory AM, Caspi A, Moffitt TE, Milne BJ, Poulton

R, Sears MR. Links between anxiety and allergies: Psychobiological reality or possible methodological bias? J Pers. 2009 Apr; 77(2):347-62.

Reddel HK, Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, deJongste JC, Kerstjens HAM, Lazarus SC, Levy ML, O’Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE, on behalf of the American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An offi-cial American Thoracic Society/European Respiratory Society statement: asthma controls and exacerbations. Standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009 Jul 1; 180(1):59-99.

Jerrett M, Finkelstein MM, Brook JR, Arain MA, Kanaroglou P, Stieb DM, Gilbert NL, Verma D, Finkelstein N, Chapman KR, Sears MR. A cohort study of traffic-related air pollution and mortality in Toronto, Ontario, Canada. Environ Health Perspect. 2009 May; 117(5):772-7.

Sutherland TJT, Taylor DR, Sears MR, McLachlan CR, Greene JM, Poulton R, Hancox RJ. Leptin, adiponec-tin and asthma: findings from a population-based cohort study. Ann Allergy Asthma Immunol. 2009 Aug; 103(2):101-7.

Sahsuvaroglu T, Jerrett M, Sears MR, McConnell R, Finkelstein N, Arain A, Newbold B, Burnett R. Spatial analysis of air pollution and childhood asthma in Hamilton, Ontario: comparing exposure methods in sensitive subgroups. Environmental Health. 2009;8:14.

Subbarao P, Mandhane PJ, Sears MR. Asthma: epide-miology, etiology and risk factors. CMAJ. 2009; 181:E181-190.

Mandhane PJ, Duncan JM, Greene JM, Inman MD, Hanna SE, Sears MR. Changes in exhaled nitric oxide related to estrogen and progesterone during the men-strual cycle. Chest. 2009 Nov; 136(5):1301-7.

Mandhane PJ, Sears MR, Poulton R, Greene JM, Lou WYW, Taylor DR, Hancox RJ. Cats and dogs and the risk of atopy in childhood and adulthood. J Allergy Clin Immunol. 2009 Oct; 124(4):745-50.e4.

Hancox RJ, Poulton R, Welch D, Olova N, McLachlan CR, Greene JM, Sears MR, Caspi A, Moffitt TE, Robertson SP, Braithwaite AW. Accelerated decline in lung function in cigarette smokers is associated with TP53/MDM2 polymorphisms. Hum Genet. 2009 Oct; 126(4):559-65.

Demoly R, Louis R, Søes-Petersen U, Naya I, Carlsheimer Å, Worth H, Almeida J, Sears MR. Budesonide/formoterol maintenance and reliever therapy versus conventional best practice. Respir Med. 2009 Nov; 103(11):1623-32.

Sears MR, Radner F. Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials. Respir Med. 2009 Dec; 103(12):1960-8.

SEBALDT, R.Publications

Sénécal M, Fodor G, Gagné C, Genest J, Lavoie MA, McPherson R, Marentette M, Sebaldt RJ. Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study--obser-vational. Curr Med Res Opin. 2009; 25:47-55.

154

PUBLICATIONS

Kaczorowski J, Karwalajtys T, Lohfeld L, Laryea S, Anderson K, Roder S, Sebaldt RJ. Women’s views on reminder letters for screening mammography: Mixed methods study of women from 23 family health net-works. Can Fam Physician 2009; 55:622-3.e1-4.

Holbrook A, Thabane L, Keshavjee K, Dolovich L, Bernstein B, Chan D, Troyan S, Foster G, Gerstein H, COMPETE II Investigators. Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial. CMAJ 2009; 181:37-44.

Tan JK, Balagurusamy M, Fung K, Gupta AK, Thomas DR, Sapra S, Lynde C, Poulin Y, Gulliver W, Sebaldt RJ. Effect of quality of life impact and clinical severity on adherence to topical acne treatment. J Cutan Med Surg. 2009; 13:204-8.

Carter M, Karwalajtys T, Chambers L, Kaczorowski J, Dolovich L, Gierman T, Cross D, Laryea S, CHAP Working Group. Implementing a standardized com-munity-based cardiovascular risk assessment program in 20 Ontario communities. Health Promot Int. 2009; 24:325-33.

Sebaldt RJ, Dalziel W, Massoud F, Tanguay A, Ward R, Thabane L, Melnyk P, Landry PA, Lescrauwaet B. Detection of cognitive impairment and dementia using the animal fluency test: the DECIDE study. Can J Neurol Sci. 2009; 36:599-604.

SEHMI, R.Publication

Fanat AI, Thomson JV, Radford K, Nair P, Sehmi R. Human airway smooth muscle promotes eosinophil differentiation. Clin Exp Allergy. 2009 Jul; 39(7):1009-17.

Book Chapters

Sehmi R, JV Thomson and A Catalli. Allergy and the Bone Marrow: transmigration pathways of hemo-poietic progenitor cells. In: Allergy Frontiers: From Epigenetics to Future Perspectives. Eds: R Pawankar, S Holgate, LJ Rosenwasser. Springer Japan.

Gauvreau GM, Sehmi R. Hematopoetic Mechanisms in Rhinitis and Asthma. In: Allergy Frontiers: From Epigenetics to Future Perspectives. Eds: R Pawankar, S Holgate, LJ Rosenwasser. Springer Japan.

SHERBINO, J.Publications

Sherbino J, Upadhye S, Worster A. Self-reported Priorities and Resources of Academic Emergency Physicians for the Maintenance of Clinical Competence: A pilot study. Can J Emerg Med. 2009; (11)3:230-4.

Sherbino J. Does this patient with a pericardial effu-sion have cardiac tamponade? Ann Emerg Med. 2009; 53(3):390-1.

Vadera R, Sherbino J. Do opiates affect the clinical evaluation of patients with acute abdominal pain? Ann Emerg Med. 2009; 54(1):126-7.

SPENCER, F.Publications

Gore JM, Spencer FA, Gurfinkel EP, López-Sendón J,

Steg PG, Granger CB, FitzGerald G, Agnelli G; GRACE Investigators. Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2009 Jan 15; 103(2):175-80.

Wasser J, Goldberg RJ, Spencer FA, Yarzebski J, Gore JM. Multidecade-long trends (1986-2005) in the utili-zation of coronary reperfusion and revascularization treatment strategies in patients with acute myocardial infarction: a community-wide perspective. Coron Artery Dis. 2009 Jan; 20(1):71-80.

Floyd KC, Yarzebski J, Spencer FA, Lessard D, Dalen JE, Alpert JS, Gore JM, Goldberg RJ. A 30-year per-spective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocar-dial infarction. Worcester Heart Attack Study. Circ Cardiovasc Qual Outcomes. 2009 Mar; 2(2):88-95.

Yarzebski J, Granillo E, Spencer FA, Lessard D, Gurwitz JH, Gore JM, Goldberg RJ. Changing trends (1986-2003) in the use of lipid lowering medication in patients hospitalized with acute myocardial infarction: A community-based perspective. Int J Cardiol. 2009 Feb 6; 132(1):66-74.

Goldberg, RJ, Spencer FA, Fox KAA, Brieger D, Steg G, Gurfinkel E, Dedrick R, Gore JM. Prehospital delay in patients with acute coronary syndromes (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2009 Mar 1; 103(5):598-603.

Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975-2005) in the mag-nitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based per-spective. Circulation. 2009 Mar 10; 119(9):1211-9.

Rao RV, Goodman SG, Yan RT, Spencer FA, Fox KA, Deyoung JP, Rose B, Grondin FR, Gallo R, Gore JM, Yan AT: Canadian Global Registry of Acute Coronary Events (GRACE/GRACE 2) Investigators. Am H J. 2009; 157:642-50.

Spencer FA, Gore JM, Reed G, Lessard D, Pacifico L, Emery C, Crowther MA, Goldberg RJ. Venous throm-boembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study. Thromb Haemost. 2009 May; 101(5):878-85.

Chan WS, Lee A, Spencer FA, Crowther M, Rodger M, Ramsay T, Ginsberg JS. Predicting deep venous throm-bosis in pregnancy: out in “LEFT” field? Ann Intern Med. 2009 Jul; 151(2):85-92.

Goldberg RJ, Darling C, Joseph B, Saczynski J, Chinali M, Lessard D, Pezzella S, Spencer FA. Epidemiology of decompensated heart failure in a single community in the northeastern USA. Am J Cardiol. 2009 Aug; 104(3):377-82.

Spencer FA, Emery C, Joffe SW, Pacifico L, Lessard D, Reed G, Gore JM, Goldberg RJ. Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. J Thrombo Thrombolys. 2009; 28:401-409.

Saczynski JS, Darling CE, Spencer FA, Lessard D, Gore JM, Golderg RJ. Clinical features, treatment practices, and hospital and long-term outcomes of older patients hospitalized with decompensated heart failure: The Worcester Heart Failure Study. J Am Geriatric Soc. 2009 Sep; 57(9):1587-94.

Becker RC, Scheiman J, Dauerman HL, Spencer FA, Rao S, Sabatine M, Johnson DA, Chan F, Abraham NS, Quigley EM; American College of Cardiology and the American College of Gastroenterology. Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. J Am Coll Cardiol. 2009 Dec; 54(24):2261-76.

Becker RC, Scheiman J, Dauerman HL, Spencer FA, Rao S, Sabatine M, Johnson DA, Chan F, Abraham NS, Quigley EM; American College of Cardiology and the American College of Gastroenterology. Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. Am J Gastroenterol. 2009 Dec; 104(12):2903-17.

SPYROPOULOS, A.Publications

Spyropoulos AC. The prevention of venous thrombo-embolism after surgery for cancer. Cancer Invest. 2009; 27(1):36-40.

Merli G, Spyropoulos AC, Caprini JA. Use of emerg-ing oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical populations. Ann Surg. 2009 Aug; 250(2):219-28.

Spyropoulos AC. Upper vs lower extremity deep vein thrombosis: outcome definitions of venous throm-boembolism for clinical predictor rules or risk factor analyses in hospitalized patients. J Thromb Haemost. 2009 Jun; 7(6):1041-2.

Spyropoulos AC, Mahan CE Venous Thromboembolism Prophylaxis in the Medical Patient: Controversies and Perspectives. Am J Med 2009; 2009 Dec;122(12):1077-84.

Spyropoulos AC, Hussein M, Lin J, Battleman D. Rates of symptomatic venous thromboembolism in US sur-gical patients: a retrospective administrative database study. J Thromb Thrombolysis. 2009 Nov; 28(4):458-64.

Gerotziafas GT, Dupont C, Spyropoulos AC, Hatmi M, Samama MM, Kiskinis D, Elalamy I. Differential inhibi-tion of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight hepa-rin. Thromb Haemost. 2009 Jul; 102(1):42-8.

Spyropoulos AC, Hussein M, Lin J, and Battleman D. Rates of venous thromboembolism occurrence in med-ical patients among the insured population. Thromb Haemost. 2009; 102:951-7.

Book Chapter

Mahan CE, Spyropoulos AC, Baca E, Amin A, Deitezweig S. Brave New World: Antithrombotics on the Horizon. In: Contemporary Hospitalists Guide to Anticoagulation, 1st Edition. Handbooks in Health Care Co, Newton, PA. 2009.

STEINBERG, G.Publications

Steinberg GR. Watt MJ, Febbraio MA. Cytokine Regulation of AMPK. Front Biosci. 2009 Jan 1; 14:1902-16.

Steinberg GR, Watt MJ, Ernst M, Birnbaum MJ, Kemp BE, Jørgensen SB. CNTF stimulates muscle glucose uptake by a PI3-kinase dependent pathway that is impaired with obesity. Diabetes. 2009 Apr; 58(4):829-39.

Dzamko N, Steinberg GR. AMPK-dependent hormonal regulation of whole-body energy metabolism. Acta Scanda Physiol. 2009; 196(1):115-27.

Cook N, Fraser SA, Katerelos M, Katsis F, Steinberg GR, Levidiotis V, Kemp BE and Power DA. Low Salt Concentrations Activate AMP-activated Protein Kinase in Mouse Macula Densa Cells. Am J Physiol Renal Physiol. 2009 Apr; 296(4):F801-9.

Drew BG, Duffy SJ, Formosa MF, Natoli AK, Henstridge DC, Penfold SA, Thomas WG, Mukhamedova N, Forbes JM, Yap FY, Kaye DM, Febbraio MA, Hall GV, Kemp BE, Sviridov D, Steinberg GR, Kingwell BA. High Density Lipoprotein Stimulates Energy Metabolism in Humans by Increasing Insulin Secretion and Activating AMP-kinase. Circulation. 2009 Apr 21; 119(15):2103-11.

Steinberg GR. Role of the AMP-activated protein kinase (AMPK) in regulating fatty acid metabolism during exercise. Appl Physiol Nutr Metab. 2009 Jun; 34(3):315-22.

Steinberg GR and Kemp BE. AMPK in Health and Disease. Physiol Rev. 2009 Jul; 89(3):1025-78.

Brown KA, McInnes KJ, Hunger NI, Oakhill JS, Clyne C, Steinberg GR, Simpson ER. The Regulation of LKB1 Provides a Link Between Obesity, Aging and Breast Cancer in Postmenopausal Women. Cancer Research. 2009; 69(13):5392-9.

Jørgensen SB, Oakhill JS, Honeyman J, Fazakerley D, Stöckli J, Kemp BE and Steinberg GR. Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation. Am J Physiol Endocrinol Metab. 2009; 297(1):E57-66.

Jørgensen SB, O´Neill H, Hewitt K, Kemp BE and Steinberg GR. Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity. Diabetalogia. 2009; 52(11):2395-404.

TANG, D.Publications

Xu H, He L, Feng X, Kapoor A, Tang D. Specific reduc-tion of fas-associated protein with death domain (FADD) in clear cell renal cell carcinoma. Cancer Invest. 2009 Oct; 27(8):836-43.

Fan C, He L, Kapoor A, Rybak AP, De Melo J, Cutz JC, Tang D. PTEN inhibits BMI1 function independently of its phosphatase activity. Mol Cancer. 2009 Nov 10;8:98.

TARNOPOLSKY, M.Publications

Abadi A, Glover E, Isfort R, Raha S, Safdar A, Yasuda N, Kaczor J, Melov S, Hubbard A, Qu X, Phillips S, Tarnopolsky M. Limb immobilization induces a coor-dinate down-regulation of mitochondrial and other metabolic pathways in men and women. PLoS One. 2009 Aug; 4(8):e6518.

Bell R, Hubbard A, Chettier R, Chen D, Miller JP, Kapahi P, Tarnopolsky M, Sahasrabuhde S, Melov S, Hughes RE. A human protein interaction network shows con-servation of aging processes between human and invertebrate species. PLoS Genet. 2009 Mar; 5(3):e1000414.

Cermak N, Solheim A, Gardner M, Tarnopolsky M,

156

PUBLICATIONS

Gibala M. Muscle metabolism during exercise with car-bohydrate or protein-carbohydrate ingestion. Med Sci Sports Exerc. 2009 Dec; 41(12):2158-64.

Fu MH, Maher AC, Hamadeh M, Ye C, Tarnopolsky M. Exercise, sex, menstrual cycle phase, and 17 beta-estradiol influence metabolism-related genes in human skeletal muscle. Physiol Genomics. 2009 Dec; 40(1):34-47.

Lach B, Tarnopolsky M, Nguyen C. Sarcoplasmic hexagonally cross-linked tubular arrays immunos-tain for caveolin-3: an excess caveolinopathy? Acta Neuropathol. 2009 Mar; 117(3):339-41.

McKay B, De Lisio M, Johnston A, O’Reilly C, Phillips S, Tarnopolsky M, Parise G. Association of interleukin-6 signalling with the muscle stem cell response follow-ing muscle-lengthening contractions in humans. PLoS One. 2009 Jun; 4(6):e6027.

Maher A, Fu M, Isfort R. Varbanov A, Qu X, Tarnopolsky M. Sex differences in global mRNA content of human skeletal muscle. PLoS One. 2009 Jul; 4(7):e6335.

Moore DR, Robinson MJ, Fry JL, Tang JE, Glover EI, Wilkinson SB, Prior T, Tarnopolsky M, Phillips SM. Ingested protein dose response of muscle and albumin protein synthesis after resistance exercise in young men. Am J Clin Nutr. 2009 Jan; 89(1):161-8.

Moore D, Tang J, Burd N, Rerecich T, Tarnopolsky M, Phillips S. Differential stimulation of myofibrillar and sarcoplasmic protein synthesis with protein ingestion at rest and after resistance exercise. J Physiol. 2009 Feb; 15:587(Pt 4):897-904.

Pelletier R, Hamel F, Beaulieu d, Patry L, Haineault C, Tarnopolsky M, Schoser B, Puymirat J. Absence of a differentiation defect in muscle satellite cells from DM2 patients. Neurobiol Dis. 2009 Oct; 36(1):181-90.

Rohrbach M, Chitayat D, Maegawa G, Shanske S, Davidzon G, Chong K, Clarke JT, Toi A, Tarnopolsky M, Robinson B, Blaser S. Intracerebral periventricular pseudocysts in a fetus with mitochondrial depletion syndrome: an association or coincidence. Fetal Diagn Ther. 2009; 25(2):177-82.

Tang J, Moore D, Kujbida G, Tarnopolsky M, Phillips S. Ingestion of whey hydrolysate, casein, or soy protein isolate: effects on mixed muscle protein synthesis at rest and following resistance exercise in young men. J Appl Physiol. 2009 Sep; 107(3):987-92.

Timmons B, Hamadeh M, Tarnopolsky M. Two meth-ods for determining plasma IL-6 in humans at rest and following exercise. Eur J Appl Physiol. 2009 Jan; 105(1):13-8.

Safdar A, Abadi A, Akhtar M, Hettinga B, Tarnopolsky M. miRNA in the regulation of skeletal muscle adap-tation to acute endurance exercise in C57BI/6J male mice. PLoS ONE. 2009; 4(5):e5610.

Sarkhy A, Persad R, Tarnopolsky M. Muscle weakness in a girl with autoimmune hepatitis and Graves’ dis-ease. Eur J Pediatr. 2009 Feb; 168(2):241-3.

Sikorska M. Sandhu J, Simon D, Pathiraja V, Sodja C, Li Y, Ribecco-Lutkiewicz M, Lanthier P, Borowy-Borowshi H, Upton A, Raha S, Pulst S, Tarnopolsky M. Identification of ataxia-associated mtDNA mutations (m.4052T>C and m.9035T>C) and evaluation of their pathogenicity in transmitochondrial cybrids. Muscle Nerve. 2009 Sep; 40(3):381-94.

TEO, K.Publications

Karthikeyan G, Teo KK, Islam S, McQueen MJ, Pais P, Wang X, Sato H, Lang CC, Sitthi-Amorn C, Pandey MR, Kazmi K, Sanderson JE, Yusuf S. Lipid profile, plasma apoliproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study. J Am Coll Cardiol. 2009; 53:244-53.

Cukierman-Yaffe T, Gerstein HC, Anderson C, Zhao F, Sleight P, Hilbrich L, Jackson SHD, Yusuf S, Teo K on behalf of the ONTARGET/TRANSCEND Investigators. Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovas-cular risk: results from the ONTARGET/TRANSCEND Research Programme. Diabetes Res Clin Pract. 2009; 83:387-93.

Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JGF, Ezekowitz M, Jafri SM, Krol WF, O’Connor CM, Schulman KA, Teo K, Warren SR, on behalf of the WATCH Trial Investigators. Randomized trial of war-farin, aspirin and clopidogrel in patients with chronic heart failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure Trial (WATCH). Circulation. 2009; 119:1616-24.

Chow CK, Lock K, Teo K, Subramanian SV, McKee M, Yusuf S. Environmental and societal influences on cardiovascular risk factors and disease at a population level: a review. Int J Epidemiol. 2009; 38:1580-594.

Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jenning GL. The car-diac MRI substudy to Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomdomzied Assessment Study in ACE-Intolerant Subjects with cardiovascular Disease: analysis protocol and baseline characteristics. Clin Res Cardiol. 2009; 98:421-33.

Majumdar SR, Kjellstrand CM, Tymchak WJ, Hervas-Malo M, Taylor DA, Teo KK. Forced euvolemic diuresis with mannitol and furosemide for prevention of con-trast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography: randomized controlled trial. Am J Kidney Dis. 2009; 54:602-9.

The Indian Polycap Study (TIPS) Investigators (writ-ing group: Yusuf S, Pais P, Afzal R, Xavier D, Teo K, Eikelboom J, Sigamani A, Mohan V, Gupta R, Thomas N). Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular dis-ease (TIPS): a phase II, double-blind, randomised trial. Lancet. 2009; 373:1341-51.

Mancini GBJ, Bates ER, Maron DJ, Hartigan P, Dada M, Gosselin G, Kostuk W, Sedlis SP, Shaw LJ, Berman DS, Berger PB, Spetus J, Mavromatis K, Knudtson M, Chaitman BR, O’Rourke RA, Weintraub WS, Teo K, Boden WE on behalf of the COURAGE Investigators and Coordinators. Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial. Circ Cardiovasc Qual Outcomes. 2009; 2:320-27.

Ravandi A, Teo KK. Blocking the renin-angiotensin system: dual- versus mono-therapy. Expert Rev Cardiovasc Ther. 2009; 7:667-74.

Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S. The PURE Investigators Writing Group. The Prospective Urban Rural Epidemiology (PURE) study: Examining

the impact of societal influences on chronic noncom-municable diseases in low-, middle- and high-income countries. Am Heart J. 2009; 158:58:1-7.

Teo KK, Liu L, Chow CK, Wang X, Islam S, Jiang L, Sanderson JE, Rangarajan S, Yusuf S. Potentially modi-fiable risk factors associated with myocardial infarction in China: The INTERHEART China Study. Heart. 2009; 54:602-9.

Mann JF, Schmeider RE, Dyal L, McQueen MJ, Schumacher H, Pogue J, Wang X, Probstfield JL, Avezum A, Cardona-Munoz E, Dagenais GR, Diaz R, Fodor G, Maillon JM, Ryden L, Yu CM, Teo KK, Yusuf S for the TRANSCEND (Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease) Investigators. Effect of telmis-artan on renal outcomes: a randomized trial. Ann Intern Med. 2009;151:1-10.

Sleight P, Redon J, Verdecchia P, Mancia G, Gao P, Fagard R, Schumacher H, Weber M, Bohm M, Williams B, Pogue J, Teo K, Yusuf S on behalf of the ONTARGET Investigators. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens. 2009; 27:1360-9.

Morrison KM, Atkinson SA, Yusuf S, Bourgeois J, McDonald S, Persadie R, Hunter B, Pogue J, Teo K and the FAMILY Investigators. The Family Atherosclerosis Monitoring in Early Life (FAMILY) Study: rationale, design and baseline data of a study examining the early determinants of atherosclerosis. (partial funding by CIHR) Am Heart J. 2009; 58:533-9.

Verdecchia P, Sleight P, Mancia G, Fagard R, Trimarco B, Schmeider RE, Kim JH, Jennings G, Jansky P, Chen JH, Liu L, Gao P, Probstfield J, Teo K, Yusuf S, for the ONTARGET /TRANSCEND Investigators. Effects of telmisartan, ramipril and their combination on left ven-tricular hypertrophy in individuals at high vascular risk in Ongoing Telmisartan Alone and in Combination with Ramiptirl Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease. Circulation. 2009; 120:1380-9.

Teo KK, Sedlis SP, Boden WE, O’Rourke RA, Maron DJ, Hartigan PM, Dada M, Gupta V, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS; the COURAGE Trial Investigators. Optimal medical therapy with or without percuta-neous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. J Am Coll Cardiol. 2009; 54:1303-8.

Boden WE, O’Rourke RA, Teo KK, Maron DJ, Hartigan PM, Sedlis SP, Dada M, Labedi M, Spertus SP, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS; COURAGE Trial Investigators. Impact of optimal medical therapy with or without percutane-sous coronary intervention on long-term cardiovascu-lar endpoints in patients with stable coronary artery disease (from the COURAGE Trial). Am J Cardiol. 2009 Jul; 104(1):1-4.

Maron DJ, Spertus JA, Mancini GB, Hartigan PM, Sedlis SP, Bates ER, Kostuk WJ, Dada M, Berman DS, Shaw LJ, Chaitman BR, Teo KK, O’Rourke RA, Weintraub WS, Boden WE, the COURAGE Research Group. Impact of an initial strategy of medical therapy without percutaneous coronary interven-tion in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug

Evaluation (COURAGE) trial. Am J Cardiol. 2009 Oct 15; 104(8):1055-62.

Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL, for the ONTARGET Investigators. Left ventricular mass and volume with telmisartan, ramiptril or combination in patients with previous atherosclerotic events or with diabetes mellitus (from Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]). Am J Cardiol. 2009 Dec 1; 104(11):1484-9.

Teo KK. Clinical evidence from ONTARGET: proven cardio- and vascular protection. Eur Heart J. 2009; 11(suppl F): F9-F15.

Bohm M, Mahfoud F, Werner C, Teo K, Baumhakel M. Cardiovascular protection: a breakthrough for high-risk patients. Eur Heart J. 2009; 11(suppl F): F19-F26.

Patterson ME, Grant WC, Glickman SW, Massie BM, Ammon SE, Armstrong PW, Cleland JG, Collins JF, Teo KK, Schulman KA, Reed SD. Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluation. J Card Fail 2009; 15:819-827.

Sedlis SP, Jurkovitz CT, Hartigan PM, Goldfarb DS, Lorin JD, Dada M, Maron DJ, Spertus JA, Mancini GB, Teo KK, O’Rourke RA, Boden WE, Weintraub WS, COURAGE Study Investigators. Optimal medical therapy with or without percutaneous coronary inter-vention for patients with stable coronary artery disease and chronic kidney disease. Am J Cardiol. 2009 Dec; 104(12):1647-53.

TODD, D.Publications

Al-Ghimlas F, Todd DC. Predictors of success in pul-monary rehabilitation for patients with interstitial lung disease. Chest. 2009 Oct; 136(4):1183-4.

Sindi A, Todd DC, Nair P. Antiinflammatory effects of long-acting beta2-agonists in patients with asthma: a systematic review and metaanalysis. Chest. 2009 Jul; 136(1):145-54.

TURPIE, A.G.Publications

Turpie AG. Direct Factor Xa and direct thrombin inhibi-tors: a clinical trial update. Curr Opin Drug Discov Devel. 2009 Jul; 12(4):497-508.

Jowett S, Bryan S, Poller L, VAN DEN Besselaar AM, VAN DER Meer FJ, Palareti G, Shiach C, Tripodi A, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, Jespersen J. The cost-effectiveness of computer-assist-ed anticoagulant dosage: results from the European Action on Anticoagulation (EAA) multicentre study. J Thromb Haemost. 2009 Sep; 7(9):1482-90.

Karthikeyan G, Eikelboom JW, Turpie AG, Hirsh J. Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism? Br J Haematol. 2009 Jul; 146(2):142-9.

Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, Benson A, Misselwitz F, Fisher WD; RECORD4 Investigators. Rivaroxaban versus enoxapa-rin for thromboprophylaxis after total knee arthroplasty

158

PUBLICATIONS

(RECORD4): a randomised trial. Lancet. 2009 May; 373(9676):1673-80.

Eriksson BI, Kakkar AK, Turpie AG, Gent M, Bandel TJ, Homering M, Misselwitz F, Lassen MR. Oral rivaroxa-ban for the prevention of symptomatic venous throm-boembolism after elective hip and knee replacement. J Bone Joint Surg Br. 2009 May; 91(5):636-44. Erratum in: J Bone Joint Surg Br. 2009 Aug; 91(8):1120.

Turpie AG, Lensing AW, Fuji T, Boyle DA. Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients. Blood Coagul Fibrinolysis. 2009 Mar; 20(2):114-21.

Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, Roberts C, van den Besselaar AM, van der Meer FJ, Tripodi A, Palareti G, Shiach C, Bryan S, Samama M, Burgess-Wilson M, Heagerty A, Maccallum P, Wright D, Jespersen J; European Action on Anticoagulation (EAA). A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dos-age program. Thromb Haemost. 2009 Mar;101(3):487-94. Erratum in: Thromb Haemost. 2009 Apr; 101(4):794.

Robinson M, Healey JS, Eikelboom J, Schulman S, Morillo CA, Nair GM, Baranchuk A, Ribas S, Evans G, Connolly SJ, Turpie AG. Postoperative low-molecu-lar-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol. 2009 Mar; 32(3):378-82.

Lassen MR, Dahl OE, Mismetti P, Destrée D, Turpie AG. AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thrombo-embolism in patients after total knee replacement sur-gery--TREK: a dose-ranging study. J Thromb Haemost. 2009 Apr; 7(4):566-72.

Turpie AG, Bauer KA, Davidson BL, Fisher WD, Gent M, Huo MH, Sinha U, Gretler DD; EXPERT Study Group. A randomized evaluation of betrixaban, an oral fac-tor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT). Thromb Haemost. 2009 Jan; 101(1):68-76.

VENDER, R.Publications

Papp K, Okun M, Vender R. Adalimumab in the treat-ment of psoriasis: pooled efficacy and safety results from three pivotal studies. J Cutan Med Surg. 2009 Sep-Oct;13 Suppl 2:S58-66.

Noiles K, Vender R. Biologic survival. J. Drugs Dermatol. 2009 Apr; 8(4):329-33.

Tan J, Thomas R, Wang B, Gratton D, Vender R, Kerrouche N, Villemagne H; CalePso Study Team. Short-contact clobetasol propionate shampoo 0.05% improves quality of life in patients with scalp psoriasis. Cutis. 2009 Mar; 83(3):157-64.

English PL, Vender R. Occurrence of plantar pustular psoriasis during treatment with infliximab. J Cutan Med Surg. 2009 Jan-Feb; 13(1):40-2.

Noiles K, Vender R. Nail psoriasis and biologics. J Cutan Med Surg. 2009 Jan-Feb; 13(1):1-5.

VERDU, E.F.Publications

Darsigny M, Babeu JP, Dupuis AA, Furth EE, Seidman

EG, Lévy E, Verdu EF, Gendron FP, Boudreau F. Loss of hepatocyte-nuclear-factor-4alpha affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice. PLoS One 2009; 4(10):e7609.

Natividad JM, Jury J, Slack E, Huang X, Sanz Y, Denou E, David CS, Yang P, Murray JA, McCoy KD, Verdú EF. Abnormal host responses to intestinal microbial antigens in gluten-sensitive mice. PloS One. 2009 Jul; 31;4(7):e6472.

Slack E, Hapfelmeier S, Stecher B, VelykoredkoY, Stoel M, Lawson MAE, Geuking MB, Beutler B, Tedder TF, Hardt WD, Bercik P, Verdu EF, McCoy KD, Macpherson AJ. Innate and adaptive immunity cooperate to maintain host-microbiota mutualism. Science. 2009; 31;325(5940):617-20.

Ghia JE, Blennerhassett P, Deng Y, Verdu EF, Khan WI, Collins SM. Re-activation of inflammatory bowel disease in a mouse model of depression. Gastroenterology. 2009; 136:2280-8.e4.

Pinier M, Verdú EF, Nasser-Eddine M, David CD, Vézina A, Rivard N, Leroux JC. Suppression of gliadin-induced toxicity by poly(hydroxyethylmethacrylate-co-sodium 4-styrene sulfonate): A potential supportive treatment for CD. Gastroenterology. 2009; 136:288-98.

Bercik P, Verdu EF, Foster JA, Lu J, Scharringa A, Kean I, Wang L, Blennerhassett P, Collins SM. Role of gut-brain axis in persistent abnormal feeding behavior in mice following eradication of Helicobacter pylori infection. Am J Physiol Regul Integr Comp Physiol. 2009; 296:R587-94.

Motomura Y, Wang H, Deng Y, El-Sharkawy RT, Verdu EF, Khan WI. Helminth antigen-based strategy to amelio-rate inflammation in an experimental model of colitis. Clin Exp Immunol. 2009;155:88-95.

Ashkar AA, Reid S, Verdu EF, Zhang K, Coombes BK. IL-15 and NK1.1+ cells provide innate protection against acute Salmonella enterica serovar Typhimurium infec-tion in the gut and in systemic tissues. Infect Immun. 2009; 77:214-22.

Collins S, Denou E, Verdu E, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syn-drome. Dig Liver Dis. 2009; 41:850-3.

Verdú EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: The ‘No Man’s Land’ of gluten sensitivity. Am J Gastroenterol. 2009 Jun; 104(6):1587-94.

WALKER, I.Publication

Teitel JM, Carcao M, Lillicrap D, Mulder K, Rivard GE, St-Louis J, Smith F, Walker I, Zourikian N. Orthopaedic surgery in haemophilia patients with inhibitors: a prac-tical guide to haemostatic, surgical and rehabilitative care. Haemophilia. 2009; 15(1):227-239.

WALLACE, J.Publications

Wallace JL, Vong L, McKnight W, Dicay M, Martin GR. Endogenous and exogenous hydrogen sulphide pro-motes resolution of colitis in rats. Gastroenterology. 2009; 137:569-78.

Wallace JL, Viappiani S, Bolla M. Cyclooxygenase-

inhibiting nitric oxide donators (CINODs) for osteoar-thritis. Trends Pharmacol Sci. 2009; 30:112-7.

McKay DM, Wallace JL. Acetic acid induced gastric ulceration in rats is not affected by infection with Hymenolepis diminuta. J Parasitol. 2009; 95:481-2.

WASERMAN, S.Publications

Arias K, Baig M, Colangelo M, Chu D, Waserman S, et al. Concurrent blockade of platelet-activating factor and histamine prevents life-threatening pea-nut-induced anaphylactic reactions. J Allergy Clin Immunol. 2009 Aug; 124(2):307-14,314.e1-2.

Arias K, Waserman S, Jordana M. Management of food-induced anaphylaxis: unsolved challenges. Curr Clin Pharmacol. 2009 May; 4(2):113-25.

Ellis AK, Waserman S. Hodgkin’s lymphoma present-ing with markedly elevated IgE: a case report. Allergy Asthma Clin Immunol. 2009 Dec; 5(1):12.

WAYE, J.Publications

Frischknecht H, Dutly F, Walker L, Nakamura-Garrett LM, Eng B, Waye JS. Three new beta-thalasse-mia mutations with varying degrees of severity. Hemoglobin. 2009; 33(3):220-5.

Waye JS, Eng B, Dutly F, Frischknecht H. alpha-Thalassemia caused by two novel splice mutations of the alpha2-globin gene: IVS-I-1 (G>A and G>T). Hemoglobin. 2009; 33(6):519-22.

Voruganti I, Eng B, Waye JS. Molecular characteriza-tion of a novel 55.1 kb (G)gamma((A)gammadeltabeta)(0)-thalassemia deletion in two Canadian families. Hemoglobin. 2009; 33:422-7.

Waye JS, Greenlay B, Eng B. Characterisation of the British alpha 0-thalassaemia deletion: evidence of a founder effect in Newfoundland, Canada. Br J Haematol. 2009 Oct; 147:150-2.

Diamandis M, Paterson AD, Rommens JM, Veljkovic DK, Blavignac J, Bulman DE, Waye JS, Derome F, Rivard GE, Hayward CPM. Quebec Platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes. Blood. 2009 Feb; 113(7):1543-6.

Waye JS, Greenlay B, Eng B. Novel 27.9 kb alpha(0)-thalassemia deletion in a Filipino woman. Am J Hematol. 2009 Mar; 84(3):197-8.

Eng B, Walker L, Waye JS. Alpha+-thalassemia trait caused by a nonsense mutation in the a2-globin gene: codon 54 (CAGÕTAG). Hemoglobin. 2009; 33(1):72-4.

Waye JS, Walker L, Nakamura LM, Eng B, McFarlane A. Hb North York [beta 117(g19)HisÕAsp]: a new ß chain hemoglobin variant. Hemoglobin. 2009; 33(1):51-3.

WEBERT, K.Publications

Heddle NM, Lui Y, Barty R, Webert KE, Whittaker S, Gagliardi KF, Lauzon D, Owens W. Factors affecting the frequency of red cell outdates: an approach to estab-

lishing benchmarking targets. Transfusion. 2009 Feb; 49:219-26.

Foley SR, Webert K, Arnold DM, Rock GA, Clark WF, Barth D, Sutton DM and Members of the Canadian Apheresis Group (CAG). A Canadian Phase II Study Evaluating the Efficacy of Rituximab in the Management of Patients with Relapsed /Refractory Thrombotic Thrombocytopenic Purpura (TTP). Kidney Int Suppl. 2009 Feb; (112):S55-8.

Ainsworth CD, Crowther MA, Treleaven D, Evanovitch D, Webert KE, Blajchman MA. Severe hemolytic ane-mia post-renal transplantation produced by donor anti-D passenger lymphocytes: case report and literature review. Transfus Med Rev. 2009 Apr; 23(2):155-9.

Hayward CP, Pai M, Liu Y, Moffat KA, Seecharan J, Webert KE, Cook RJ, Heddle NM. Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost. 2009 Apr; 7(4):676-84.

Arnold DM, Webert KE, Adhikari N, Cook D. Pilot tri-als in Transfusion Medicine. Transfusion. 2009 Jul; 49(7):1293-5.

WEITZ, J.Publications

Smyth SS, Woulfe DS, Weitz JI, Gachet C, Conley PB, Goodman SG, Roe MT, Kuliopulos A, Moliterno DJ, French PA, Steinhubl SR, Becker RC, for the 2008 Platelet Colloquium Participants. G-Protein-coupled receptors as signalling targets for antiplatelet therapy. Arterioscler Thromb Vasc Biol. 2009 Apr; 29(4):449-57.

Eriksson BI, Quinlan DJ, Weitz JI. Comparative phar-macodynamics and pharmacokinetics of new oral factor IIa and Xa inhibitors in development. Clin Pharmacokinet. 2009; 48(1):1-22.

Weitz JI. Unanswered questions in venous thrombo-embolism. Thromb Res. 2009; 123 Suppl 4:S2-S10.

Zhou J, May L, Liao P, Gross PL, Weitz JI. Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats. Arterioscler Thromb Vasc Biol. 2009 Jun; 29(6):863-9.

Weitz JI. Prevention and treatment of venous throm-boembolism during pregnancy. Catheterization and Cardiovascular Interventions 74(Suppl 1):S22-S26, 2009.

Gross PL, Weitz JI. New antithrombotic drugs. Clinical Pharmacology and Therapeutics 86(2):139-146, 2009.

Chan MY, Weitz JI, Merhi Y, Harrington RA, Becker RC. Catheter thrombosis and percutaneous coronary intervention: Fundamental perspectives on blood, artificial surfaces and antithrombotic drugs. Journal of Thrombosis and Thrombolysis 28(3):366-380, 2009.

Eikelboom JW, Weitz JI. Otamixaban in acute coronary syndromes. Lancet 374(9692):762-764, 2009.

Petrera NS, Stafford AR, Leslie BA, Kretz CA, Fredenburgh JC, Weitz JI. Long range communication between exosites 1 and 2 modulates thrombin func-tion. J Biol Chem. 2009 Sep;84(38):25620-9.

Bai X, Weitz JI, Gross PL. Leukocyte urokinase plas-minogen activator receptor and PSGL-1 play a role in endogenous arterial fibrinolysis. Thromb Haemost.

160

PUBLICATIONS

2009 Dec; 102(6):1212-8.

Book Chapters

Michelson AD, Frelinger AL, Weitz JI. Laboratory assessments of platelet function and coagulation. In: Clinical Guide to the Use of Antithrombotic Drugs in Coronary Artery Disease. Angiolillo, Kastrati and Simon (eds.), Informa UK Ltd., Chapter 3, pages 19-31, 2009.

Qushmaq N, Weitz JI. Overview of New Anticoagulant Drugs. In: New Therapeutic Agents in Thrombosis and Thrombolysis, 3rd Edition. Freedman/Loscalzo (eds.), Chapter 9, pages 133-54, 2009.

WELSFORD, M.Publications

Kollek D, Welsford M, Wanger K. Chemical, biological, radiological and nuclear preparedness training for emergency medical providers. CJEM. 2009 Jul; 11(4): 337-42.

Brooks SC, Allan KS, Welsford M, Verbeek PR, Arntz HR, Morrison LJ. Prehospital triage and direct transport of patients with ST-elevation myocardial infarction to primary percutaneous coronary intervention centers: A systematic review and meta-analyis. CJEM. 2009 Sep; 11:481-92.

Book Chapters

Welsford M, Pardhan A (2009). Penetrating Trauma. In: Krohmer JR , Sahni R, Schwartz B, Wang HE (Eds). Clinical Aspects of Prehospital Medicine. Volume 1. Dubuque, IA: Kendall/Hunt.

Welsford M (2009). Chapter 27: Cardiac. In: Emergency Care in the Streets – Canadian Edition. Ed. N Caroline. Toronto, ON; Jones& Bartlett.

Welsford M. Diaphragmatic Injuries. eMedicine: Emergency Medicine [online book] 1998-2009 Available at: http://www.emedicine.com/emerg/topic136.htm

WERSTUCK, G.Publications

Khan MI, Pichna B, Shi YY, Bowes AJ, Werstuck GH. Endoplasmic Reticulum Stress plays a Causal Role in the Development of Atherosclerosis in a Hyperglycemic Mouse Model. Antioxid Redox Signal. 2009; 11:2289-98.

Bowes AJ, Khan MI, Shi YY, Robertson L, Werstuck GH. A role for glycogen synthase kinase–3 in endoplasmic reticulum stress-associated lipid accumulation and accelerated atherogenesis in hyperglycemic ApoE-defi-cient mice. Am J Pathol. 2009; 174:330-42.

Zeadin M, Butcher M, Werstuck GH, Khan M, Yee CK, Shaughnessy S. The Effect of Leptin on Vascular Calcification in Apolipoprotein E-Deficient Mice. Arterioloscler Thromb Vasc Biol. 2009; 29:2069-75.

Lee RMKW, Chao L, Su L-Y, Werstuck GH, Gao Y-J. Effects of hyperglycemia on the modulation of vascular function by perivascular adipose tissue. J Hypertens. 2009 Jan; 27:118-31.

WONG, R.Book Chapters

Sagar SM, Sze DMY, Wong RK. Chinese Herbal Therapies as Immune Modulators for Anti-Cancer Therapeutics. In: Compendium of Bioactive Natural Products, M/S (eds.), Studium Press LLC, USA. 2009.

Sagar SM, Wong RK, Jr. Yance Dr. Development of Anit-Angiogenesis Therpies for Treating Cancer from Chinese Medicinal Herbs. In: Compendium of Bioactive Natural Products, M/S (eds.), Studium Press LLC, USA. 2009.

WORSTER, A.Publications

Worster A. Review: 3 prediction rules, particularly ABCD, identify ED patients who can be discharged with low risk of stroke after TIA. Evid Based Med. 2009 Dec; 14(6):187.

Worster A. ACP Journal Club. Review: 3 prediction rules, particularly ABCD, identify ED patients who can be discharged with low risk for stroke after TIA. Ann Intern Med. 2009 Sep; 151(6):JC3-15.

MacMillan HL, Wathen CN, Jamieson E, Boyle MH, Shannon HS, Ford-Gilboe M, Worster A, Lent B, Coben JH, Campbell JC, McNutt LA. McMaster Violence Against Women Research Group. Screening for inti-mate partner violence in health care settings: a ran-domized trial. JAMA. 2009 Aug;302(5):493-501.

Wathen CN, Tanaka M, Catallo C, Lebner AC, Friedman MK, Hanson MD, Freeman C, Jack SM, Jamieson E, Macmillan HL, Worster A. McMaster IPV Education Research Team. Are clinicians being prepared to care for abused women? A survey of health professional education in Ontario, Canada. BMC Med Educ. 2009 Jun;9:34.

Worster A, Keim SM, Carpenter CR, Adeoye O. Best Evidence in Emergency Medicine (BEEM) Group. Does early intensive lowering of blood pressure reduce hematoma volume and improve clinical outcome after acute cerebral hemorrhage? J Emerg Med. 2009 Nov; 37(4):433-8.

Sherbino J, Upadhye S, Worster A. Self-reported priori-ties and resources of academic emergency physicians for the maintenance of clinical competence: a pilot study. CJEM. 2009 May; 11(3):230-4.

Rowe BH, Villa-Roel C, Guttman A, Ross S, Mackey D, Sivilotti ML, Worster A, Stiell IG, Willis V, Borgundvaag B. Predictors of hospital admission for chronic obstruc-tive pulmonary disease exacerbations in Canadian emergency departments. Acad Emerg Med. 2009 Apr; 16(4):316-24.

Milne WK, Worster A. Evidence-based Emergency Medicine/Rational Clinical Examination Abstract. Does the clinical examination predict lower extremity peripheral arterial disease? Ann Emerg Med. 2009 Nov; 54(5):748-50.

Book Chapters

Worster A, McKibbon A. Quality Improvement. In: Evidence-Based Emergency Medicine. (eds.), Rowe BH, Lang E, Brown M, Houry D, Newman D, Wyer P. Pgs 43-8. Blackwell-BMJ Books, London, UK, ,2009.

Worster A. Acute Ureteric Colic. In: Evidence-Based Emergency Medicine. (eds.) Rowe BH, Lang E, Brown

M, Houry D, Newman D, Wyer P. Pgs 404-11. Blackwell-BMJ Books, London, UK, 2009.

YANG, R.Publication

Yang RC, Young A, Nevis IFP, Lee D, Jain AK, Dominic A, Pullenayegum E, Klarenbach S, Garg AX. Life insur-ance for living kidney donors: a Canadian undercover investigation. Am J Transplant 2009 Jul; 9(7):1585-90.

YOU, J.Publications

Briel M, Ferreira-Gonzalez I, You JJ, Karanicolas PJ, Akl EA, Wu P, Blechacz B, Bassler D, Wei X, Sharman A, Whitt I, da Silva SA, Khalid Z, Nordmann A, Zhou Q, Walter S, Vale N, Bhatnagar N, O’Regan C, Mills E, Bucher HC, Montori V, Guyatt GH. Association between change in high density lipoprotein cholesterol and car-diovascular disease morbidity and mortality: a system-atic review and meta-regression analysis. BMJ. 2009 Feb; 338:b92.

You JJ, Venkatesh V, Laupacis A. Better access to out-patient magnetic resonance imaging in Ontario: but for whom? Open Med. 2009 Mar 3; 3(1):e22-5.

Akl EA, Briel M, You JJ, Lamontagne F, Gangji A, Cukierman-Yaffe T, Alshurafa M, Sun X, Nerenberg K, Johnston BC, Vera C, Mills E, Bassler D, Salazar A, Bhatnagar N, Busse JW, Khalid Z, Walter SD, Cook DJ, Schünemann HJ, Altman DG, Guyatt GH. LOST to fol-low-up Information in Trials (LOST-IT): a protocol on the potential impact. Trials. 2009 Jun;10:40.

Briel M, Lane M, Montori VM, Bassler D, Glasziou P, Malaga G, Akl EA, Ferreira-Gonzalez I, Alonso-Coello P, Urrutia G, Kunz R, Culebro CR, da Silva SA, Flynn DN, Elamin MB, Strahm B, Murad M, Djulbegovic B, Adhikari NKJ, Mills EJ, Gwadry-Sridhar F, Kirpalani H, Soares HP, Elnour NOA, You JJ, Karanicolas PJ, Bucher HC, Lampropulos JF, Nordmann AJ, Burns KEA, Mulla SM, Raatz H, Sood A, Kaur J, Bankhead CR, Mullan RJ, Nerenberg KA, Vandvik PO, Coto-Yglesias F, Schünemann H, Tuche F, Cook DJ, Lutz K, Ribic CM, Erwin PJ, Perera R, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH. Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2). Trials. 2009 Jul;10:49.

You JJ, Levinson W, Laupacis A. Attitudes of family physicians, specialists, and radiologists about the use of computed tomography and magnetic resonance imaging in Ontario. Healthcare Policy. 2009; 15:54-65.

Sun X, Briel M, Busse JW, Akl EA, You JJ, Mejza F, Bala M, Diaz-Granados N, Bassler D, Mertz D, Srinathan SK, Vandvik PO, Malaga G, Alshurafa M, Dahm P, Alonso-Coello P, Heels-Ansdell D, Bhatnagar N, Johnston B, Wang L, Walter SD, Altman DG, Guyatt GH. Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials. Trials. 2009 Nov; 10:101.

Book Chapter

Haynes RB, You JJ. The architecture of diagnostic research. In: Knottnerus JA, Buntinx F,(eds.), The Evidence Base of Clinical Diagnosis. Theory and meth-ods of diagnostic research. Second edition. Pgs 20-41. Oxford, Wiley-Blackwell, 2009.

YUSUF, S.Publications

Allen LA, Felker GM, Pocock S, McMurray JJV, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB for the CHARM investigators. Liver func-tion abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Failure. 2009; 11:170-7.

Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiogra-phy or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J. 2009 Jan; 157(1):132-40.

Xavier D, Pais P, Sigamani A, Pogue J, Afzal R, Yusuf S. The need to test the theories behind the Polypill: ratio-nale behind the Indian Polycap Study. Nat Clin Pract Cardiovasc Med. 2009 Feb; 6(2):96-7.

Karthikeyan G, Teo KK, Islam S, McQueen MJ, Pais P, Wang X, Sato H, Lang CC, Sitthi-Amorn C, Pandey MR, Kazmi K, Sanderson JE, Yusuf S. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarc-tion among Asians: an analysis from the INTERHEART Study. J Am Coll Cardiol. 2009 Jan 20; 53(3):244-53.

Cukierman-Yaffe T, Gerstein HC, Anderson C, Zhao F, Sleight P, Hilbrich L, Jackson SH, Yusuf S, Teo K; On behalf of the ONTARGET/TRANSCEND Investigators. Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascu-lar risk: Results from the ONTARGET/TRANSCEND Research Programme. Diabetes Res Clin Pract. 2009 Mar; 83(3):387-93.

Preiss D, Zetterstrand S, McMurray JJV, Ostergren J, Michelson EL, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Gerstein HC, Sattar N for the CHARM Investigators. Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Diabetes Care. 2009 May; 32(5):915-20.

Swahn E, Alfredsson J, Afzal R, Budaj A, Chrolavicius S, Fox K, Jolly S, Mehta SR, de Winter R, Yusuf S. Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syn-dromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trials. Eur Heart J. 2009 Feb 7.

Joyner CD, Peterse RJG, Afzal R, Cholaviciuis S, Mehta SR, Fox KAA, Granger CB, Franzosi MG, Flather M, Budaj A, Bassand JP, Yusuf S. Fondaparinux com-pared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk. Am Heart J. 2009 Mar; 157(3):502-8.

Chow CK, Lock K, Teo K, Subramanian SV, McKee M, Yusuf S. Environmental and societal influences acting on cardiovascular risk factors and disease at a popula-tion level: a review. Int J Epidemiol. 2009; 38(6):1580-94.

Liu X, Wang X, Shen Y, Wu L, Ruan X, Lindpaintner K, Yusuf S, Engert JC, Anand S, Tan X, Liu L. The func-tional variant rs1048990 in PSMA6 is associated with susceptibility to myocardial infarction in a Chinese population. Atherosclerosis. 2009; 206(1):199-203.

Lanktree M, Anand SS, Yusuf S, Hegele RA. Replication

162

PUBLICATIONS

of genetic associations with plasma lipoproteins and triglycerides in a multi-ethnic sample using a targeted cardiovascular SNP microarray. J Lipid Research. 2009; 50(7):1487-96.

White M, Rouleau JL, Afzal R, Floras J, Yusuf S, McKelvie RS. Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and func-tion in patients with heart failure not treated with a beta-blocker. Ther Adv Cardiovasc Dis. 2009; 3:113-21.

The Indian Polycap Study (TIPS). Yusuf S, Pais P, Afzal R, Xavier D, Teo K, Eikelboom J, Sigamani A, Mohan V, Gupta R, Thomas N. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomized trial. Lancet. 2009; 373:1341-51.

ACTIVE Investigators. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009; 360(20): 2066-78.

Goyal A, Mehta SR, Gerstein HC, Diaz R, Afzal R, Xavier D, Zhu J, Pais P, Lisheng L, Kazmi KA, Zubaid M, Piegas LS, Widimsky P, Budaj A, Avezum A, Yusuf S. Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction. Am Heart J. 2009; 157:763-70.

Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL. The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmis-artan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics. Clin Res Cardiol. 2009 Jul; 98(7):421-33.

Vaz M, Bharathi AV, Thomas T, Yusuf S, Kurpad AV. The repeatability of self reported physical activity pat-terns in rural South India. Asia Pac J Clin Nutr. 2009; 18(1):71-5.

Motlagh B, O’Donnell M, Yusuf S. Prevalence of car-diovascular risk factors in the Middle East: a system-atic review. Eur J Cardiovasc Prev Rehabil. 2009 Jun; 16(3):268-80.

Ezekowitz MD, Connolly S, Parekh A, Reilly PA, Varrone J, Wang S, Oldgren J, Themeles E, Wallentin L, Yusuf S. Rationale and design of RE-LY: randomized evalu-ation of long-term anticoagulant therapy, warfarin, compared with dabigatran. Am Heart J. 2009 May; 157(5):805-10, 810.e1-2.

Mann JF, Schmieder RE, Dyal L, McQueen MJ, Schumacher H, Pogue J, Wang X, Probstfield JL, Avezum A, Cardona-Munoz E, Dagenais GR, Diaz R, Fodor G, Maillon JM, Rydén L, Yu CM, Teo KK, Yusuf S; for the TRANSCEND (Telmisartan Randomised Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease) Investigators. Effect of Telmisartan on Renal Outcomes: A Randomized Trial. Ann Intern Med. 2009; 151(1):1-10.

Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J, Natarajan MK, Horsman C, Fox KA, Yusuf S; TIMACS Investigators. Early versus delayed invasive interven-tion in acute coronary syndromes. N Engl J Med. 2009; 360(21):2165-75.

Lonn EM, Gerstein HC, Sheridan P, Smith S, Diaz R, Mohan V, Bosch J, Yusuf S, Dagenais GR; DREAM (Diabetes REduction Assessment with ramipril and

rosiglitazone Medication) and STARR Investigators. Effect of ramipril and of rosiglitazone on carotid inti-ma-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone). J Am Coll Cardiol. 2009; 53(22):2028-35.

Teo KK, Liu L, Chow CK, Wang X, Islam S, Jiang L, Sanderson JE, Rangarajan S, Yusuf S. Potentially modi-fiable risk factors associated with myocardial infarction in China: The INTERHEART China Study. Heart. 2009; 95(22):1857-64.

Sleight P, Redon J, Verdecchia P, Mancia G, Gao P, Fagard R, Schumacher H, Weber M, Böhm M, Williams B, Pogue J, Koon T, Yusuf S; on behalf of the ONTARGET investigators. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens. 2009; 27(7):1360-9.

Pogue J, Walter SD, Yusuf S. Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs. Clin Trials.2009 Jun; 6(3):239-51.

Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S; PURE Investigators-Writing Group. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommuni-cable diseases in low, middle- and high-income coun-tries. Am Heart J. 2009; 158(1):1-7.

Jolly SS, Faxon DP, Fox KA, Afzal R, Boden WE, Widimsky P, Steg PG, Valentin V, Budaj A, Granger CB, Joyner CD, Chrolavicius S, Yusuf S, Mehta SR. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial. J Am Coll Cardiol. 2009; 54(5):468-76.

Lanktree MB, Hegele RA, Yusuf S, Anand SS. Multi-Ethnic Genetic Association Study of Carotid Intima-Media Thickness Using a Targeted Cardiovascular SNP Microarray. Stroke. 2009 Oct; 40(10):3173-9.

Hegele RA, Ban MR, Hsueh N, Kennedy BA, Cao H, Zou GY, Anand S, Yusuf S, Huff MW, Wang J. A polygenic basis for four classical Fredrickson hyperlipoprotein-emia phenotypes that are characterized by hypertri-glyceridemia. Hum Mol Genet. 2009; 18(21):4189-94.

Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ; CHARM Investigators and Committees. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet. 2009 Aug; 374(9689):543-50.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis B, Darius H, Diener HC, Joyner CD, Wallentin L, for the RELY Steering Committee and RELY investiga-tors. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 36(12):1139-51.

Verdecchia P, Sleight P, Mancia G, Fagard R, Trimarco B, Schmieder RE, Kim JH, Jennings G, Jansky P, Chen JH, Liu L, Gao P, Probstfield J, Teo K, Yusuf S; ONTARGET/TRANSCEND Investigators.Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant

Subjects With Cardiovascular Disease. Circulation. 2009 Oct 6; 120(14):1380-9.

Morrison KM, Atkinson SA, Yusuf S, Bourgeois J, McDonald S, McQueen MJ, Persadie R, Hunter B, Pogue J, Teo K; FAMILY investigators. The Family Atherosclerosis Monitoring In earLY life (FAMILY) study: rationale, design, and baseline data of a study examining the early determinants of atherosclerosis. Am Heart J. 2009; 158(4):533-9.

Bath PM, Martin RH, Palesch Y, Cotton D, Yusuf S, Sacco R, Diener HC, Toni D, Estol C, Roberts R; PRoFESS Study Group. Effect of Telmisartan on func-tional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke. 2009; 40(11):3541-6.

Rosengren A, Subramanian SV, Islam S, Chow CK, Avezum A Jr, Kazmi K, Sliwa K, Zubaid M, Rangarajan S, Yusuf S. Education and risk for acute myocardial infarction in 52 high, middle and low income countries. INTERHEART case-control study. Heart, 2009; Oct 12.

Karthikeyan G, Moncur RA, Levine O, Heels-Ansdell D, Chan MT, Alonso-Coello P, Yusuf S, Sessier D, Villar JC, Berwanger O, McQueen M, Mathew A, Hill S, Gibson S, Berry C, Yeh HM, Devereaux PJ. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natri-uretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol. 2009; 54(17):1599-606.

Heid IM, Huth C, Loos RJ, Kronenberg F, Adamkova V, Anand SS, Ardlie K, Biebermann H, Bjerregaard P, Boeing H, Bouchard C, Ciullo M, Cooper JA, Corella D, Dina C, Engert JC, Fisher E, Francès F, Froguel P, Hebebrand J, Hegele RA, Hinney A, Hoehe MR, Hu FB, Hubacek JA, Humphries SE, Hunt SC, Illig T, Järvelin MR, Kaakinen M, Kollerits B, Krude H, Kumar J, Lange LA, Langer B, Li S, Luchner A, Lyon HN, Meyre D, Mohlke KL, Mooser V, Nebel A, Nguyen TT,

Paulweber B, Perusse L, Qi L, Rankinen T, Rosskopf D, Schreiber S, Sengupta S, Sorice R, Suk A, Thorleifsson G, Thorsteinsdottir U, Völzke H, Vimaleswaran KS, Wareham NJ, Waterworth D, Yusuf S, Lindgren C, McCarthy MI, Lange C, Hirschhorn JN, Laird N, Wichmann HE. Meta-analysis of the INSGI2 association with obesity including 74,345 individuals: does het-erogeneity of estimates relate to study design? PLoS Genet. 2009 Oct; 5(10):e1000694.

Granger BB, Ekman I, Granger CB, Ostergren J, Olofsson B, Michelson E, McMurray JJ, Yusuf S, Pfeffer MA, Swedberg K. Adherence to medication according to sex and age in the CHARM programme. Eur J Heart Fail. 2009; 11(11):1092-8.

Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL; ONTARGET Investigators. Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]). Am J Cardiol. 2009 Dec; 104(11):1484-9.

Goyal A, Mehta SR, Diaz R, Gerstein HC, Afzal R, Xavier D, Liu L, Pais P, Yusuf S. Differential clinical outcomes associated with hypoglycemia and hypergly-cemia in acute myocardial infarction. Circulation. 2009; 120(24): 2429-37.

Anand SS, Xie C, Paré G, Montpetit A, Rangarajan S, McQueen MJ, Cordell HJ, Keavney B, Yusuf S, Hudson TJ, Engert JC; INTERHEART Investigators. Genetic vari-ants associated with myocardial infarction risk factors in over 8000 individuals from five ethnic groups: The INTERHEART Genetics Study. Circ Cardiovasc Genet. 2009; 2(1):1602.

Rahim SA, Mody A, Pickering J, Devereaux PJ, Yusuf S. Iatrogenic adverse events in the coronary care unit. Circ Cardiovasc Qual Outcomes. 2009; 2(5):437-42.